disease,drug,phase,status,target,num_ev_strings
non-small cell lung carcinoma,ERLOTINIB,2,Completed,EGFR,75
non-small cell lung carcinoma,GEMCITABINE,2,Completed,RRM1,73
non-small cell lung carcinoma,GEMCITABINE,2,Completed,POLE3,73
non-small cell lung carcinoma,GEMCITABINE,2,Completed,POLE2,73
non-small cell lung carcinoma,GEMCITABINE,2,Completed,POLE,73
non-small cell lung carcinoma,GEMCITABINE,2,Completed,POLD4,73
non-small cell lung carcinoma,GEMCITABINE,2,Completed,POLD3,73
non-small cell lung carcinoma,GEMCITABINE,2,Completed,PRIM2,73
non-small cell lung carcinoma,GEMCITABINE,2,Completed,POLD1,73
non-small cell lung carcinoma,GEMCITABINE,2,Completed,POLA2,73
non-small cell lung carcinoma,GEMCITABINE,2,Completed,POLA1,73
non-small cell lung carcinoma,GEMCITABINE,2,Completed,POLD2,73
non-small cell lung carcinoma,GEMCITABINE,2,Completed,PRIM1,73
non-small cell lung carcinoma,PACLITAXEL,2,Completed,TUBB6,70
non-small cell lung carcinoma,PACLITAXEL,2,Completed,TUBB,70
non-small cell lung carcinoma,PACLITAXEL,2,Completed,TUBB1,70
non-small cell lung carcinoma,PACLITAXEL,2,Completed,TUBB2A,70
non-small cell lung carcinoma,PACLITAXEL,2,Completed,TUBB8,70
non-small cell lung carcinoma,PACLITAXEL,2,Completed,TUBB2B,70
non-small cell lung carcinoma,PACLITAXEL,2,Completed,TUBB3,70
non-small cell lung carcinoma,PACLITAXEL,2,Completed,TUBB4A,70
non-small cell lung carcinoma,PACLITAXEL,2,Completed,TUBB4B,70
non-small cell lung carcinoma,DOCETAXEL,2,Completed,TUBB,69
non-small cell lung carcinoma,DOCETAXEL,2,Completed,TUBB1,69
non-small cell lung carcinoma,DOCETAXEL,2,Completed,TUBB2B,69
non-small cell lung carcinoma,DOCETAXEL,2,Completed,TUBB4A,69
non-small cell lung carcinoma,DOCETAXEL,2,Completed,TUBB4B,69
non-small cell lung carcinoma,DOCETAXEL,2,Completed,TUBB6,69
non-small cell lung carcinoma,DOCETAXEL,2,Completed,TUBB8,69
non-small cell lung carcinoma,DOCETAXEL,2,Completed,TUBB3,69
non-small cell lung carcinoma,DOCETAXEL,2,Completed,TUBB2A,69
non-small cell lung carcinoma,PEMETREXED,2,Completed,GART,66
non-small cell lung carcinoma,PEMETREXED,2,Completed,DHFR,66
non-small cell lung carcinoma,PEMETREXED,2,Completed,TYMS,66
non-small cell lung carcinoma,BEVACIZUMAB,2,Completed,VEGFA,44
non-small cell lung carcinoma,OSIMERTINIB,2,Recruiting,EGFR,38
non-small cell lung carcinoma,DOCETAXEL,3,Completed,TUBB4B,36
non-small cell lung carcinoma,DOCETAXEL,3,Completed,TUBB4A,36
non-small cell lung carcinoma,DOCETAXEL,3,Completed,TUBB3,36
non-small cell lung carcinoma,DOCETAXEL,3,Completed,TUBB2B,36
non-small cell lung carcinoma,DOCETAXEL,3,Completed,TUBB2A,36
non-small cell lung carcinoma,DOCETAXEL,3,Completed,TUBB1,36
non-small cell lung carcinoma,DOCETAXEL,3,Completed,TUBB,36
non-small cell lung carcinoma,DOCETAXEL,3,Completed,TUBB8,36
non-small cell lung carcinoma,DOCETAXEL,3,Completed,TUBB6,36
non-small cell lung carcinoma,ERLOTINIB,1,Completed,EGFR,31
non-small cell lung carcinoma,PACLITAXEL,1,Completed,TUBB3,29
non-small cell lung carcinoma,PACLITAXEL,1,Completed,TUBB,29
non-small cell lung carcinoma,PACLITAXEL,1,Completed,TUBB1,29
non-small cell lung carcinoma,PACLITAXEL,1,Completed,TUBB2A,29
non-small cell lung carcinoma,PACLITAXEL,1,Completed,TUBB2B,29
non-small cell lung carcinoma,PACLITAXEL,1,Completed,TUBB4A,29
non-small cell lung carcinoma,PACLITAXEL,1,Completed,TUBB4B,29
non-small cell lung carcinoma,PACLITAXEL,1,Completed,TUBB6,29
non-small cell lung carcinoma,PACLITAXEL,1,Completed,TUBB8,29
non-small cell lung carcinoma,ERLOTINIB,3,Completed,EGFR,28
non-small cell lung carcinoma,OSIMERTINIB,1,Recruiting,EGFR,28
non-small cell lung carcinoma,PEMBROLIZUMAB,2,Recruiting,PDCD1,28
non-small cell lung carcinoma,DOCETAXEL,2,Terminated,TUBB6,26
non-small cell lung carcinoma,DOCETAXEL,2,Terminated,TUBB2A,26
non-small cell lung carcinoma,DOCETAXEL,2,Terminated,TUBB2B,26
non-small cell lung carcinoma,DOCETAXEL,2,Terminated,TUBB4B,26
non-small cell lung carcinoma,DOCETAXEL,2,Terminated,TUBB4A,26
non-small cell lung carcinoma,DOCETAXEL,2,Terminated,TUBB3,26
non-small cell lung carcinoma,DOCETAXEL,2,Terminated,TUBB,26
non-small cell lung carcinoma,DOCETAXEL,2,Terminated,TUBB1,26
non-small cell lung carcinoma,DOCETAXEL,2,Terminated,TUBB8,26
non-small cell lung carcinoma,PEMETREXED,1,Completed,DHFR,25
non-small cell lung carcinoma,PEMETREXED,1,Completed,GART,25
non-small cell lung carcinoma,PEMETREXED,3,"Active, not recruiting",TYMS,25
non-small cell lung carcinoma,PEMETREXED,3,"Active, not recruiting",GART,25
non-small cell lung carcinoma,PEMETREXED,3,"Active, not recruiting",DHFR,25
non-small cell lung carcinoma,PEMETREXED,1,Completed,TYMS,25
non-small cell lung carcinoma,ERLOTINIB,2,Unknown status,EGFR,24
non-small cell lung carcinoma,PEMETREXED,2,Unknown status,TYMS,24
non-small cell lung carcinoma,PEMETREXED,2,Unknown status,GART,24
non-small cell lung carcinoma,PEMETREXED,2,Unknown status,DHFR,24
non-small cell lung carcinoma,PEMETREXED,2,Terminated,TYMS,24
non-small cell lung carcinoma,PEMETREXED,2,Terminated,GART,24
non-small cell lung carcinoma,PEMETREXED,2,Terminated,DHFR,24
non-small cell lung carcinoma,GEMCITABINE,3,Completed,POLD4,23
non-small cell lung carcinoma,GEMCITABINE,3,Completed,PRIM1,23
non-small cell lung carcinoma,GEMCITABINE,3,Completed,POLE3,23
non-small cell lung carcinoma,GEMCITABINE,3,Completed,POLA2,23
non-small cell lung carcinoma,GEMCITABINE,3,Completed,POLD1,23
non-small cell lung carcinoma,GEMCITABINE,3,Completed,POLD2,23
non-small cell lung carcinoma,GEMCITABINE,3,Completed,POLE2,23
non-small cell lung carcinoma,NIVOLUMAB,2,Recruiting,PDCD1,23
non-small cell lung carcinoma,GEMCITABINE,3,Completed,POLE,23
non-small cell lung carcinoma,GEMCITABINE,3,Completed,PRIM2,23
non-small cell lung carcinoma,GEMCITABINE,3,Completed,RRM1,23
non-small cell lung carcinoma,PEMETREXED,3,Completed,DHFR,23
non-small cell lung carcinoma,GEMCITABINE,3,Completed,POLD3,23
non-small cell lung carcinoma,GEMCITABINE,3,Completed,POLA1,23
non-small cell lung carcinoma,PEMETREXED,3,Completed,TYMS,23
non-small cell lung carcinoma,PEMETREXED,3,Completed,GART,23
non-small cell lung carcinoma,GEFITINIB,2,Completed,EGFR,22
non-small cell lung carcinoma,PACLITAXEL,3,Completed,TUBB3,21
non-small cell lung carcinoma,PACLITAXEL,3,Completed,TUBB6,21
non-small cell lung carcinoma,PACLITAXEL,3,Completed,TUBB2A,21
non-small cell lung carcinoma,PACLITAXEL,3,Completed,TUBB1,21
non-small cell lung carcinoma,PACLITAXEL,3,Completed,TUBB,21
non-small cell lung carcinoma,PACLITAXEL,3,Completed,TUBB2B,21
non-small cell lung carcinoma,CETUXIMAB,2,Completed,EGFR,21
non-small cell lung carcinoma,PACLITAXEL,3,Completed,TUBB4A,21
non-small cell lung carcinoma,PACLITAXEL,3,Completed,TUBB8,21
non-small cell lung carcinoma,PACLITAXEL,3,Completed,TUBB4B,21
non-small cell lung carcinoma,PEMETREXED,2,Recruiting,TYMS,19
non-small cell lung carcinoma,VINORELBINE,2,Completed,TUBB,19
non-small cell lung carcinoma,VINORELBINE,2,Completed,TUBB1,19
non-small cell lung carcinoma,VINORELBINE,2,Completed,TUBB2A,19
non-small cell lung carcinoma,VINORELBINE,2,Completed,TUBB4A,19
non-small cell lung carcinoma,VINORELBINE,2,Completed,TUBB2B,19
non-small cell lung carcinoma,VINORELBINE,2,Completed,TUBB3,19
non-small cell lung carcinoma,VINORELBINE,2,Completed,TUBB4B,19
non-small cell lung carcinoma,VINORELBINE,2,Completed,TUBB6,19
non-small cell lung carcinoma,PEMETREXED,2,Recruiting,DHFR,19
non-small cell lung carcinoma,VINORELBINE,2,Completed,TUBB8,19
non-small cell lung carcinoma,PEMETREXED,2,Recruiting,GART,19
non-small cell lung carcinoma,PEMETREXED,3,Recruiting,DHFR,19
non-small cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB1,19
non-small cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB4B,19
non-small cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB3,19
non-small cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB2B,19
non-small cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB2A,19
non-small cell lung carcinoma,OSIMERTINIB,2,Recruiting,ERBB2,19
non-small cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB,19
non-small cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB6,19
non-small cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB8,19
non-small cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB8,19
non-small cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB6,19
non-small cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB4B,19
non-small cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB4A,19
non-small cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB3,19
non-small cell lung carcinoma,PEMETREXED,3,Recruiting,GART,19
non-small cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB2B,19
non-small cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB2A,19
non-small cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB1,19
non-small cell lung carcinoma,PEMETREXED,3,Recruiting,TYMS,19
non-small cell lung carcinoma,OSIMERTINIB,2,Recruiting,ERBB4,19
non-small cell lung carcinoma,OSIMERTINIB,2,Recruiting,ERBB3,19
non-small cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB,19
non-small cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB4A,19
non-small cell lung carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB,18
non-small cell lung carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB1,18
non-small cell lung carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB2A,18
non-small cell lung carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB2B,18
non-small cell lung carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB3,18
non-small cell lung carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB4A,18
non-small cell lung carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB4B,18
non-small cell lung carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB6,18
non-small cell lung carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB8,18
non-small cell lung carcinoma,BEVACIZUMAB,2,Terminated,VEGFA,18
non-small cell lung carcinoma,ERLOTINIB,2,Terminated,EGFR,18
non-small cell lung carcinoma,OSIMERTINIB,1,"Active, not recruiting",EGFR,18
non-small cell lung carcinoma,PEMBROLIZUMAB,1,Recruiting,PDCD1,17
non-small cell lung carcinoma,ERLOTINIB,1,Terminated,EGFR,16
non-small cell lung carcinoma,GEMCITABINE,2,Terminated,POLA2,15
non-small cell lung carcinoma,GEMCITABINE,2,Terminated,POLA1,15
non-small cell lung carcinoma,GEFITINIB,2,Unknown status,EGFR,15
non-small cell lung carcinoma,PACLITAXEL,3,Recruiting,TUBB3,15
non-small cell lung carcinoma,PACLITAXEL,3,Recruiting,TUBB8,15
non-small cell lung carcinoma,PACLITAXEL,3,Recruiting,TUBB1,15
non-small cell lung carcinoma,PACLITAXEL,1,Terminated,TUBB6,15
non-small cell lung carcinoma,DOCETAXEL,2,Recruiting,TUBB8,15
non-small cell lung carcinoma,DOCETAXEL,2,Recruiting,TUBB6,15
non-small cell lung carcinoma,DOCETAXEL,2,Recruiting,TUBB4B,15
non-small cell lung carcinoma,DOCETAXEL,2,Recruiting,TUBB4A,15
non-small cell lung carcinoma,DOCETAXEL,2,Recruiting,TUBB3,15
non-small cell lung carcinoma,DOCETAXEL,2,Recruiting,TUBB2B,15
non-small cell lung carcinoma,DOCETAXEL,2,Recruiting,TUBB2A,15
non-small cell lung carcinoma,DOCETAXEL,2,Recruiting,TUBB1,15
non-small cell lung carcinoma,DOCETAXEL,2,Recruiting,TUBB,15
non-small cell lung carcinoma,PACLITAXEL,3,Recruiting,TUBB,15
non-small cell lung carcinoma,PACLITAXEL,1,Terminated,TUBB4B,15
non-small cell lung carcinoma,PACLITAXEL,3,Recruiting,TUBB6,15
non-small cell lung carcinoma,PACLITAXEL,1,Terminated,TUBB4A,15
non-small cell lung carcinoma,PACLITAXEL,1,Terminated,TUBB3,15
non-small cell lung carcinoma,PACLITAXEL,1,Terminated,TUBB2B,15
non-small cell lung carcinoma,PACLITAXEL,1,Terminated,TUBB2A,15
non-small cell lung carcinoma,PACLITAXEL,1,Terminated,TUBB1,15
non-small cell lung carcinoma,PACLITAXEL,1,Terminated,TUBB,15
non-small cell lung carcinoma,PACLITAXEL,3,Recruiting,TUBB2A,15
non-small cell lung carcinoma,PACLITAXEL,3,Recruiting,TUBB2B,15
non-small cell lung carcinoma,GEMCITABINE,2,Terminated,POLD2,15
non-small cell lung carcinoma,PACLITAXEL,3,Recruiting,TUBB4A,15
non-small cell lung carcinoma,PACLITAXEL,3,Recruiting,TUBB4B,15
non-small cell lung carcinoma,GEMCITABINE,2,Terminated,POLD1,15
non-small cell lung carcinoma,PACLITAXEL,1,Terminated,TUBB8,15
non-small cell lung carcinoma,GEMCITABINE,2,Terminated,POLD3,15
non-small cell lung carcinoma,GEMCITABINE,2,Terminated,POLE3,15
non-small cell lung carcinoma,GEMCITABINE,2,Terminated,PRIM2,15
non-small cell lung carcinoma,GEMCITABINE,2,Terminated,RRM1,15
non-small cell lung carcinoma,GEMCITABINE,2,Terminated,PRIM1,15
non-small cell lung carcinoma,GEMCITABINE,2,Terminated,POLE,15
non-small cell lung carcinoma,GEMCITABINE,2,Terminated,POLE2,15
non-small cell lung carcinoma,GEMCITABINE,2,Terminated,POLD4,15
non-small cell lung carcinoma,OSIMERTINIB,1,Recruiting,ERBB4,14
non-small cell lung carcinoma,GEMCITABINE,3,"Active, not recruiting",POLD3,14
non-small cell lung carcinoma,BEVACIZUMAB,3,Completed,VEGFA,14
non-small cell lung carcinoma,GEMCITABINE,3,"Active, not recruiting",POLA1,14
non-small cell lung carcinoma,GEMCITABINE,3,"Active, not recruiting",POLA2,14
non-small cell lung carcinoma,GEMCITABINE,3,"Active, not recruiting",POLD1,14
non-small cell lung carcinoma,GEMCITABINE,3,"Active, not recruiting",POLD2,14
non-small cell lung carcinoma,GEMCITABINE,3,"Active, not recruiting",POLD4,14
non-small cell lung carcinoma,OSIMERTINIB,1,Recruiting,ERBB3,14
non-small cell lung carcinoma,GEMCITABINE,3,"Active, not recruiting",POLE2,14
non-small cell lung carcinoma,GEMCITABINE,3,"Active, not recruiting",POLE3,14
non-small cell lung carcinoma,GEMCITABINE,3,"Active, not recruiting",PRIM1,14
non-small cell lung carcinoma,GEMCITABINE,3,"Active, not recruiting",PRIM2,14
non-small cell lung carcinoma,GEMCITABINE,3,"Active, not recruiting",RRM1,14
non-small cell lung carcinoma,OSIMERTINIB,1,Recruiting,ERBB2,14
non-small cell lung carcinoma,ATEZOLIZUMAB,2,Recruiting,CD274,14
non-small cell lung carcinoma,GEMCITABINE,3,"Active, not recruiting",POLE,14
non-small cell lung carcinoma,GEMCITABINE,2,Unknown status,PRIM2,13
non-small cell lung carcinoma,PACLITAXEL,3,Terminated,TUBB4B,13
non-small cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB2A,13
non-small cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB1,13
non-small cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB,13
non-small cell lung carcinoma,GEMCITABINE,2,Unknown status,RRM1,13
non-small cell lung carcinoma,GEFITINIB,3,Completed,EGFR,13
non-small cell lung carcinoma,PACLITAXEL,3,Terminated,TUBB8,13
non-small cell lung carcinoma,PACLITAXEL,3,Terminated,TUBB6,13
non-small cell lung carcinoma,GEMCITABINE,2,Unknown status,POLA1,13
non-small cell lung carcinoma,GEMCITABINE,2,Unknown status,POLA2,13
non-small cell lung carcinoma,GEMCITABINE,2,Unknown status,POLD1,13
non-small cell lung carcinoma,GEMCITABINE,2,Unknown status,POLD2,13
non-small cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB6,13
non-small cell lung carcinoma,PACLITAXEL,3,Terminated,TUBB4A,13
non-small cell lung carcinoma,GEMCITABINE,2,Unknown status,POLD3,13
non-small cell lung carcinoma,PACLITAXEL,3,Terminated,TUBB3,13
non-small cell lung carcinoma,PACLITAXEL,3,Terminated,TUBB2B,13
non-small cell lung carcinoma,GEMCITABINE,2,Unknown status,POLD4,13
non-small cell lung carcinoma,PACLITAXEL,3,Terminated,TUBB2A,13
non-small cell lung carcinoma,GEMCITABINE,2,Unknown status,POLE,13
non-small cell lung carcinoma,GEMCITABINE,2,Unknown status,POLE2,13
non-small cell lung carcinoma,GEMCITABINE,2,Unknown status,POLE3,13
non-small cell lung carcinoma,GEMCITABINE,2,Unknown status,PRIM1,13
non-small cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB8,13
non-small cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB4B,13
non-small cell lung carcinoma,PACLITAXEL,3,Terminated,TUBB,13
non-small cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB4A,13
non-small cell lung carcinoma,PEMETREXED,1,Recruiting,TYMS,13
non-small cell lung carcinoma,PEMETREXED,1,Recruiting,GART,13
non-small cell lung carcinoma,PEMETREXED,1,Recruiting,DHFR,13
non-small cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB4A,13
non-small cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB6,13
non-small cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB4B,13
non-small cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB8,13
non-small cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB3,13
non-small cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB2B,13
non-small cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,13
non-small cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB1,13
non-small cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB2A,13
non-small cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB2B,13
non-small cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB3,13
non-small cell lung carcinoma,PACLITAXEL,3,Terminated,TUBB1,13
non-small cell lung carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB,12
non-small cell lung carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB1,12
non-small cell lung carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB2A,12
non-small cell lung carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB2B,12
non-small cell lung carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB3,12
non-small cell lung carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB4A,12
non-small cell lung carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB4B,12
non-small cell lung carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB6,12
non-small cell lung carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB8,12
non-small cell lung carcinoma,DURVALUMAB,2,Recruiting,CD274,12
non-small cell lung carcinoma,VINORELBINE,3,Completed,TUBB8,11
non-small cell lung carcinoma,PACLITAXEL,4,n/a,TUBB2B,11
non-small cell lung carcinoma,PACLITAXEL,4,n/a,TUBB6,11
non-small cell lung carcinoma,PACLITAXEL,4,n/a,TUBB4B,11
non-small cell lung carcinoma,PACLITAXEL,4,n/a,TUBB4A,11
non-small cell lung carcinoma,PEMETREXED,1,"Active, not recruiting",DHFR,11
non-small cell lung carcinoma,DOCETAXEL,3,Terminated,TUBB8,11
non-small cell lung carcinoma,DOCETAXEL,3,Terminated,TUBB6,11
non-small cell lung carcinoma,DOCETAXEL,3,Terminated,TUBB4B,11
non-small cell lung carcinoma,VINORELBINE,3,Completed,TUBB6,11
non-small cell lung carcinoma,VINORELBINE,3,Completed,TUBB4B,11
non-small cell lung carcinoma,VINORELBINE,3,Completed,TUBB4A,11
non-small cell lung carcinoma,VINORELBINE,3,Completed,TUBB3,11
non-small cell lung carcinoma,VINORELBINE,3,Completed,TUBB2B,11
non-small cell lung carcinoma,VINORELBINE,3,Completed,TUBB2A,11
non-small cell lung carcinoma,DOCETAXEL,3,Terminated,TUBB4A,11
non-small cell lung carcinoma,PEMETREXED,1,"Active, not recruiting",GART,11
non-small cell lung carcinoma,DOCETAXEL,3,Terminated,TUBB3,11
non-small cell lung carcinoma,DOCETAXEL,3,Terminated,TUBB2B,11
non-small cell lung carcinoma,DOCETAXEL,3,Terminated,TUBB2A,11
non-small cell lung carcinoma,PEMETREXED,1,"Active, not recruiting",TYMS,11
non-small cell lung carcinoma,DOCETAXEL,3,Terminated,TUBB1,11
non-small cell lung carcinoma,DOCETAXEL,3,Terminated,TUBB,11
non-small cell lung carcinoma,PACLITAXEL,4,n/a,TUBB3,11
non-small cell lung carcinoma,PACLITAXEL,4,n/a,TUBB,11
non-small cell lung carcinoma,PACLITAXEL,4,n/a,TUBB1,11
non-small cell lung carcinoma,PACLITAXEL,4,n/a,TUBB8,11
non-small cell lung carcinoma,PACLITAXEL,4,n/a,TUBB2A,11
non-small cell lung carcinoma,DOCETAXEL,1,Completed,TUBB,11
non-small cell lung carcinoma,DOCETAXEL,1,Completed,TUBB2A,11
non-small cell lung carcinoma,DOCETAXEL,1,Completed,TUBB6,11
non-small cell lung carcinoma,DOCETAXEL,1,Completed,TUBB4B,11
non-small cell lung carcinoma,DOCETAXEL,1,Completed,TUBB8,11
non-small cell lung carcinoma,DOCETAXEL,1,Completed,TUBB4A,11
non-small cell lung carcinoma,DOCETAXEL,1,Completed,TUBB3,11
non-small cell lung carcinoma,VINORELBINE,3,Completed,TUBB,11
non-small cell lung carcinoma,NIVOLUMAB,2,"Active, not recruiting",PDCD1,11
non-small cell lung carcinoma,VINORELBINE,3,Completed,TUBB1,11
non-small cell lung carcinoma,NIVOLUMAB,1,Recruiting,PDCD1,11
non-small cell lung carcinoma,DOCETAXEL,1,Completed,TUBB2B,11
non-small cell lung carcinoma,DOCETAXEL,1,Completed,TUBB1,11
non-small cell lung carcinoma,DOCETAXEL,1,Terminated,TUBB2B,10
non-small cell lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB,10
non-small cell lung carcinoma,BEVACIZUMAB,1,Completed,VEGFA,10
non-small cell lung carcinoma,DOCETAXEL,1,Terminated,TUBB4A,10
non-small cell lung carcinoma,DOCETAXEL,1,Terminated,TUBB4B,10
non-small cell lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB1,10
non-small cell lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB2A,10
non-small cell lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB2B,10
non-small cell lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB3,10
non-small cell lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB4A,10
non-small cell lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB4B,10
non-small cell lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB6,10
non-small cell lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB8,10
non-small cell lung carcinoma,DOCETAXEL,1,Terminated,TUBB8,10
non-small cell lung carcinoma,DOCETAXEL,1,Terminated,TUBB6,10
non-small cell lung carcinoma,DOCETAXEL,1,Terminated,TUBB3,10
non-small cell lung carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB4B,10
non-small cell lung carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB8,10
non-small cell lung carcinoma,ERLOTINIB,2,"Active, not recruiting",EGFR,10
non-small cell lung carcinoma,VINORELBINE,2,Unknown status,TUBB1,10
non-small cell lung carcinoma,VINORELBINE,2,Unknown status,TUBB,10
non-small cell lung carcinoma,VINORELBINE,2,Unknown status,TUBB2A,10
non-small cell lung carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB6,10
non-small cell lung carcinoma,VINORELBINE,2,Unknown status,TUBB2B,10
non-small cell lung carcinoma,VINORELBINE,2,Unknown status,TUBB3,10
non-small cell lung carcinoma,VINORELBINE,2,Unknown status,TUBB4A,10
non-small cell lung carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB,10
non-small cell lung carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB1,10
non-small cell lung carcinoma,VINORELBINE,2,Unknown status,TUBB4B,10
non-small cell lung carcinoma,VINORELBINE,2,Unknown status,TUBB6,10
non-small cell lung carcinoma,VINORELBINE,2,Unknown status,TUBB8,10
non-small cell lung carcinoma,DOCETAXEL,1,Terminated,TUBB,10
non-small cell lung carcinoma,DOCETAXEL,1,Terminated,TUBB1,10
non-small cell lung carcinoma,DOCETAXEL,1,Terminated,TUBB2A,10
non-small cell lung carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB2A,10
non-small cell lung carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB2B,10
non-small cell lung carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB3,10
non-small cell lung carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB4A,10
non-small cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB6,9
non-small cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB4A,9
non-small cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB3,9
non-small cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB2B,9
non-small cell lung carcinoma,NIVOLUMAB,3,Recruiting,PDCD1,9
non-small cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB2A,9
non-small cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB4B,9
non-small cell lung carcinoma,PEMETREXED,1,Terminated,TYMS,9
non-small cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB8,9
non-small cell lung carcinoma,GEMCITABINE,3,Recruiting,POLD4,9
non-small cell lung carcinoma,AFATINIB,2,Completed,ERBB2,9
non-small cell lung carcinoma,AFATINIB,2,Completed,ERBB4,9
non-small cell lung carcinoma,PEMETREXED,1,Terminated,GART,9
non-small cell lung carcinoma,PEMETREXED,1,Terminated,DHFR,9
non-small cell lung carcinoma,OSIMERTINIB,1,"Active, not recruiting",ERBB2,9
non-small cell lung carcinoma,OSIMERTINIB,1,"Active, not recruiting",ERBB3,9
non-small cell lung carcinoma,GEMCITABINE,3,Recruiting,POLD3,9
non-small cell lung carcinoma,GEMCITABINE,3,Recruiting,POLD2,9
non-small cell lung carcinoma,OSIMERTINIB,1,"Active, not recruiting",ERBB4,9
non-small cell lung carcinoma,GEMCITABINE,3,Recruiting,POLA1,9
non-small cell lung carcinoma,GEMCITABINE,3,Recruiting,POLA2,9
non-small cell lung carcinoma,GEMCITABINE,3,Recruiting,POLD1,9
non-small cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB,9
non-small cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB1,9
non-small cell lung carcinoma,GEMCITABINE,3,Recruiting,PRIM2,9
non-small cell lung carcinoma,AFATINIB,2,Completed,EGFR,9
non-small cell lung carcinoma,DOCETAXEL,4,n/a,TUBB4A,9
non-small cell lung carcinoma,DOCETAXEL,4,n/a,TUBB3,9
non-small cell lung carcinoma,PACLITAXEL,1,Recruiting,TUBB6,9
non-small cell lung carcinoma,PACLITAXEL,1,Recruiting,TUBB4B,9
non-small cell lung carcinoma,DOCETAXEL,4,n/a,TUBB2B,9
non-small cell lung carcinoma,PACLITAXEL,1,Recruiting,TUBB4A,9
non-small cell lung carcinoma,PACLITAXEL,1,Recruiting,TUBB3,9
non-small cell lung carcinoma,PACLITAXEL,1,Recruiting,TUBB2B,9
non-small cell lung carcinoma,DOCETAXEL,4,n/a,TUBB2A,9
non-small cell lung carcinoma,DOCETAXEL,4,n/a,TUBB1,9
non-small cell lung carcinoma,PACLITAXEL,1,Recruiting,TUBB2A,9
non-small cell lung carcinoma,PACLITAXEL,1,Recruiting,TUBB1,9
non-small cell lung carcinoma,PACLITAXEL,1,Recruiting,TUBB8,9
non-small cell lung carcinoma,PACLITAXEL,1,Recruiting,TUBB,9
non-small cell lung carcinoma,DOCETAXEL,4,n/a,TUBB,9
non-small cell lung carcinoma,GEMCITABINE,3,Recruiting,POLE3,9
non-small cell lung carcinoma,DOCETAXEL,4,n/a,TUBB4B,9
non-small cell lung carcinoma,DOCETAXEL,4,n/a,TUBB6,9
non-small cell lung carcinoma,GEMCITABINE,3,Recruiting,RRM1,9
non-small cell lung carcinoma,DOCETAXEL,4,n/a,TUBB8,9
non-small cell lung carcinoma,GEMCITABINE,3,Recruiting,PRIM1,9
non-small cell lung carcinoma,GEMCITABINE,3,Recruiting,POLE2,9
non-small cell lung carcinoma,GEMCITABINE,3,Recruiting,POLE,9
non-small cell lung carcinoma,PEMETREXED,2,Not yet recruiting,TYMS,8
non-small cell lung carcinoma,DACOMITINIB,2,Completed,EGFR,8
non-small cell lung carcinoma,GEMCITABINE,1,Completed,POLE2,8
non-small cell lung carcinoma,GEMCITABINE,1,Completed,POLE3,8
non-small cell lung carcinoma,GEMCITABINE,1,Completed,PRIM1,8
non-small cell lung carcinoma,GEMCITABINE,1,Completed,PRIM2,8
non-small cell lung carcinoma,PEMETREXED,2,Not yet recruiting,DHFR,8
non-small cell lung carcinoma,PEMETREXED,2,Not yet recruiting,GART,8
non-small cell lung carcinoma,GEMCITABINE,2,Recruiting,POLE,8
non-small cell lung carcinoma,APATINIB,2,Recruiting,KDR,8
non-small cell lung carcinoma,GEMCITABINE,2,Recruiting,POLE2,8
non-small cell lung carcinoma,GEMCITABINE,1,Completed,RRM1,8
non-small cell lung carcinoma,GEMCITABINE,2,Recruiting,RRM1,8
non-small cell lung carcinoma,GEMCITABINE,2,Recruiting,PRIM2,8
non-small cell lung carcinoma,DACOMITINIB,2,Completed,ERBB4,8
non-small cell lung carcinoma,GEMCITABINE,2,Recruiting,PRIM1,8
non-small cell lung carcinoma,GEMCITABINE,2,Recruiting,POLE3,8
non-small cell lung carcinoma,DACOMITINIB,2,Completed,ERBB2,8
non-small cell lung carcinoma,GEMCITABINE,1,Completed,POLD4,8
non-small cell lung carcinoma,GEMCITABINE,1,Completed,POLE,8
non-small cell lung carcinoma,GEMCITABINE,1,Completed,POLA2,8
non-small cell lung carcinoma,GEMCITABINE,2,Recruiting,POLA1,8
non-small cell lung carcinoma,GEMCITABINE,2,Recruiting,POLD4,8
non-small cell lung carcinoma,OSIMERTINIB,2,"Active, not recruiting",EGFR,8
non-small cell lung carcinoma,GEMCITABINE,2,Recruiting,POLA2,8
non-small cell lung carcinoma,GEMCITABINE,2,Recruiting,POLD1,8
non-small cell lung carcinoma,GEMCITABINE,1,Completed,POLA1,8
non-small cell lung carcinoma,OSIMERTINIB,3,"Active, not recruiting",EGFR,8
non-small cell lung carcinoma,GEMCITABINE,1,Completed,POLD1,8
non-small cell lung carcinoma,GEMCITABINE,1,Completed,POLD2,8
non-small cell lung carcinoma,GEMCITABINE,1,Completed,POLD3,8
non-small cell lung carcinoma,OSIMERTINIB,2,Not yet recruiting,EGFR,8
non-small cell lung carcinoma,GEMCITABINE,2,Recruiting,POLD2,8
non-small cell lung carcinoma,GEMCITABINE,2,Recruiting,POLD3,8
non-small cell lung carcinoma,PEMBROLIZUMAB,2,"Active, not recruiting",PDCD1,8
non-small cell lung carcinoma,ATEZOLIZUMAB,3,"Active, not recruiting",CD274,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,SRC,7
non-small cell lung carcinoma,PEMBROLIZUMAB,1,"Active, not recruiting",PDCD1,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,RET,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,ERBB4,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,PTK6,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,ERBB2,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,ERBB3,7
non-small cell lung carcinoma,PEMBROLIZUMAB,3,"Active, not recruiting",PDCD1,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,FLT1,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,FLT4,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,KDR,7
non-small cell lung carcinoma,ATEZOLIZUMAB,1,Recruiting,CD274,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,EPHA10,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,TEK,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,EPHA2,7
non-small cell lung carcinoma,SORAFENIB,2,Completed,BRAF,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,EPHB2,7
non-small cell lung carcinoma,ERLOTINIB,3,Terminated,EGFR,7
non-small cell lung carcinoma,BORTEZOMIB,2,Completed,PSMB5,7
non-small cell lung carcinoma,ERLOTINIB,4,Completed,EGFR,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,EPHA8,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,EPHA1,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,EGFR,7
non-small cell lung carcinoma,DURVALUMAB,2,Not yet recruiting,CD274,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,EPHA4,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,EPHA5,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,EPHA6,7
non-small cell lung carcinoma,IPILIMUMAB,2,Recruiting,CTLA4,7
non-small cell lung carcinoma,BEVACIZUMAB,2,Unknown status,VEGFA,7
non-small cell lung carcinoma,SORAFENIB,2,Completed,FLT1,7
non-small cell lung carcinoma,BEVACIZUMAB,3,"Active, not recruiting",VEGFA,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,EPHA7,7
non-small cell lung carcinoma,SORAFENIB,2,Completed,FLT3,7
non-small cell lung carcinoma,SORAFENIB,2,Completed,FLT4,7
non-small cell lung carcinoma,SORAFENIB,2,Completed,KDR,7
non-small cell lung carcinoma,SORAFENIB,2,Completed,KIT,7
non-small cell lung carcinoma,SORAFENIB,2,Completed,PDGFRB,7
non-small cell lung carcinoma,BEVACIZUMAB,3,Recruiting,VEGFA,7
non-small cell lung carcinoma,IPILIMUMAB,3,Recruiting,CTLA4,7
non-small cell lung carcinoma,SORAFENIB,2,Completed,RAF1,7
non-small cell lung carcinoma,SORAFENIB,2,Completed,RET,7
non-small cell lung carcinoma,GEFITINIB,1,Completed,EGFR,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,EPHB1,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,EPHA3,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,EPHB3,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,EPHB4,7
non-small cell lung carcinoma,VANDETANIB,2,Completed,EPHB6,7
non-small cell lung carcinoma,NINTEDANIB,1,Completed,FLT1,6
non-small cell lung carcinoma,GEMCITABINE,3,Terminated,POLE,6
non-small cell lung carcinoma,AFATINIB,3,Completed,ERBB4,6
non-small cell lung carcinoma,AFATINIB,3,Completed,ERBB2,6
non-small cell lung carcinoma,AFATINIB,3,Completed,EGFR,6
non-small cell lung carcinoma,GEMCITABINE,3,Terminated,POLE2,6
non-small cell lung carcinoma,GEMCITABINE,3,Terminated,POLE3,6
non-small cell lung carcinoma,GEMCITABINE,3,Terminated,PRIM1,6
non-small cell lung carcinoma,GEMCITABINE,3,Terminated,PRIM2,6
non-small cell lung carcinoma,GEMCITABINE,3,Terminated,RRM1,6
non-small cell lung carcinoma,VORINOSTAT,1,Terminated,HDAC6,6
non-small cell lung carcinoma,DOCETAXEL,3,Recruiting,TUBB,6
non-small cell lung carcinoma,DOCETAXEL,3,Recruiting,TUBB1,6
non-small cell lung carcinoma,GEMCITABINE,3,Terminated,POLD3,6
non-small cell lung carcinoma,DOCETAXEL,3,Recruiting,TUBB2A,6
non-small cell lung carcinoma,DOCETAXEL,3,Recruiting,TUBB2B,6
non-small cell lung carcinoma,DOCETAXEL,3,Recruiting,TUBB3,6
non-small cell lung carcinoma,PEMETREXED,3,Unknown status,TYMS,6
non-small cell lung carcinoma,GEMCITABINE,3,Terminated,POLA2,6
non-small cell lung carcinoma,GEMCITABINE,3,Terminated,POLA1,6
non-small cell lung carcinoma,PEMETREXED,3,Unknown status,GART,6
non-small cell lung carcinoma,PEMETREXED,3,Unknown status,DHFR,6
non-small cell lung carcinoma,SUNITINIB,2,Completed,KDR,6
non-small cell lung carcinoma,SUNITINIB,2,Completed,KIT,6
non-small cell lung carcinoma,VINORELBINE,3,Recruiting,TUBB2B,6
non-small cell lung carcinoma,VINORELBINE,3,Recruiting,TUBB,6
non-small cell lung carcinoma,GEMCITABINE,3,Terminated,POLD4,6
non-small cell lung carcinoma,DURVALUMAB,3,Recruiting,CD274,6
non-small cell lung carcinoma,VINORELBINE,3,Recruiting,TUBB1,6
non-small cell lung carcinoma,AFATINIB,2,"Active, not recruiting",EGFR,6
non-small cell lung carcinoma,AFATINIB,2,"Active, not recruiting",ERBB4,6
non-small cell lung carcinoma,GEFITINIB,1,"Active, not recruiting",EGFR,6
non-small cell lung carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB2A,6
non-small cell lung carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB2B,6
non-small cell lung carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB3,6
non-small cell lung carcinoma,VINORELBINE,3,Recruiting,TUBB3,6
non-small cell lung carcinoma,VINORELBINE,3,Recruiting,TUBB4A,6
non-small cell lung carcinoma,VINORELBINE,3,Recruiting,TUBB4B,6
non-small cell lung carcinoma,VINORELBINE,3,Recruiting,TUBB6,6
non-small cell lung carcinoma,VINORELBINE,3,Recruiting,TUBB8,6
non-small cell lung carcinoma,GEMCITABINE,3,Terminated,POLD1,6
non-small cell lung carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB4A,6
non-small cell lung carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB4B,6
non-small cell lung carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB6,6
non-small cell lung carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB8,6
non-small cell lung carcinoma,GEMCITABINE,3,Terminated,POLD2,6
non-small cell lung carcinoma,SUNITINIB,2,Completed,FLT1,6
non-small cell lung carcinoma,SUNITINIB,2,Completed,FLT3,6
non-small cell lung carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB1,6
non-small cell lung carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB,6
non-small cell lung carcinoma,SUNITINIB,2,Completed,FLT4,6
non-small cell lung carcinoma,VORINOSTAT,1,Terminated,HDAC1,6
non-small cell lung carcinoma,VORINOSTAT,1,Terminated,HDAC2,6
non-small cell lung carcinoma,AFATINIB,2,"Active, not recruiting",ERBB2,6
non-small cell lung carcinoma,VORINOSTAT,1,Terminated,HDAC3,6
non-small cell lung carcinoma,VINORELBINE,3,Recruiting,TUBB2A,6
non-small cell lung carcinoma,SUNITINIB,2,Completed,PDGFRB,6
non-small cell lung carcinoma,SUNITINIB,2,Completed,PDGFRA,6
non-small cell lung carcinoma,VINORELBINE,1,Completed,TUBB8,6
non-small cell lung carcinoma,NINTEDANIB,1,Completed,FGFR2,6
non-small cell lung carcinoma,NINTEDANIB,1,Completed,FGFR3,6
non-small cell lung carcinoma,VINORELBINE,1,Completed,TUBB,6
non-small cell lung carcinoma,DOCETAXEL,3,Recruiting,TUBB8,6
non-small cell lung carcinoma,DOCETAXEL,3,Recruiting,TUBB4B,6
non-small cell lung carcinoma,NINTEDANIB,1,Completed,FLT4,6
non-small cell lung carcinoma,NINTEDANIB,1,Completed,FGFR4,6
non-small cell lung carcinoma,DOCETAXEL,3,Recruiting,TUBB6,6
non-small cell lung carcinoma,VINORELBINE,1,Completed,TUBB6,6
non-small cell lung carcinoma,NINTEDANIB,1,Completed,KDR,6
non-small cell lung carcinoma,VINORELBINE,1,Completed,TUBB4B,6
non-small cell lung carcinoma,VINORELBINE,1,Completed,TUBB4A,6
non-small cell lung carcinoma,VINORELBINE,1,Completed,TUBB3,6
non-small cell lung carcinoma,VINORELBINE,1,Completed,TUBB2B,6
non-small cell lung carcinoma,VINORELBINE,1,Completed,TUBB2A,6
non-small cell lung carcinoma,ERLOTINIB,3,"Active, not recruiting",EGFR,6
non-small cell lung carcinoma,NIVOLUMAB,3,"Active, not recruiting",PDCD1,6
non-small cell lung carcinoma,VINORELBINE,1,Completed,TUBB1,6
non-small cell lung carcinoma,NINTEDANIB,1,Completed,FGFR1,6
non-small cell lung carcinoma,SUNITINIB,2,Completed,CSF1R,6
non-small cell lung carcinoma,DOCETAXEL,3,Recruiting,TUBB4A,6
non-small cell lung carcinoma,DURVALUMAB,3,"Active, not recruiting",CD274,6
non-small cell lung carcinoma,SUNITINIB,2,Completed,RET,6
non-small cell lung carcinoma,CETUXIMAB,1,Completed,EGFR,6
non-small cell lung carcinoma,NINTEDANIB,1,Completed,PDGFRA,6
non-small cell lung carcinoma,GEFITINIB,3,Recruiting,EGFR,6
non-small cell lung carcinoma,NINTEDANIB,1,Completed,PDGFRB,6
non-small cell lung carcinoma,EVEROLIMUS,1,Completed,FKBP1A,6
non-small cell lung carcinoma,BEVACIZUMAB,2,Recruiting,VEGFA,6
non-small cell lung carcinoma,GEMCITABINE,1,Recruiting,POLD2,5
non-small cell lung carcinoma,GEMCITABINE,1,"Active, not recruiting",POLD3,5
non-small cell lung carcinoma,GEMCITABINE,1,"Active, not recruiting",POLD2,5
non-small cell lung carcinoma,GEMCITABINE,1,"Active, not recruiting",POLA2,5
non-small cell lung carcinoma,GEMCITABINE,1,Recruiting,POLE2,5
non-small cell lung carcinoma,GEMCITABINE,1,"Active, not recruiting",POLD1,5
non-small cell lung carcinoma,GEMCITABINE,1,"Active, not recruiting",POLA1,5
non-small cell lung carcinoma,GEMCITABINE,1,Recruiting,POLD3,5
non-small cell lung carcinoma,GEMCITABINE,1,Recruiting,POLD1,5
non-small cell lung carcinoma,GEMCITABINE,1,"Active, not recruiting",POLE2,5
non-small cell lung carcinoma,GEMCITABINE,1,Recruiting,POLA2,5
non-small cell lung carcinoma,GEMCITABINE,1,Recruiting,POLA1,5
non-small cell lung carcinoma,GEMCITABINE,1,"Active, not recruiting",POLE,5
non-small cell lung carcinoma,GEMCITABINE,1,Recruiting,POLE,5
non-small cell lung carcinoma,GEFITINIB,3,"Active, not recruiting",EGFR,5
non-small cell lung carcinoma,BORTEZOMIB,2,Terminated,PSMB5,5
non-small cell lung carcinoma,TRAMETINIB,1,Recruiting,MAP2K2,5
non-small cell lung carcinoma,TRAMETINIB,1,Recruiting,MAP2K1,5
non-small cell lung carcinoma,GEMCITABINE,1,"Active, not recruiting",RRM1,5
non-small cell lung carcinoma,GEMCITABINE,1,"Active, not recruiting",PRIM2,5
non-small cell lung carcinoma,GEMCITABINE,1,"Active, not recruiting",PRIM1,5
non-small cell lung carcinoma,GEMCITABINE,1,Recruiting,POLD4,5
non-small cell lung carcinoma,GEMCITABINE,1,"Active, not recruiting",POLD4,5
non-small cell lung carcinoma,GEMCITABINE,1,"Active, not recruiting",POLE3,5
non-small cell lung carcinoma,DURVALUMAB,1,Recruiting,CD274,5
non-small cell lung carcinoma,GEFITINIB,1,Recruiting,EGFR,5
non-small cell lung carcinoma,DOCETAXEL,1,Recruiting,TUBB6,5
non-small cell lung carcinoma,IRINOTECAN,2,Completed,TOP1,5
non-small cell lung carcinoma,ERLOTINIB,1,"Active, not recruiting",EGFR,5
non-small cell lung carcinoma,PEMETREXED,3,Terminated,TYMS,5
non-small cell lung carcinoma,PEMETREXED,3,Terminated,GART,5
non-small cell lung carcinoma,PEMETREXED,3,Terminated,DHFR,5
non-small cell lung carcinoma,APATINIB,2,Not yet recruiting,KDR,5
non-small cell lung carcinoma,ENZASTAURIN,2,Completed,PRKCB,5
non-small cell lung carcinoma,GEMCITABINE,1,Recruiting,PRIM2,5
non-small cell lung carcinoma,ETOPOSIDE,1,Terminated,TOP2A,5
non-small cell lung carcinoma,ETOPOSIDE,1,Terminated,TOP2B,5
non-small cell lung carcinoma,PEMBROLIZUMAB,3,Recruiting,PDCD1,5
non-small cell lung carcinoma,DOCETAXEL,1,Recruiting,TUBB8,5
non-small cell lung carcinoma,GEMCITABINE,1,Recruiting,POLE3,5
non-small cell lung carcinoma,DOCETAXEL,1,Recruiting,TUBB4B,5
non-small cell lung carcinoma,GEMCITABINE,1,Recruiting,RRM1,5
non-small cell lung carcinoma,DOCETAXEL,1,Recruiting,TUBB3,5
non-small cell lung carcinoma,DOCETAXEL,1,Recruiting,TUBB2B,5
non-small cell lung carcinoma,DOCETAXEL,1,Recruiting,TUBB2A,5
non-small cell lung carcinoma,GEMCITABINE,1,Recruiting,PRIM1,5
non-small cell lung carcinoma,DOCETAXEL,1,Recruiting,TUBB1,5
non-small cell lung carcinoma,DOCETAXEL,1,Recruiting,TUBB4A,5
non-small cell lung carcinoma,DOCETAXEL,1,Recruiting,TUBB,5
non-small cell lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB3,4
non-small cell lung carcinoma,GEMCITABINE,4,n/a,RRM1,4
non-small cell lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB1,4
non-small cell lung carcinoma,PACLITAXEL,3,Not yet recruiting,TUBB,4
non-small cell lung carcinoma,PACLITAXEL,3,Not yet recruiting,TUBB1,4
non-small cell lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB2A,4
non-small cell lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB2B,4
non-small cell lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB6,4
non-small cell lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB4A,4
non-small cell lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB4B,4
non-small cell lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB8,4
non-small cell lung carcinoma,VINORELBINE,3,"Active, not recruiting",TUBB2B,4
non-small cell lung carcinoma,VINORELBINE,3,"Active, not recruiting",TUBB3,4
non-small cell lung carcinoma,VINORELBINE,3,"Active, not recruiting",TUBB4A,4
non-small cell lung carcinoma,VINORELBINE,3,"Active, not recruiting",TUBB4B,4
non-small cell lung carcinoma,VINORELBINE,3,"Active, not recruiting",TUBB8,4
non-small cell lung carcinoma,IPILIMUMAB,1,Recruiting,CTLA4,4
non-small cell lung carcinoma,VINORELBINE,3,"Active, not recruiting",TUBB6,4
non-small cell lung carcinoma,GEMCITABINE,4,n/a,POLD2,4
non-small cell lung carcinoma,GEMCITABINE,4,n/a,PRIM2,4
non-small cell lung carcinoma,GEMCITABINE,3,Unknown status,RRM1,4
non-small cell lung carcinoma,PACLITAXEL,2,Withdrawn,TUBB2A,4
non-small cell lung carcinoma,PACLITAXEL,2,Withdrawn,TUBB2B,4
non-small cell lung carcinoma,PACLITAXEL,2,Withdrawn,TUBB3,4
non-small cell lung carcinoma,PACLITAXEL,2,Withdrawn,TUBB4A,4
non-small cell lung carcinoma,PACLITAXEL,2,Withdrawn,TUBB4B,4
non-small cell lung carcinoma,PACLITAXEL,2,Withdrawn,TUBB6,4
non-small cell lung carcinoma,PACLITAXEL,2,Withdrawn,TUBB8,4
non-small cell lung carcinoma,GEMCITABINE,4,n/a,POLA2,4
non-small cell lung carcinoma,GEMCITABINE,3,Unknown status,PRIM1,4
non-small cell lung carcinoma,GEMCITABINE,3,Unknown status,PRIM2,4
non-small cell lung carcinoma,GEMCITABINE,4,n/a,POLA1,4
non-small cell lung carcinoma,DOCETAXEL,3,Unknown status,TUBB1,4
non-small cell lung carcinoma,DOCETAXEL,2,Withdrawn,TUBB,4
non-small cell lung carcinoma,DOCETAXEL,2,Withdrawn,TUBB1,4
non-small cell lung carcinoma,DOCETAXEL,2,Withdrawn,TUBB2A,4
non-small cell lung carcinoma,DOCETAXEL,2,Withdrawn,TUBB2B,4
non-small cell lung carcinoma,DOCETAXEL,2,Withdrawn,TUBB3,4
non-small cell lung carcinoma,DOCETAXEL,2,Withdrawn,TUBB4A,4
non-small cell lung carcinoma,DOCETAXEL,2,Withdrawn,TUBB4B,4
non-small cell lung carcinoma,DOCETAXEL,2,Withdrawn,TUBB6,4
non-small cell lung carcinoma,DOCETAXEL,2,Withdrawn,TUBB8,4
non-small cell lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB8,4
non-small cell lung carcinoma,DOCETAXEL,3,Unknown status,TUBB,4
non-small cell lung carcinoma,DOCETAXEL,3,Unknown status,TUBB2A,4
non-small cell lung carcinoma,GEMCITABINE,4,n/a,PRIM1,4
non-small cell lung carcinoma,GEMCITABINE,3,Unknown status,POLD3,4
non-small cell lung carcinoma,GEMCITABINE,4,n/a,POLE3,4
non-small cell lung carcinoma,GEMCITABINE,4,n/a,POLE2,4
non-small cell lung carcinoma,GEMCITABINE,4,n/a,POLE,4
non-small cell lung carcinoma,GEMCITABINE,4,n/a,POLD4,4
non-small cell lung carcinoma,GEMCITABINE,4,n/a,POLD3,4
non-small cell lung carcinoma,GEMCITABINE,4,n/a,POLD1,4
non-small cell lung carcinoma,GEMCITABINE,3,Unknown status,POLA1,4
non-small cell lung carcinoma,GEMCITABINE,3,Unknown status,POLA2,4
non-small cell lung carcinoma,GEMCITABINE,3,Unknown status,POLD1,4
non-small cell lung carcinoma,GEMCITABINE,3,Unknown status,POLD2,4
non-small cell lung carcinoma,GEMCITABINE,3,Unknown status,POLD4,4
non-small cell lung carcinoma,DOCETAXEL,3,Unknown status,TUBB2B,4
non-small cell lung carcinoma,GEMCITABINE,3,Unknown status,POLE,4
non-small cell lung carcinoma,GEMCITABINE,3,Unknown status,POLE2,4
non-small cell lung carcinoma,PACLITAXEL,2,Withdrawn,TUBB,4
non-small cell lung carcinoma,PACLITAXEL,2,Withdrawn,TUBB1,4
non-small cell lung carcinoma,DOCETAXEL,3,Unknown status,TUBB8,4
non-small cell lung carcinoma,GEMCITABINE,3,Unknown status,POLE3,4
non-small cell lung carcinoma,DOCETAXEL,3,Unknown status,TUBB6,4
non-small cell lung carcinoma,DOCETAXEL,3,Unknown status,TUBB4B,4
non-small cell lung carcinoma,DOCETAXEL,3,Unknown status,TUBB4A,4
non-small cell lung carcinoma,DOCETAXEL,3,Unknown status,TUBB3,4
non-small cell lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB,4
non-small cell lung carcinoma,OSIMERTINIB,2,Not yet recruiting,ERBB2,4
non-small cell lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB6,4
non-small cell lung carcinoma,PAZOPANIB,2,Completed,FLT4,4
non-small cell lung carcinoma,CRIZOTINIB,2,"Active, not recruiting",MET,4
non-small cell lung carcinoma,NIVOLUMAB,1,"Active, not recruiting",PDCD1,4
non-small cell lung carcinoma,CRIZOTINIB,3,"Active, not recruiting",ALK,4
non-small cell lung carcinoma,CRIZOTINIB,3,"Active, not recruiting",MET,4
non-small cell lung carcinoma,NIVOLUMAB,2,Not yet recruiting,PDCD1,4
non-small cell lung carcinoma,DACOMITINIB,1,Completed,EGFR,4
non-small cell lung carcinoma,DACOMITINIB,1,Completed,ERBB2,4
non-small cell lung carcinoma,ANLOTINIB,4,Not yet recruiting,PDGFRB,4
non-small cell lung carcinoma,ANLOTINIB,4,Not yet recruiting,KIT,4
non-small cell lung carcinoma,ANLOTINIB,4,Not yet recruiting,KDR,4
non-small cell lung carcinoma,ANLOTINIB,4,Not yet recruiting,FLT4,4
non-small cell lung carcinoma,DACOMITINIB,2,Completed,ERBB3,4
non-small cell lung carcinoma,PEMBROLIZUMAB,1,Not yet recruiting,PDCD1,4
non-small cell lung carcinoma,OSIMERTINIB,2,"Active, not recruiting",ERBB2,4
non-small cell lung carcinoma,OSIMERTINIB,2,"Active, not recruiting",ERBB3,4
non-small cell lung carcinoma,OSIMERTINIB,2,"Active, not recruiting",ERBB4,4
non-small cell lung carcinoma,OSIMERTINIB,2,Not yet recruiting,ERBB3,4
non-small cell lung carcinoma,OSIMERTINIB,2,Not yet recruiting,ERBB4,4
non-small cell lung carcinoma,PAZOPANIB,2,Completed,PDGFRB,4
non-small cell lung carcinoma,PAZOPANIB,2,Completed,PDGFRA,4
non-small cell lung carcinoma,PAZOPANIB,2,Completed,LCK,4
non-small cell lung carcinoma,PAZOPANIB,2,Completed,KIT,4
non-small cell lung carcinoma,PAZOPANIB,2,Completed,KDR,4
non-small cell lung carcinoma,CRIZOTINIB,2,"Active, not recruiting",ALK,4
non-small cell lung carcinoma,CRIZOTINIB,1,Completed,MET,4
non-small cell lung carcinoma,CRIZOTINIB,1,Completed,ALK,4
non-small cell lung carcinoma,CERITINIB,2,Recruiting,ALK,4
non-small cell lung carcinoma,CAPMATINIB,2,Recruiting,MET,4
non-small cell lung carcinoma,GEFITINIB,2,Recruiting,EGFR,4
non-small cell lung carcinoma,SELUMETINIB,2,Completed,MAP2K2,4
non-small cell lung carcinoma,SELUMETINIB,2,Completed,MAP2K1,4
non-small cell lung carcinoma,NECITUMUMAB,1,"Active, not recruiting",EGFR,4
non-small cell lung carcinoma,NERATINIB,2,Completed,EGFR,4
non-small cell lung carcinoma,NERATINIB,2,Completed,ERBB2,4
non-small cell lung carcinoma,CERITINIB,1,Recruiting,ALK,4
non-small cell lung carcinoma,ETOPOSIDE,2,Completed,TOP2B,4
non-small cell lung carcinoma,SELUMETINIB,1,Completed,MAP2K2,4
non-small cell lung carcinoma,SELUMETINIB,1,Completed,MAP2K1,4
non-small cell lung carcinoma,PEMETREXED,4,Recruiting,DHFR,4
non-small cell lung carcinoma,ETOPOSIDE,2,Completed,TOP2A,4
non-small cell lung carcinoma,CETUXIMAB,3,Completed,EGFR,4
non-small cell lung carcinoma,ERLOTINIB,3,Unknown status,EGFR,4
non-small cell lung carcinoma,ERLOTINIB,3,Recruiting,EGFR,4
non-small cell lung carcinoma,ERLOTINIB,1,Recruiting,EGFR,4
non-small cell lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB4B,4
non-small cell lung carcinoma,BEVACIZUMAB,1,Terminated,VEGFA,4
non-small cell lung carcinoma,PEMETREXED,4,Recruiting,TYMS,4
non-small cell lung carcinoma,PEMETREXED,4,Recruiting,GART,4
non-small cell lung carcinoma,BEVACIZUMAB,1,Recruiting,VEGFA,4
non-small cell lung carcinoma,PAZOPANIB,2,Completed,ITK,4
non-small cell lung carcinoma,DACOMITINIB,1,Completed,ERBB4,4
non-small cell lung carcinoma,PAZOPANIB,2,Completed,FLT1,4
non-small cell lung carcinoma,DOCETAXEL,1,Unknown status,TUBB1,4
non-small cell lung carcinoma,VINORELBINE,2,Terminated,TUBB8,4
non-small cell lung carcinoma,VINORELBINE,3,"Active, not recruiting",TUBB,4
non-small cell lung carcinoma,VINORELBINE,3,"Active, not recruiting",TUBB1,4
non-small cell lung carcinoma,VINORELBINE,3,"Active, not recruiting",TUBB2A,4
non-small cell lung carcinoma,PACLITAXEL,3,Not yet recruiting,TUBB8,4
non-small cell lung carcinoma,PACLITAXEL,3,Not yet recruiting,TUBB6,4
non-small cell lung carcinoma,PACLITAXEL,3,Not yet recruiting,TUBB4B,4
non-small cell lung carcinoma,PACLITAXEL,3,Not yet recruiting,TUBB4A,4
non-small cell lung carcinoma,PAZOPANIB,2,Completed,FGFR3,4
non-small cell lung carcinoma,PACLITAXEL,3,Not yet recruiting,TUBB2B,4
non-small cell lung carcinoma,PACLITAXEL,3,Not yet recruiting,TUBB2A,4
non-small cell lung carcinoma,DOCETAXEL,1,Unknown status,TUBB,4
non-small cell lung carcinoma,DOCETAXEL,1,Unknown status,TUBB2A,4
non-small cell lung carcinoma,PACLITAXEL,3,Unknown status,TUBB,4
non-small cell lung carcinoma,DOCETAXEL,1,Unknown status,TUBB2B,4
non-small cell lung carcinoma,DOCETAXEL,1,Unknown status,TUBB3,4
non-small cell lung carcinoma,DOCETAXEL,1,Unknown status,TUBB4A,4
non-small cell lung carcinoma,DOCETAXEL,1,Unknown status,TUBB4B,4
non-small cell lung carcinoma,DOCETAXEL,1,Unknown status,TUBB6,4
non-small cell lung carcinoma,DOCETAXEL,1,Unknown status,TUBB8,4
non-small cell lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB,4
non-small cell lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB1,4
non-small cell lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB2A,4
non-small cell lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB2B,4
non-small cell lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB3,4
non-small cell lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB4A,4
non-small cell lung carcinoma,VINORELBINE,2,Terminated,TUBB6,4
non-small cell lung carcinoma,PACLITAXEL,3,Not yet recruiting,TUBB3,4
non-small cell lung carcinoma,DEXAMETHASONE,2,Completed,NR3C1,4
non-small cell lung carcinoma,PACLITAXEL,3,Unknown status,TUBB8,4
non-small cell lung carcinoma,PAZOPANIB,2,Completed,FGFR1,4
non-small cell lung carcinoma,VINORELBINE,2,Terminated,TUBB4A,4
non-small cell lung carcinoma,VINORELBINE,2,Terminated,TUBB3,4
non-small cell lung carcinoma,VINORELBINE,2,Terminated,TUBB2B,4
non-small cell lung carcinoma,VINORELBINE,2,Terminated,TUBB2A,4
non-small cell lung carcinoma,VINORELBINE,2,Terminated,TUBB1,4
non-small cell lung carcinoma,PACLITAXEL,3,Unknown status,TUBB6,4
non-small cell lung carcinoma,VINORELBINE,2,Terminated,TUBB,4
non-small cell lung carcinoma,PACLITAXEL,3,Unknown status,TUBB4B,4
non-small cell lung carcinoma,PACLITAXEL,3,Unknown status,TUBB4A,4
non-small cell lung carcinoma,OSIMERTINIB,3,"Active, not recruiting",ERBB4,4
non-small cell lung carcinoma,VINORELBINE,2,Terminated,TUBB4B,4
non-small cell lung carcinoma,OSIMERTINIB,3,"Active, not recruiting",ERBB3,4
non-small cell lung carcinoma,PACLITAXEL,3,Unknown status,TUBB3,4
non-small cell lung carcinoma,PACLITAXEL,3,Unknown status,TUBB2B,4
non-small cell lung carcinoma,OSIMERTINIB,3,"Active, not recruiting",ERBB2,4
non-small cell lung carcinoma,PACLITAXEL,3,Unknown status,TUBB2A,4
non-small cell lung carcinoma,PACLITAXEL,3,Unknown status,TUBB1,4
non-small cell lung carcinoma,PAZOPANIB,2,Completed,CSF1R,4
non-small cell lung carcinoma,METFORMIN,2,Terminated,MT-ND2,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,MT-ND1,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,GPD2,3
non-small cell lung carcinoma,GEFITINIB,4,Completed,EGFR,3
non-small cell lung carcinoma,GEMCITABINE,2,Not yet recruiting,POLE2,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,MT-ND4L,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,MT-ND3,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFA2,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFA7,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFA6,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFA5,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFA4L2,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFA4,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFA3,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFA13,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,MT-ND4,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFA12,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFA10,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFA1,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,MT-ND6,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,MT-ND5,3
non-small cell lung carcinoma,GEMCITABINE,1,Withdrawn,POLA2,3
non-small cell lung carcinoma,GEMCITABINE,1,Withdrawn,POLA1,3
non-small cell lung carcinoma,GEMCITABINE,1,Withdrawn,PRIM1,3
non-small cell lung carcinoma,GEMCITABINE,1,Withdrawn,POLD1,3
non-small cell lung carcinoma,GEMCITABINE,1,Withdrawn,RRM1,3
non-small cell lung carcinoma,GEMCITABINE,2,Not yet recruiting,POLE,3
non-small cell lung carcinoma,GEMCITABINE,2,Not yet recruiting,POLD4,3
non-small cell lung carcinoma,GEMCITABINE,2,Not yet recruiting,POLD3,3
non-small cell lung carcinoma,GEMCITABINE,2,Not yet recruiting,POLD2,3
non-small cell lung carcinoma,GEMCITABINE,2,Not yet recruiting,POLE3,3
non-small cell lung carcinoma,GEMCITABINE,2,Not yet recruiting,POLD1,3
non-small cell lung carcinoma,GEMCITABINE,2,Not yet recruiting,POLA2,3
non-small cell lung carcinoma,GEMCITABINE,2,Not yet recruiting,POLA1,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFA9,3
non-small cell lung carcinoma,IPILIMUMAB,2,Completed,CTLA4,3
non-small cell lung carcinoma,GEMCITABINE,2,Not yet recruiting,PRIM1,3
non-small cell lung carcinoma,GEMCITABINE,1,Withdrawn,POLD2,3
non-small cell lung carcinoma,DURVALUMAB,2,Withdrawn,CD274,3
non-small cell lung carcinoma,GEMCITABINE,1,Withdrawn,PRIM2,3
non-small cell lung carcinoma,GEMCITABINE,2,Not yet recruiting,PRIM2,3
non-small cell lung carcinoma,GEMCITABINE,2,Not yet recruiting,RRM1,3
non-small cell lung carcinoma,DURVALUMAB,2,"Active, not recruiting",CD274,3
non-small cell lung carcinoma,GEMCITABINE,1,Withdrawn,POLE3,3
non-small cell lung carcinoma,GEMCITABINE,1,Withdrawn,POLE2,3
non-small cell lung carcinoma,GEMCITABINE,1,Withdrawn,POLE,3
non-small cell lung carcinoma,GEMCITABINE,1,Withdrawn,POLD4,3
non-small cell lung carcinoma,GEMCITABINE,1,Withdrawn,POLD3,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFA8,3
non-small cell lung carcinoma,ERIBULIN,2,Completed,TUBB8,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFAB1,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFAF1,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFV2,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFV3,3
non-small cell lung carcinoma,ETOPOSIDE,3,Completed,TOP2B,3
non-small cell lung carcinoma,ETOPOSIDE,3,Completed,TOP2A,3
non-small cell lung carcinoma,ERLOTINIB,2,Recruiting,EGFR,3
non-small cell lung carcinoma,ERIBULIN,2,Completed,TUBB6,3
non-small cell lung carcinoma,ERIBULIN,2,Completed,TUBB4B,3
non-small cell lung carcinoma,ERIBULIN,2,Completed,TUBB4A,3
non-small cell lung carcinoma,IRINOTECAN,2,Unknown status,TOP1,3
non-small cell lung carcinoma,LENALIDOMIDE,1,Terminated,CRBN,3
non-small cell lung carcinoma,LENALIDOMIDE,1,Terminated,CUL4A,3
non-small cell lung carcinoma,LENALIDOMIDE,1,Terminated,DDB1,3
non-small cell lung carcinoma,ERIBULIN,2,Completed,TUBB2B,3
non-small cell lung carcinoma,ERIBULIN,2,Completed,TUBB2A,3
non-small cell lung carcinoma,ERIBULIN,2,Completed,TUBB1,3
non-small cell lung carcinoma,ERIBULIN,2,Completed,TUBB,3
non-small cell lung carcinoma,NIVOLUMAB,1,Not yet recruiting,PDCD1,3
non-small cell lung carcinoma,NIVOLUMAB,2,Withdrawn,PDCD1,3
non-small cell lung carcinoma,OLAPARIB,2,Recruiting,PARP1,3
non-small cell lung carcinoma,OLAPARIB,2,Recruiting,PARP2,3
non-small cell lung carcinoma,OLAPARIB,2,Recruiting,PARP3,3
non-small cell lung carcinoma,LENALIDOMIDE,1,Terminated,RBX1,3
non-small cell lung carcinoma,ONARTUZUMAB,3,Completed,MET,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFV1,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFS8,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFS7,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFB5,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFAF2,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFAF3,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFAF4,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFB1,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFB10,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFB11,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFB2,3
non-small cell lung carcinoma,FIGITUMUMAB,1,Completed,IGF1R,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFB3,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFB4,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFB6,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFS6,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFB7,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFB8,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFB9,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFC1,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFC2,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFS1,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFS2,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFS3,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFS4,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFS5,3
non-small cell lung carcinoma,ERIBULIN,2,Completed,TUBB3,3
non-small cell lung carcinoma,METFORMIN,2,Terminated,NDUFA11,3
non-small cell lung carcinoma,AVELUMAB,1,Recruiting,CD274,3
non-small cell lung carcinoma,APATINIB,2,Unknown status,KDR,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,EPHA3,3
non-small cell lung carcinoma,PEMETREXED,2,Withdrawn,DHFR,3
non-small cell lung carcinoma,PEMETREXED,2,Withdrawn,GART,3
non-small cell lung carcinoma,PEMETREXED,2,Withdrawn,TYMS,3
non-small cell lung carcinoma,PEMETREXED,3,Not yet recruiting,DHFR,3
non-small cell lung carcinoma,PEMETREXED,3,Not yet recruiting,GART,3
non-small cell lung carcinoma,PEMETREXED,3,Not yet recruiting,TYMS,3
non-small cell lung carcinoma,CRIZOTINIB,2,Recruiting,MET,3
non-small cell lung carcinoma,CRIZOTINIB,2,Recruiting,ALK,3
non-small cell lung carcinoma,SELUMETINIB,2,"Active, not recruiting",MAP2K2,3
non-small cell lung carcinoma,CELECOXIB,2,Completed,PTGS2,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,EPHA2,3
non-small cell lung carcinoma,SELUMETINIB,2,"Active, not recruiting",MAP2K1,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,EPHA10,3
non-small cell lung carcinoma,SUNITINIB,1,Completed,CSF1R,3
non-small cell lung carcinoma,PEMETREXED,2,"Active, not recruiting",TYMS,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,EPHA4,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,EGFR,3
non-small cell lung carcinoma,BRIGATINIB,2,Recruiting,EGFR,3
non-small cell lung carcinoma,PEMBROLIZUMAB,3,Not yet recruiting,PDCD1,3
non-small cell lung carcinoma,VINORELBINE,4,Completed,TUBB6,3
non-small cell lung carcinoma,VINORELBINE,4,Completed,TUBB4B,3
non-small cell lung carcinoma,PEMETREXED,1,Not yet recruiting,DHFR,3
non-small cell lung carcinoma,PEMETREXED,1,Not yet recruiting,TYMS,3
non-small cell lung carcinoma,VINORELBINE,4,Completed,TUBB4A,3
non-small cell lung carcinoma,VINORELBINE,4,Completed,TUBB3,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,EPHA7,3
non-small cell lung carcinoma,ATEZOLIZUMAB,2,Not yet recruiting,CD274,3
non-small cell lung carcinoma,ATEZOLIZUMAB,2,Completed,CD274,3
non-small cell lung carcinoma,PEMETREXED,2,"Active, not recruiting",DHFR,3
non-small cell lung carcinoma,PEMETREXED,2,"Active, not recruiting",GART,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,EPHA6,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,EPHA5,3
non-small cell lung carcinoma,BRIGATINIB,2,Recruiting,ALK,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,EPHA1,3
non-small cell lung carcinoma,BEVACIZUMAB,2,Not yet recruiting,VEGFA,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,EPHB1,3
non-small cell lung carcinoma,ALECTINIB,2,Recruiting,ALK,3
non-small cell lung carcinoma,VINORELBINE,2,Recruiting,TUBB8,3
non-small cell lung carcinoma,VINORELBINE,2,Recruiting,TUBB6,3
non-small cell lung carcinoma,CIXUTUMUMAB,2,Completed,IGF1R,3
non-small cell lung carcinoma,VINORELBINE,2,Recruiting,TUBB4B,3
non-small cell lung carcinoma,VINORELBINE,2,Recruiting,TUBB4A,3
non-small cell lung carcinoma,ANLOTINIB,2,Not yet recruiting,FLT4,3
non-small cell lung carcinoma,ANLOTINIB,2,Not yet recruiting,KDR,3
non-small cell lung carcinoma,ANLOTINIB,2,Not yet recruiting,KIT,3
non-small cell lung carcinoma,ANLOTINIB,2,Not yet recruiting,PDGFRB,3
non-small cell lung carcinoma,VINORELBINE,2,Recruiting,TUBB3,3
non-small cell lung carcinoma,VINORELBINE,2,Recruiting,TUBB2B,3
non-small cell lung carcinoma,VINORELBINE,2,Recruiting,TUBB2A,3
non-small cell lung carcinoma,VINORELBINE,2,Recruiting,TUBB1,3
non-small cell lung carcinoma,SUNITINIB,1,Completed,FLT1,3
non-small cell lung carcinoma,RAMUCIRUMAB,2,Completed,KDR,3
non-small cell lung carcinoma,ALECTINIB,2,Recruiting,RET,3
non-small cell lung carcinoma,SUNITINIB,1,Completed,FLT3,3
non-small cell lung carcinoma,BEVACIZUMAB,1,"Active, not recruiting",VEGFA,3
non-small cell lung carcinoma,SUNITINIB,1,Completed,FLT4,3
non-small cell lung carcinoma,PEMETREXED,4,Completed,DHFR,3
non-small cell lung carcinoma,PEMETREXED,4,Completed,GART,3
non-small cell lung carcinoma,PEMETREXED,4,Completed,TYMS,3
non-small cell lung carcinoma,VINORELBINE,4,Completed,TUBB2B,3
non-small cell lung carcinoma,VINORELBINE,4,Completed,TUBB2A,3
non-small cell lung carcinoma,VINORELBINE,4,Completed,TUBB1,3
non-small cell lung carcinoma,VINORELBINE,4,Completed,TUBB,3
non-small cell lung carcinoma,VINORELBINE,2,Recruiting,TUBB,3
non-small cell lung carcinoma,CERITINIB,2,Completed,ALK,3
non-small cell lung carcinoma,SUNITINIB,1,Completed,RET,3
non-small cell lung carcinoma,SUNITINIB,1,Completed,PDGFRB,3
non-small cell lung carcinoma,SUNITINIB,1,Completed,PDGFRA,3
non-small cell lung carcinoma,CETUXIMAB,2,"Active, not recruiting",EGFR,3
non-small cell lung carcinoma,SUNITINIB,1,Completed,KIT,3
non-small cell lung carcinoma,SUNITINIB,1,Completed,KDR,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,EPHA8,3
non-small cell lung carcinoma,PEMETREXED,1,Not yet recruiting,GART,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,EPHB2,3
non-small cell lung carcinoma,DASATINIB,2,Terminated,YES1,3
non-small cell lung carcinoma,DASATINIB,2,Terminated,SRC,3
non-small cell lung carcinoma,DASATINIB,2,Terminated,PDGFRB,3
non-small cell lung carcinoma,DASATINIB,2,Terminated,LYN,3
non-small cell lung carcinoma,DASATINIB,2,Terminated,LCK,3
non-small cell lung carcinoma,DASATINIB,2,Terminated,KIT,3
non-small cell lung carcinoma,DASATINIB,2,Terminated,HCK,3
non-small cell lung carcinoma,VORINOSTAT,1,Completed,HDAC3,3
non-small cell lung carcinoma,AFATINIB,1,Completed,EGFR,3
non-small cell lung carcinoma,AFATINIB,1,Completed,ERBB2,3
non-small cell lung carcinoma,AFATINIB,1,Completed,ERBB4,3
non-small cell lung carcinoma,VORINOSTAT,1,Completed,HDAC2,3
non-small cell lung carcinoma,VORINOSTAT,1,Completed,HDAC1,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,KDR,3
non-small cell lung carcinoma,CANAKINUMAB,3,Recruiting,IL1B,3
non-small cell lung carcinoma,PEGFILGRASTIM,2,Terminated,CSF3R,3
non-small cell lung carcinoma,DASATINIB,2,Terminated,SRMS,3
non-small cell lung carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB,3
non-small cell lung carcinoma,DASATINIB,2,Terminated,FRK,3
non-small cell lung carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB1,3
non-small cell lung carcinoma,TREMELIMUMAB,3,"Active, not recruiting",CTLA4,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,RET,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,PTK6,3
non-small cell lung carcinoma,VORINOSTAT,2,Completed,HDAC6,3
non-small cell lung carcinoma,VORINOSTAT,2,Completed,HDAC3,3
non-small cell lung carcinoma,VORINOSTAT,2,Completed,HDAC2,3
non-small cell lung carcinoma,VORINOSTAT,2,Completed,HDAC1,3
non-small cell lung carcinoma,VORINOSTAT,1,Completed,HDAC6,3
non-small cell lung carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB8,3
non-small cell lung carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB6,3
non-small cell lung carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB4B,3
non-small cell lung carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB4A,3
non-small cell lung carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB3,3
non-small cell lung carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB2B,3
non-small cell lung carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB2A,3
non-small cell lung carcinoma,DASATINIB,2,Terminated,FYN,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,FLT4,3
non-small cell lung carcinoma,DASATINIB,2,Terminated,FGR,3
non-small cell lung carcinoma,SORAFENIB,1,Completed,RET,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,EPHB6,3
non-small cell lung carcinoma,CAPMATINIB,1,Recruiting,MET,3
non-small cell lung carcinoma,PAZOPANIB,1,Completed,LCK,3
non-small cell lung carcinoma,PAZOPANIB,1,Completed,PDGFRA,3
non-small cell lung carcinoma,PAZOPANIB,1,Completed,PDGFRB,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,SRC,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,TEK,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,EPHB4,3
non-small cell lung carcinoma,SORAFENIB,1,Completed,RAF1,3
non-small cell lung carcinoma,PAZOPANIB,1,Completed,KDR,3
non-small cell lung carcinoma,SORAFENIB,1,Completed,PDGFRB,3
non-small cell lung carcinoma,SORAFENIB,1,Completed,KIT,3
non-small cell lung carcinoma,SORAFENIB,1,Completed,KDR,3
non-small cell lung carcinoma,SORAFENIB,1,Completed,FLT4,3
non-small cell lung carcinoma,SORAFENIB,1,Completed,FLT3,3
non-small cell lung carcinoma,SORAFENIB,1,Completed,FLT1,3
non-small cell lung carcinoma,SORAFENIB,1,Completed,BRAF,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,EPHB3,3
non-small cell lung carcinoma,PAZOPANIB,1,Completed,KIT,3
non-small cell lung carcinoma,VINORELBINE,4,Completed,TUBB8,3
non-small cell lung carcinoma,PAZOPANIB,1,Completed,FGFR1,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,ERBB3,3
non-small cell lung carcinoma,DASATINIB,2,Terminated,EPHA2,3
non-small cell lung carcinoma,PAZOPANIB,1,Completed,ITK,3
non-small cell lung carcinoma,DASATINIB,2,Terminated,BLK,3
non-small cell lung carcinoma,PAZOPANIB,1,Completed,FLT4,3
non-small cell lung carcinoma,PAZOPANIB,1,Completed,FLT1,3
non-small cell lung carcinoma,DASATINIB,2,Terminated,ABL1,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,FLT1,3
non-small cell lung carcinoma,PAZOPANIB,1,Completed,FGFR3,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,ERBB4,3
non-small cell lung carcinoma,PAZOPANIB,1,Completed,CSF1R,3
non-small cell lung carcinoma,VANDETANIB,3,Completed,ERBB2,3
non-small cell lung carcinoma,VANDETANIB,1,Terminated,SRC,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,RET,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,EPHB3,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,FLT1,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,ERBB4,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,PTK6,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,KDR,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,FLT4,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,EPHB6,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,ERBB2,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,ERBB3,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,TEK,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,EPHB4,2
non-small cell lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB1,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,EPHB2,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,EPHA3,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS6,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,ERBB2,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,EPHB6,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,EPHB4,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,EPHB3,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,EPHB2,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,EPHB1,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,EPHA8,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,EPHA7,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,EPHA6,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,EPHA5,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,EPHA4,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS7,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS4,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS8,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFV1,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFV2,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFV3,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,GPD2,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,MT-ND1,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,MT-ND2,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,MT-ND3,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,MT-ND4,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,MT-ND4L,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,MT-ND5,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,EPHA2,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS5,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS3,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,EPHB1,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,RET,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,EPHA8,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,EPHA7,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,EPHA6,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,EPHA5,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,EPHA4,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,EPHA3,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,EPHA2,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,EPHA10,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,EPHA1,2
non-small cell lung carcinoma,VANDETANIB,1,Terminated,EGFR,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,TEK,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,SRC,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,PTK6,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS2,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,KDR,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB5,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,FLT1,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,ERBB4,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,ERBB3,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB6,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB7,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB8,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB9,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFC1,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFC2,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFS1,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,FLT4,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA5,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB4,2
non-small cell lung carcinoma,LINSITINIB,2,Completed,INSR,2
non-small cell lung carcinoma,LENVATINIB,3,Not yet recruiting,FLT1,2
non-small cell lung carcinoma,LENVATINIB,3,Not yet recruiting,FLT4,2
non-small cell lung carcinoma,LENVATINIB,3,Not yet recruiting,KDR,2
non-small cell lung carcinoma,LINIFANIB,2,Completed,CSF1R,2
non-small cell lung carcinoma,LINIFANIB,2,Completed,FLT1,2
non-small cell lung carcinoma,LINIFANIB,2,Completed,FLT3,2
non-small cell lung carcinoma,LINIFANIB,2,Completed,FLT4,2
non-small cell lung carcinoma,LINIFANIB,2,Completed,KDR,2
non-small cell lung carcinoma,LINIFANIB,2,Completed,PDGFRA,2
non-small cell lung carcinoma,LINIFANIB,2,Completed,PDGFRB,2
non-small cell lung carcinoma,LINSITINIB,2,Completed,IGF1R,2
non-small cell lung carcinoma,MAPATUMUMAB,2,Completed,TNFRSF10A,2
non-small cell lung carcinoma,IXABEPILONE,2,Completed,TUBB6,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",GPD2,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND1,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND2,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND3,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND4,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND4L,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND5,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",MT-ND6,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA1,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA10,2
non-small cell lung carcinoma,VINORELBINE,3,Unknown status,TUBB8,2
non-small cell lung carcinoma,IXABEPILONE,2,Completed,TUBB8,2
non-small cell lung carcinoma,IXABEPILONE,2,Completed,TUBB4B,2
non-small cell lung carcinoma,VINORELBINE,3,Unknown status,TUBB4B,2
non-small cell lung carcinoma,IXABEPILONE,1,Completed,TUBB1,2
non-small cell lung carcinoma,IMATINIB,2,Completed,PDGFRB,2
non-small cell lung carcinoma,IPILIMUMAB,1,"Active, not recruiting",CTLA4,2
non-small cell lung carcinoma,IPILIMUMAB,1,Completed,CTLA4,2
non-small cell lung carcinoma,VORINOSTAT,1,"Active, not recruiting",HDAC6,2
non-small cell lung carcinoma,VORINOSTAT,1,"Active, not recruiting",HDAC3,2
non-small cell lung carcinoma,VORINOSTAT,1,"Active, not recruiting",HDAC2,2
non-small cell lung carcinoma,VORINOSTAT,1,"Active, not recruiting",HDAC1,2
non-small cell lung carcinoma,VOLOCIXIMAB,1,Completed,ITGB1,2
non-small cell lung carcinoma,IRINOTECAN,1,Terminated,TOP1,2
non-small cell lung carcinoma,VOLOCIXIMAB,1,Completed,ITGA5,2
non-small cell lung carcinoma,IXABEPILONE,1,Completed,TUBB,2
non-small cell lung carcinoma,IXABEPILONE,1,Completed,TUBB2A,2
non-small cell lung carcinoma,IXABEPILONE,2,Completed,TUBB4A,2
non-small cell lung carcinoma,IXABEPILONE,1,Completed,TUBB2B,2
non-small cell lung carcinoma,IXABEPILONE,1,Completed,TUBB3,2
non-small cell lung carcinoma,IXABEPILONE,1,Completed,TUBB4A,2
non-small cell lung carcinoma,IXABEPILONE,1,Completed,TUBB4B,2
non-small cell lung carcinoma,IXABEPILONE,1,Completed,TUBB6,2
non-small cell lung carcinoma,IXABEPILONE,1,Completed,TUBB8,2
non-small cell lung carcinoma,IXABEPILONE,2,Completed,TUBB,2
non-small cell lung carcinoma,IXABEPILONE,2,Completed,TUBB1,2
non-small cell lung carcinoma,IXABEPILONE,2,Completed,TUBB2A,2
non-small cell lung carcinoma,IXABEPILONE,2,Completed,TUBB2B,2
non-small cell lung carcinoma,IXABEPILONE,2,Completed,TUBB3,2
non-small cell lung carcinoma,VINORELBINE,3,Unknown status,TUBB6,2
non-small cell lung carcinoma,VINORELBINE,3,Unknown status,TUBB4A,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB3,2
non-small cell lung carcinoma,VELIPARIB,2,Completed,PARP1,2
non-small cell lung carcinoma,VINORELBINE,2,Not yet recruiting,TUBB4A,2
non-small cell lung carcinoma,VINORELBINE,2,Not yet recruiting,TUBB3,2
non-small cell lung carcinoma,VINORELBINE,2,Not yet recruiting,TUBB2B,2
non-small cell lung carcinoma,VINORELBINE,2,Not yet recruiting,TUBB2A,2
non-small cell lung carcinoma,VINORELBINE,2,Not yet recruiting,TUBB1,2
non-small cell lung carcinoma,VINORELBINE,2,Not yet recruiting,TUBB,2
non-small cell lung carcinoma,VELIPARIB,3,"Active, not recruiting",PARP3,2
non-small cell lung carcinoma,VELIPARIB,3,"Active, not recruiting",PARP2,2
non-small cell lung carcinoma,VELIPARIB,3,"Active, not recruiting",PARP1,2
non-small cell lung carcinoma,VELIPARIB,2,Completed,PARP3,2
non-small cell lung carcinoma,VELIPARIB,2,Completed,PARP2,2
non-small cell lung carcinoma,VELIPARIB,1,"Active, not recruiting",PARP3,2
non-small cell lung carcinoma,VINORELBINE,2,Not yet recruiting,TUBB6,2
non-small cell lung carcinoma,VELIPARIB,1,"Active, not recruiting",PARP2,2
non-small cell lung carcinoma,VELIPARIB,1,"Active, not recruiting",PARP1,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFAB1,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFAF1,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFAF2,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFAF3,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFAF4,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB1,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB10,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB11,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFB2,2
non-small cell lung carcinoma,VINORELBINE,2,Not yet recruiting,TUBB4B,2
non-small cell lung carcinoma,VINORELBINE,2,Not yet recruiting,TUBB8,2
non-small cell lung carcinoma,VINORELBINE,3,Unknown status,TUBB3,2
non-small cell lung carcinoma,VINORELBINE,3,Terminated,TUBB1,2
non-small cell lung carcinoma,VINORELBINE,3,Unknown status,TUBB2B,2
non-small cell lung carcinoma,VINORELBINE,3,Unknown status,TUBB2A,2
non-small cell lung carcinoma,VINORELBINE,3,Unknown status,TUBB1,2
non-small cell lung carcinoma,VINORELBINE,3,Unknown status,TUBB,2
non-small cell lung carcinoma,VINORELBINE,3,Terminated,TUBB8,2
non-small cell lung carcinoma,VINORELBINE,3,Terminated,TUBB6,2
non-small cell lung carcinoma,VINORELBINE,3,Terminated,TUBB4B,2
non-small cell lung carcinoma,VINORELBINE,3,Terminated,TUBB4A,2
non-small cell lung carcinoma,VINORELBINE,3,Terminated,TUBB3,2
non-small cell lung carcinoma,VINORELBINE,3,Terminated,TUBB2B,2
non-small cell lung carcinoma,VINORELBINE,3,Terminated,TUBB2A,2
non-small cell lung carcinoma,VINORELBINE,3,Terminated,TUBB,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA9,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA11,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA12,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA13,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA2,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA3,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA4,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA4L2,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,EPHA1,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA6,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA7,2
non-small cell lung carcinoma,METFORMIN,2,"Active, not recruiting",NDUFA8,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,EPHA10,2
non-small cell lung carcinoma,SUNITINIB,3,Completed,KIT,2
non-small cell lung carcinoma,VANDETANIB,1,Completed,EGFR,2
non-small cell lung carcinoma,NINTEDANIB,1,Recruiting,FLT4,2
non-small cell lung carcinoma,PONATINIB,1,Recruiting,BCR,2
non-small cell lung carcinoma,PONATINIB,1,Recruiting,ABL1,2
non-small cell lung carcinoma,PIOGLITAZONE,2,Terminated,PPARG,2
non-small cell lung carcinoma,PICTILISIB,1,Completed,PIK3R5,2
non-small cell lung carcinoma,NINTEDANIB,1,Recruiting,FGFR1,2
non-small cell lung carcinoma,PICTILISIB,1,Completed,PIK3R3,2
non-small cell lung carcinoma,PICTILISIB,1,Completed,PIK3R2,2
non-small cell lung carcinoma,PICTILISIB,1,Completed,PIK3R1,2
non-small cell lung carcinoma,PICTILISIB,1,Completed,PIK3CG,2
non-small cell lung carcinoma,NINTEDANIB,1,Recruiting,FGFR2,2
non-small cell lung carcinoma,NINTEDANIB,1,Recruiting,FGFR3,2
non-small cell lung carcinoma,NINTEDANIB,1,Recruiting,FGFR4,2
non-small cell lung carcinoma,NINTEDANIB,1,Recruiting,FLT1,2
non-small cell lung carcinoma,NINTEDANIB,1,Recruiting,KDR,2
non-small cell lung carcinoma,NINTEDANIB,2,Completed,KDR,2
non-small cell lung carcinoma,NINTEDANIB,1,Recruiting,PDGFRA,2
non-small cell lung carcinoma,NINTEDANIB,1,Recruiting,PDGFRB,2
non-small cell lung carcinoma,NINTEDANIB,2,Completed,FGFR1,2
non-small cell lung carcinoma,NINTEDANIB,2,Completed,FGFR2,2
non-small cell lung carcinoma,NINTEDANIB,2,Completed,FGFR3,2
non-small cell lung carcinoma,PICTILISIB,1,Completed,PIK3CD,2
non-small cell lung carcinoma,PICTILISIB,1,Completed,PIK3CB,2
non-small cell lung carcinoma,PICTILISIB,1,Completed,PIK3CA,2
non-small cell lung carcinoma,PERTUZUMAB,2,Completed,ERBB2,2
non-small cell lung carcinoma,PEMETREXED,3,Withdrawn,TYMS,2
non-small cell lung carcinoma,PEMETREXED,3,Withdrawn,GART,2
non-small cell lung carcinoma,NINTEDANIB,2,Completed,FGFR4,2
non-small cell lung carcinoma,NINTEDANIB,2,Completed,FLT1,2
non-small cell lung carcinoma,PONATINIB,2,"Active, not recruiting",ABL1,2
non-small cell lung carcinoma,PONATINIB,2,"Active, not recruiting",BCR,2
non-small cell lung carcinoma,PONATINIB,2,Completed,ABL1,2
non-small cell lung carcinoma,PONATINIB,2,Completed,BCR,2
non-small cell lung carcinoma,NECITUMUMAB,2,Completed,EGFR,2
non-small cell lung carcinoma,SELUMETINIB,1,Recruiting,MAP2K2,2
non-small cell lung carcinoma,SELUMETINIB,1,Recruiting,MAP2K1,2
non-small cell lung carcinoma,NERATINIB,2,Completed,ERBB3,2
non-small cell lung carcinoma,NERATINIB,2,Completed,ERBB4,2
non-small cell lung carcinoma,NIMOTUZUMAB,2,Terminated,EGFR,2
non-small cell lung carcinoma,NINTEDANIB,1,"Active, not recruiting",FGFR1,2
non-small cell lung carcinoma,SELUMETINIB,1,"Active, not recruiting",MAP2K2,2
non-small cell lung carcinoma,NINTEDANIB,1,"Active, not recruiting",FGFR2,2
non-small cell lung carcinoma,NINTEDANIB,1,"Active, not recruiting",FGFR3,2
non-small cell lung carcinoma,SELUMETINIB,1,"Active, not recruiting",MAP2K1,2
non-small cell lung carcinoma,NINTEDANIB,1,"Active, not recruiting",FGFR4,2
non-small cell lung carcinoma,NINTEDANIB,1,"Active, not recruiting",FLT1,2
non-small cell lung carcinoma,NINTEDANIB,1,"Active, not recruiting",FLT4,2
non-small cell lung carcinoma,NINTEDANIB,1,"Active, not recruiting",KDR,2
non-small cell lung carcinoma,NINTEDANIB,1,"Active, not recruiting",PDGFRA,2
non-small cell lung carcinoma,NINTEDANIB,1,"Active, not recruiting",PDGFRB,2
non-small cell lung carcinoma,RAMUCIRUMAB,2,Not yet recruiting,KDR,2
non-small cell lung carcinoma,RAMUCIRUMAB,1,"Active, not recruiting",KDR,2
non-small cell lung carcinoma,PYROTINIB,2,Unknown status,ERBB2,2
non-small cell lung carcinoma,PYROTINIB,2,Unknown status,EGFR,2
non-small cell lung carcinoma,POZIOTINIB,2,Recruiting,ERBB4,2
non-small cell lung carcinoma,POZIOTINIB,2,Recruiting,ERBB3,2
non-small cell lung carcinoma,POZIOTINIB,2,Recruiting,ERBB2,2
non-small cell lung carcinoma,POZIOTINIB,2,Recruiting,EGFR,2
non-small cell lung carcinoma,PONATINIB,2,Terminated,BCR,2
non-small cell lung carcinoma,PONATINIB,2,Terminated,ABL1,2
non-small cell lung carcinoma,NINTEDANIB,2,Completed,FLT4,2
non-small cell lung carcinoma,NINTEDANIB,2,Completed,PDGFRA,2
non-small cell lung carcinoma,TREMELIMUMAB,2,Completed,CTLA4,2
non-small cell lung carcinoma,PACLITAXEL,1,Not yet recruiting,TUBB2A,2
non-small cell lung carcinoma,PAZOPANIB,2,Terminated,FLT1,2
non-small cell lung carcinoma,PAZOPANIB,2,Terminated,FGFR3,2
non-small cell lung carcinoma,PAZOPANIB,2,Terminated,FGFR1,2
non-small cell lung carcinoma,PAZOPANIB,2,Terminated,CSF1R,2
non-small cell lung carcinoma,OSIMERTINIB,3,Recruiting,EGFR,2
non-small cell lung carcinoma,OSIMERTINIB,4,Not yet recruiting,EGFR,2
non-small cell lung carcinoma,OSIMERTINIB,4,n/a,EGFR,2
non-small cell lung carcinoma,PALBOCICLIB,2,Recruiting,CCND1,2
non-small cell lung carcinoma,PALBOCICLIB,2,"Active, not recruiting",CCND1,2
non-small cell lung carcinoma,PALBOCICLIB,1,Recruiting,CCND1,2
non-small cell lung carcinoma,PALBOCICLIB,1,"Active, not recruiting",CCND1,2
non-small cell lung carcinoma,PACLITAXEL,1,Not yet recruiting,TUBB,2
non-small cell lung carcinoma,PACLITAXEL,1,Not yet recruiting,TUBB1,2
non-small cell lung carcinoma,PACLITAXEL,1,Not yet recruiting,TUBB2B,2
non-small cell lung carcinoma,NINTEDANIB,2,Completed,PDGFRB,2
non-small cell lung carcinoma,PACLITAXEL,1,Not yet recruiting,TUBB3,2
non-small cell lung carcinoma,PACLITAXEL,1,Not yet recruiting,TUBB4A,2
non-small cell lung carcinoma,PACLITAXEL,1,Not yet recruiting,TUBB4B,2
non-small cell lung carcinoma,PACLITAXEL,1,Not yet recruiting,TUBB6,2
non-small cell lung carcinoma,PACLITAXEL,1,Not yet recruiting,TUBB8,2
non-small cell lung carcinoma,IMATINIB,2,Completed,ABL1,2
non-small cell lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB8,2
non-small cell lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB6,2
non-small cell lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB4B,2
non-small cell lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB4A,2
non-small cell lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB3,2
non-small cell lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB2B,2
non-small cell lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB2A,2
non-small cell lung carcinoma,PAZOPANIB,2,Terminated,FLT4,2
non-small cell lung carcinoma,PAZOPANIB,2,Terminated,ITK,2
non-small cell lung carcinoma,PAZOPANIB,2,Terminated,KDR,2
non-small cell lung carcinoma,PAZOPANIB,2,Terminated,KIT,2
non-small cell lung carcinoma,NIRAPARIB,1,Recruiting,PARP1,2
non-small cell lung carcinoma,NIRAPARIB,1,Recruiting,PARP2,2
non-small cell lung carcinoma,NITROGLYCERIN,2,Unknown status,GUCY1B1,2
non-small cell lung carcinoma,NITROGLYCERIN,2,Unknown status,GUCY1B2,2
non-small cell lung carcinoma,PEMETREXED,3,Withdrawn,DHFR,2
non-small cell lung carcinoma,NIVOLUMAB,3,Withdrawn,PDCD1,2
non-small cell lung carcinoma,OLAPARIB,1,Recruiting,PARP1,2
non-small cell lung carcinoma,OLAPARIB,1,Recruiting,PARP2,2
non-small cell lung carcinoma,OLAPARIB,1,Recruiting,PARP3,2
non-small cell lung carcinoma,OLAPARIB,2,"Active, not recruiting",PARP1,2
non-small cell lung carcinoma,OLAPARIB,2,"Active, not recruiting",PARP2,2
non-small cell lung carcinoma,OLAPARIB,2,"Active, not recruiting",PARP3,2
non-small cell lung carcinoma,PEMETREXED,1,Unknown status,TYMS,2
non-small cell lung carcinoma,OLMUTINIB,2,"Active, not recruiting",EGFR,2
non-small cell lung carcinoma,ONARTUZUMAB,2,Completed,MET,2
non-small cell lung carcinoma,PEMETREXED,1,Unknown status,GART,2
non-small cell lung carcinoma,PEMETREXED,1,Unknown status,DHFR,2
non-small cell lung carcinoma,OSIMERTINIB,1,Completed,EGFR,2
non-small cell lung carcinoma,OSIMERTINIB,1,Not yet recruiting,EGFR,2
non-small cell lung carcinoma,PEMBROLIZUMAB,2,Not yet recruiting,PDCD1,2
non-small cell lung carcinoma,PEMBROLIZUMAB,1,Terminated,PDCD1,2
non-small cell lung carcinoma,PEMBROLIZUMAB,0,Recruiting,PDCD1,2
non-small cell lung carcinoma,PEGFILGRASTIM,2,Completed,CSF3R,2
non-small cell lung carcinoma,PAZOPANIB,2,Terminated,PDGFRB,2
non-small cell lung carcinoma,PAZOPANIB,2,Terminated,PDGFRA,2
non-small cell lung carcinoma,OSIMERTINIB,2,Completed,EGFR,2
non-small cell lung carcinoma,PAZOPANIB,2,Terminated,LCK,2
non-small cell lung carcinoma,NECITUMUMAB,1,Recruiting,EGFR,2
non-small cell lung carcinoma,MOTESANIB,3,Terminated,RET,2
non-small cell lung carcinoma,MOTESANIB,3,Terminated,PDGFRB,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFAF1,2
non-small cell lung carcinoma,TEMSIROLIMUS,2,Completed,FKBP1A,2
non-small cell lung carcinoma,TARIQUIDAR,3,Terminated,ABCB1,2
non-small cell lung carcinoma,SUNITINIB,3,Completed,RET,2
non-small cell lung carcinoma,SUNITINIB,3,Completed,PDGFRB,2
non-small cell lung carcinoma,SUNITINIB,3,Completed,PDGFRA,2
non-small cell lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB,2
non-small cell lung carcinoma,SUNITINIB,3,Completed,KDR,2
non-small cell lung carcinoma,SUNITINIB,3,Completed,FLT4,2
non-small cell lung carcinoma,SUNITINIB,3,Completed,FLT3,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFA7,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFA8,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFA9,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFAB1,2
non-small cell lung carcinoma,SUNITINIB,3,Completed,FLT1,2
non-small cell lung carcinoma,MOTESANIB,3,Terminated,PDGFRA,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFAF2,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFAF3,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFAF4,2
non-small cell lung carcinoma,SUNITINIB,3,Completed,CSF1R,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFB1,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFB10,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFB11,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFB2,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFB3,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFB4,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFB5,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFB6,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFB7,2
non-small cell lung carcinoma,THALIDOMIDE,2,Unknown status,CRBN,2
non-small cell lung carcinoma,THALIDOMIDE,2,Unknown status,CUL4A,2
non-small cell lung carcinoma,THALIDOMIDE,2,Unknown status,DDB1,2
non-small cell lung carcinoma,THALIDOMIDE,2,Unknown status,RBX1,2
non-small cell lung carcinoma,TREMELIMUMAB,1,Recruiting,CTLA4,2
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Recruiting,TUBB8,2
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Recruiting,TUBB6,2
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Recruiting,TUBB4B,2
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Recruiting,TUBB4A,2
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Recruiting,TUBB3,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,MT-ND6,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFA1,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFA10,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFA11,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFA12,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFA13,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFA2,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFA3,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFA4,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFA4L2,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFA5,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFA6,2
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Recruiting,TUBB2B,2
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Recruiting,TUBB2A,2
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Recruiting,TUBB1,2
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Recruiting,TUBB,2
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Recruiting,ERBB2,2
non-small cell lung carcinoma,TRAMETINIB,1,Terminated,MAP2K2,2
non-small cell lung carcinoma,TRAMETINIB,1,Terminated,MAP2K1,2
non-small cell lung carcinoma,TOPOTECAN,3,Completed,TOP1MT,2
non-small cell lung carcinoma,TIVANTINIB,2,Completed,MET,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFB8,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFB9,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFC1,2
non-small cell lung carcinoma,SORAFENIB,3,Completed,BRAF,2
non-small cell lung carcinoma,SORAFENIB,2,Terminated,RAF1,2
non-small cell lung carcinoma,SORAFENIB,2,Terminated,PDGFRB,2
non-small cell lung carcinoma,SORAFENIB,2,Terminated,KIT,2
non-small cell lung carcinoma,SORAFENIB,2,Terminated,KDR,2
non-small cell lung carcinoma,SORAFENIB,2,Terminated,FLT4,2
non-small cell lung carcinoma,SORAFENIB,2,Terminated,FLT3,2
non-small cell lung carcinoma,SORAFENIB,2,Terminated,FLT1,2
non-small cell lung carcinoma,SORAFENIB,2,Terminated,BRAF,2
non-small cell lung carcinoma,SORAFENIB,1,Terminated,RET,2
non-small cell lung carcinoma,SORAFENIB,1,Terminated,RAF1,2
non-small cell lung carcinoma,SORAFENIB,1,Terminated,PDGFRB,2
non-small cell lung carcinoma,SORAFENIB,1,Terminated,KIT,2
non-small cell lung carcinoma,SORAFENIB,1,Terminated,KDR,2
non-small cell lung carcinoma,SORAFENIB,1,Terminated,FLT4,2
non-small cell lung carcinoma,SORAFENIB,1,Terminated,FLT3,2
non-small cell lung carcinoma,SORAFENIB,1,Terminated,FLT1,2
non-small cell lung carcinoma,SORAFENIB,1,Terminated,BRAF,2
non-small cell lung carcinoma,SIROLIMUS,1,Recruiting,FKBP1A,2
non-small cell lung carcinoma,SIROLIMUS,1,Completed,FKBP1A,2
non-small cell lung carcinoma,SELUMETINIB,2,Recruiting,MAP2K2,2
non-small cell lung carcinoma,MOMELOTINIB,1,Terminated,JAK1,2
non-small cell lung carcinoma,MOMELOTINIB,1,Terminated,JAK2,2
non-small cell lung carcinoma,MOTESANIB,3,Terminated,FLT1,2
non-small cell lung carcinoma,SELUMETINIB,2,Recruiting,MAP2K1,2
non-small cell lung carcinoma,MOTESANIB,3,Terminated,FLT4,2
non-small cell lung carcinoma,MOTESANIB,3,Terminated,KDR,2
non-small cell lung carcinoma,MOTESANIB,3,Terminated,KIT,2
non-small cell lung carcinoma,SORAFENIB,2,Terminated,RET,2
non-small cell lung carcinoma,SORAFENIB,3,Completed,FLT1,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFC2,2
non-small cell lung carcinoma,SORAFENIB,3,Completed,FLT3,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFS1,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFS2,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFS3,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFS4,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFS5,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFS6,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFS7,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFS8,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFV1,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFV2,2
non-small cell lung carcinoma,METFORMIN,2,Recruiting,NDUFV3,2
non-small cell lung carcinoma,SORAFENIB,3,Terminated,RET,2
non-small cell lung carcinoma,SORAFENIB,3,Terminated,RAF1,2
non-small cell lung carcinoma,SORAFENIB,3,Terminated,PDGFRB,2
non-small cell lung carcinoma,SORAFENIB,3,Terminated,KIT,2
non-small cell lung carcinoma,SORAFENIB,3,Terminated,KDR,2
non-small cell lung carcinoma,SORAFENIB,3,Terminated,FLT4,2
non-small cell lung carcinoma,SORAFENIB,3,Terminated,FLT3,2
non-small cell lung carcinoma,SORAFENIB,3,Terminated,FLT1,2
non-small cell lung carcinoma,SORAFENIB,3,Terminated,BRAF,2
non-small cell lung carcinoma,ABEMACICLIB,1,"Active, not recruiting",CDK6,2
non-small cell lung carcinoma,SORAFENIB,3,Completed,RET,2
non-small cell lung carcinoma,SORAFENIB,3,Completed,RAF1,2
non-small cell lung carcinoma,SORAFENIB,3,Completed,PDGFRB,2
non-small cell lung carcinoma,SORAFENIB,3,Completed,KIT,2
non-small cell lung carcinoma,SORAFENIB,3,Completed,KDR,2
non-small cell lung carcinoma,SORAFENIB,3,Completed,FLT4,2
non-small cell lung carcinoma,IMATINIB,2,Completed,KIT,2
non-small cell lung carcinoma,ABEMACICLIB,1,"Active, not recruiting",CDK4,2
non-small cell lung carcinoma,CRIZOTINIB,3,Recruiting,ALK,2
non-small cell lung carcinoma,DOCETAXEL,1,Not yet recruiting,TUBB2B,2
non-small cell lung carcinoma,DASATINIB,1,Completed,KIT,2
non-small cell lung carcinoma,DASATINIB,1,Completed,LCK,2
non-small cell lung carcinoma,DASATINIB,1,Completed,LYN,2
non-small cell lung carcinoma,DASATINIB,1,Completed,PDGFRB,2
non-small cell lung carcinoma,DASATINIB,1,Completed,SRC,2
non-small cell lung carcinoma,DASATINIB,1,Completed,SRMS,2
non-small cell lung carcinoma,DASATINIB,1,Completed,YES1,2
non-small cell lung carcinoma,DECITABINE,1,Completed,DNMT1,2
non-small cell lung carcinoma,DECITABINE,1,Completed,DNMT3A,2
non-small cell lung carcinoma,DEXAMETHASONE,3,Completed,NR3C1,2
non-small cell lung carcinoma,DOCETAXEL,1,Not yet recruiting,TUBB,2
non-small cell lung carcinoma,DOCETAXEL,1,Not yet recruiting,TUBB1,2
non-small cell lung carcinoma,DOCETAXEL,1,Not yet recruiting,TUBB2A,2
non-small cell lung carcinoma,DOCETAXEL,1,Not yet recruiting,TUBB3,2
non-small cell lung carcinoma,DASATINIB,1,Completed,FYN,2
non-small cell lung carcinoma,DOCETAXEL,1,Not yet recruiting,TUBB4A,2
non-small cell lung carcinoma,DOCETAXEL,1,Not yet recruiting,TUBB4B,2
non-small cell lung carcinoma,DOCETAXEL,1,Not yet recruiting,TUBB6,2
non-small cell lung carcinoma,DOCETAXEL,1,Not yet recruiting,TUBB8,2
non-small cell lung carcinoma,DOCETAXEL,4,Completed,TUBB,2
non-small cell lung carcinoma,DOCETAXEL,4,Completed,TUBB1,2
non-small cell lung carcinoma,DOCETAXEL,4,Completed,TUBB2A,2
non-small cell lung carcinoma,DOCETAXEL,4,Completed,TUBB2B,2
non-small cell lung carcinoma,DOCETAXEL,4,Completed,TUBB3,2
non-small cell lung carcinoma,DOCETAXEL,4,Completed,TUBB4A,2
non-small cell lung carcinoma,DOCETAXEL,4,Completed,TUBB4B,2
non-small cell lung carcinoma,DOCETAXEL,4,Completed,TUBB6,2
non-small cell lung carcinoma,DOCETAXEL,4,Completed,TUBB8,2
non-small cell lung carcinoma,DASATINIB,1,Completed,HCK,2
non-small cell lung carcinoma,DASATINIB,1,Completed,FRK,2
non-small cell lung carcinoma,DOCETAXEL,4,Unknown status,TUBB1,2
non-small cell lung carcinoma,DASATINIB,1,"Active, not recruiting",EPHA2,2
non-small cell lung carcinoma,DACOMITINIB,1,Terminated,ERBB2,2
non-small cell lung carcinoma,DACOMITINIB,1,Terminated,ERBB4,2
non-small cell lung carcinoma,DACOMITINIB,2,"Active, not recruiting",EGFR,2
non-small cell lung carcinoma,DACOMITINIB,2,"Active, not recruiting",ERBB2,2
non-small cell lung carcinoma,DACOMITINIB,2,"Active, not recruiting",ERBB4,2
non-small cell lung carcinoma,DACOMITINIB,3,"Active, not recruiting",EGFR,2
non-small cell lung carcinoma,DACOMITINIB,3,"Active, not recruiting",ERBB2,2
non-small cell lung carcinoma,DACOMITINIB,3,"Active, not recruiting",ERBB4,2
non-small cell lung carcinoma,DACOMITINIB,3,Completed,EGFR,2
non-small cell lung carcinoma,DACOMITINIB,3,Completed,ERBB2,2
non-small cell lung carcinoma,DACOMITINIB,3,Completed,ERBB4,2
non-small cell lung carcinoma,DASATINIB,1,"Active, not recruiting",ABL1,2
non-small cell lung carcinoma,DASATINIB,1,"Active, not recruiting",BLK,2
non-small cell lung carcinoma,DASATINIB,1,"Active, not recruiting",FGR,2
non-small cell lung carcinoma,DASATINIB,1,Completed,FGR,2
non-small cell lung carcinoma,DASATINIB,1,"Active, not recruiting",FRK,2
non-small cell lung carcinoma,DASATINIB,1,"Active, not recruiting",FYN,2
non-small cell lung carcinoma,DASATINIB,1,"Active, not recruiting",HCK,2
non-small cell lung carcinoma,DASATINIB,1,"Active, not recruiting",KIT,2
non-small cell lung carcinoma,DASATINIB,1,"Active, not recruiting",LCK,2
non-small cell lung carcinoma,DASATINIB,1,"Active, not recruiting",LYN,2
non-small cell lung carcinoma,DASATINIB,1,"Active, not recruiting",PDGFRB,2
non-small cell lung carcinoma,DASATINIB,1,"Active, not recruiting",SRC,2
non-small cell lung carcinoma,DASATINIB,1,"Active, not recruiting",SRMS,2
non-small cell lung carcinoma,DASATINIB,1,"Active, not recruiting",YES1,2
non-small cell lung carcinoma,DASATINIB,1,Completed,ABL1,2
non-small cell lung carcinoma,DASATINIB,1,Completed,BLK,2
non-small cell lung carcinoma,DASATINIB,1,Completed,EPHA2,2
non-small cell lung carcinoma,DOCETAXEL,4,Unknown status,TUBB,2
non-small cell lung carcinoma,DOCETAXEL,4,Unknown status,TUBB2A,2
non-small cell lung carcinoma,DACOMITINIB,1,Suspended,ERBB4,2
non-small cell lung carcinoma,EVEROLIMUS,1,Terminated,FKBP1A,2
non-small cell lung carcinoma,ERLOTINIB,1,Withdrawn,EGFR,2
non-small cell lung carcinoma,ERLOTINIB,2,Withdrawn,EGFR,2
non-small cell lung carcinoma,ERLOTINIB,3,Withdrawn,EGFR,2
non-small cell lung carcinoma,ETOPOSIDE,1,Completed,TOP2A,2
non-small cell lung carcinoma,ETOPOSIDE,1,Completed,TOP2B,2
non-small cell lung carcinoma,ETOPOSIDE,2,Not yet recruiting,TOP2A,2
non-small cell lung carcinoma,ETOPOSIDE,2,Not yet recruiting,TOP2B,2
non-small cell lung carcinoma,ETOPOSIDE,2,Recruiting,TOP2A,2
non-small cell lung carcinoma,ETOPOSIDE,2,Recruiting,TOP2B,2
non-small cell lung carcinoma,ETOPOSIDE,2,Terminated,TOP2A,2
non-small cell lung carcinoma,ETOPOSIDE,2,Terminated,TOP2B,2
non-small cell lung carcinoma,ETOPOSIDE,3,Recruiting,TOP2A,2
non-small cell lung carcinoma,ETOPOSIDE,3,Recruiting,TOP2B,2
non-small cell lung carcinoma,FIGITUMUMAB,3,Terminated,IGF1R,2
non-small cell lung carcinoma,ENTINOSTAT,2,Terminated,HDAC9,2
non-small cell lung carcinoma,GEFITINIB,1,Unknown status,EGFR,2
non-small cell lung carcinoma,GEFITINIB,2,"Active, not recruiting",EGFR,2
non-small cell lung carcinoma,GEFITINIB,2,Not yet recruiting,EGFR,2
non-small cell lung carcinoma,GEFITINIB,2,Terminated,EGFR,2
non-small cell lung carcinoma,GEFITINIB,3,Not yet recruiting,EGFR,2
non-small cell lung carcinoma,GEFITINIB,3,Terminated,EGFR,2
non-small cell lung carcinoma,GEFITINIB,3,Unknown status,EGFR,2
non-small cell lung carcinoma,GEFITINIB,3,Withdrawn,EGFR,2
non-small cell lung carcinoma,GEFITINIB,4,Terminated,EGFR,2
non-small cell lung carcinoma,GEMCITABINE,1,Terminated,POLA1,2
non-small cell lung carcinoma,GEMCITABINE,1,Terminated,POLA2,2
non-small cell lung carcinoma,GEMCITABINE,1,Terminated,POLD1,2
non-small cell lung carcinoma,GEMCITABINE,1,Terminated,POLD2,2
non-small cell lung carcinoma,ERLOTINIB,1,Unknown status,EGFR,2
non-small cell lung carcinoma,ENTINOSTAT,2,Terminated,HDAC8,2
non-small cell lung carcinoma,DOCETAXEL,4,Unknown status,TUBB2B,2
non-small cell lung carcinoma,ENTINOSTAT,1,Completed,HDAC3,2
non-small cell lung carcinoma,DOCETAXEL,4,Unknown status,TUBB3,2
non-small cell lung carcinoma,DOCETAXEL,4,Unknown status,TUBB4A,2
non-small cell lung carcinoma,DOCETAXEL,4,Unknown status,TUBB4B,2
non-small cell lung carcinoma,DOCETAXEL,4,Unknown status,TUBB6,2
non-small cell lung carcinoma,DOCETAXEL,4,Unknown status,TUBB8,2
non-small cell lung carcinoma,DURVALUMAB,1,"Active, not recruiting",CD274,2
non-small cell lung carcinoma,DURVALUMAB,1,Not yet recruiting,CD274,2
non-small cell lung carcinoma,EGF816,1,Recruiting,EGFR,2
non-small cell lung carcinoma,ENOBOSARM,3,Completed,AR,2
non-small cell lung carcinoma,ENTINOSTAT,1,Completed,HDAC1,2
non-small cell lung carcinoma,ENTINOSTAT,1,Completed,HDAC10,2
non-small cell lung carcinoma,ENTINOSTAT,1,Completed,HDAC11,2
non-small cell lung carcinoma,ENTINOSTAT,1,Completed,HDAC2,2
non-small cell lung carcinoma,ENTINOSTAT,1,Completed,HDAC4,2
non-small cell lung carcinoma,ENTINOSTAT,2,Terminated,HDAC7,2
non-small cell lung carcinoma,ENTINOSTAT,1,Completed,HDAC5,2
non-small cell lung carcinoma,ENTINOSTAT,1,Completed,HDAC6,2
non-small cell lung carcinoma,ENTINOSTAT,1,Completed,HDAC7,2
non-small cell lung carcinoma,ENTINOSTAT,1,Completed,HDAC8,2
non-small cell lung carcinoma,ENTINOSTAT,1,Completed,HDAC9,2
non-small cell lung carcinoma,ENTINOSTAT,2,Terminated,HDAC1,2
non-small cell lung carcinoma,ENTINOSTAT,2,Terminated,HDAC10,2
non-small cell lung carcinoma,ENTINOSTAT,2,Terminated,HDAC11,2
non-small cell lung carcinoma,ENTINOSTAT,2,Terminated,HDAC2,2
non-small cell lung carcinoma,ENTINOSTAT,2,Terminated,HDAC3,2
non-small cell lung carcinoma,ENTINOSTAT,2,Terminated,HDAC4,2
non-small cell lung carcinoma,ENTINOSTAT,2,Terminated,HDAC5,2
non-small cell lung carcinoma,ENTINOSTAT,2,Terminated,HDAC6,2
non-small cell lung carcinoma,DACOMITINIB,1,Terminated,EGFR,2
non-small cell lung carcinoma,DACOMITINIB,1,Suspended,ERBB2,2
non-small cell lung carcinoma,GEMCITABINE,1,Terminated,POLD4,2
non-small cell lung carcinoma,AZD-1775,2,Terminated,WEE1,2
non-small cell lung carcinoma,ASPIRIN,2,Not yet recruiting,PTGS2,2
non-small cell lung carcinoma,ATEZOLIZUMAB,1,"Active, not recruiting",CD274,2
non-small cell lung carcinoma,ATEZOLIZUMAB,2,"Active, not recruiting",CD274,2
non-small cell lung carcinoma,ATEZOLIZUMAB,3,Recruiting,CD274,2
non-small cell lung carcinoma,AVELUMAB,2,"Active, not recruiting",CD274,2
non-small cell lung carcinoma,AVELUMAB,3,"Active, not recruiting",CD274,2
non-small cell lung carcinoma,AXITINIB,2,Completed,FLT1,2
non-small cell lung carcinoma,AXITINIB,2,Completed,FLT4,2
non-small cell lung carcinoma,AXITINIB,2,Completed,KDR,2
non-small cell lung carcinoma,AZACITIDINE,1,Completed,DNMT1,2
non-small cell lung carcinoma,AZACITIDINE,1,Completed,DNMT3A,2
non-small cell lung carcinoma,AZACITIDINE,2,Terminated,DNMT1,2
non-small cell lung carcinoma,AZACITIDINE,2,Terminated,DNMT3A,2
non-small cell lung carcinoma,BELINOSTAT,1,Terminated,HDAC1,2
non-small cell lung carcinoma,APRICOXIB,2,Completed,PTGS2,2
non-small cell lung carcinoma,BELINOSTAT,1,Terminated,HDAC10,2
non-small cell lung carcinoma,BELINOSTAT,1,Terminated,HDAC11,2
non-small cell lung carcinoma,BELINOSTAT,1,Terminated,HDAC2,2
non-small cell lung carcinoma,BELINOSTAT,1,Terminated,HDAC3,2
non-small cell lung carcinoma,BELINOSTAT,1,Terminated,HDAC4,2
non-small cell lung carcinoma,BELINOSTAT,1,Terminated,HDAC5,2
non-small cell lung carcinoma,BELINOSTAT,1,Terminated,HDAC6,2
non-small cell lung carcinoma,BELINOSTAT,1,Terminated,HDAC7,2
non-small cell lung carcinoma,BELINOSTAT,1,Terminated,HDAC8,2
non-small cell lung carcinoma,BELINOSTAT,1,Terminated,HDAC9,2
non-small cell lung carcinoma,BEVACIZUMAB,3,Not yet recruiting,VEGFA,2
non-small cell lung carcinoma,BEVACIZUMAB,4,Completed,VEGFA,2
non-small cell lung carcinoma,BEXAROTENE,3,Completed,RXRA,2
non-small cell lung carcinoma,ASPIRIN,2,Not yet recruiting,PTGS1,2
non-small cell lung carcinoma,APATINIB,3,Unknown status,KDR,2
non-small cell lung carcinoma,BEXAROTENE,3,Completed,RXRG,2
non-small cell lung carcinoma,ALECTINIB,1,Completed,ALK,2
non-small cell lung carcinoma,ABEMACICLIB,2,"Active, not recruiting",CDK4,2
non-small cell lung carcinoma,ABEMACICLIB,2,"Active, not recruiting",CDK6,2
non-small cell lung carcinoma,AFATINIB,1,"Active, not recruiting",EGFR,2
non-small cell lung carcinoma,AFATINIB,1,"Active, not recruiting",ERBB2,2
non-small cell lung carcinoma,AFATINIB,1,"Active, not recruiting",ERBB4,2
non-small cell lung carcinoma,AFATINIB,1,Unknown status,EGFR,2
non-small cell lung carcinoma,AFATINIB,1,Unknown status,ERBB2,2
non-small cell lung carcinoma,AFATINIB,1,Unknown status,ERBB4,2
non-small cell lung carcinoma,AFATINIB,2,Unknown status,EGFR,2
non-small cell lung carcinoma,AFATINIB,2,Unknown status,ERBB2,2
non-small cell lung carcinoma,AFATINIB,2,Unknown status,ERBB4,2
non-small cell lung carcinoma,ALECTINIB,1,"Active, not recruiting",ALK,2
non-small cell lung carcinoma,ALECTINIB,1,"Active, not recruiting",RET,2
non-small cell lung carcinoma,ALECTINIB,1,Completed,RET,2
non-small cell lung carcinoma,APATINIB,3,Recruiting,KDR,2
non-small cell lung carcinoma,ALECTINIB,1,Recruiting,ALK,2
non-small cell lung carcinoma,ALECTINIB,1,Recruiting,RET,2
non-small cell lung carcinoma,ALECTINIB,3,"Active, not recruiting",ALK,2
non-small cell lung carcinoma,ALECTINIB,3,"Active, not recruiting",RET,2
non-small cell lung carcinoma,ANLOTINIB,2,Completed,FLT4,2
non-small cell lung carcinoma,ANLOTINIB,2,Completed,KDR,2
non-small cell lung carcinoma,ANLOTINIB,2,Completed,KIT,2
non-small cell lung carcinoma,ANLOTINIB,2,Completed,PDGFRB,2
non-small cell lung carcinoma,ANLOTINIB,2,Recruiting,FLT4,2
non-small cell lung carcinoma,ANLOTINIB,2,Recruiting,KDR,2
non-small cell lung carcinoma,ANLOTINIB,2,Recruiting,KIT,2
non-small cell lung carcinoma,ANLOTINIB,2,Recruiting,PDGFRB,2
non-small cell lung carcinoma,APATINIB,1,Recruiting,KDR,2
non-small cell lung carcinoma,BEXAROTENE,3,Completed,RXRB,2
non-small cell lung carcinoma,BINIMETINIB,1,Recruiting,MAP2K1,2
non-small cell lung carcinoma,DACOMITINIB,1,Suspended,EGFR,2
non-small cell lung carcinoma,CERITINIB,3,"Active, not recruiting",ALK,2
non-small cell lung carcinoma,CABOZANTINIB,1,Completed,KDR,2
non-small cell lung carcinoma,CABOZANTINIB,1,Completed,MET,2
non-small cell lung carcinoma,CABOZANTINIB,2,Recruiting,KDR,2
non-small cell lung carcinoma,CABOZANTINIB,2,Recruiting,MET,2
non-small cell lung carcinoma,CAPECITABINE,2,Completed,TYMS,2
non-small cell lung carcinoma,CC-223,1,Completed,MTOR,2
non-small cell lung carcinoma,CEDIRANIB,2,Completed,FLT1,2
non-small cell lung carcinoma,CEDIRANIB,2,Completed,FLT4,2
non-small cell lung carcinoma,CEDIRANIB,2,Completed,KDR,2
non-small cell lung carcinoma,CEDIRANIB,2,Completed,KIT,2
non-small cell lung carcinoma,CEDIRANIB,2,Completed,PDGFRA,2
non-small cell lung carcinoma,CEDIRANIB,2,Completed,PDGFRB,2
non-small cell lung carcinoma,CERITINIB,1,Completed,ALK,2
non-small cell lung carcinoma,CETUXIMAB,2,Terminated,EGFR,2
non-small cell lung carcinoma,CABAZITAXEL,2,Completed,TUBB6,2
non-small cell lung carcinoma,CILENGITIDE,1,Completed,ITGAV,2
non-small cell lung carcinoma,CILENGITIDE,2,Completed,ITGAV,2
non-small cell lung carcinoma,COBIMETINIB,1,Recruiting,MAP2K1,2
non-small cell lung carcinoma,COBIMETINIB,1,Recruiting,MAP2K2,2
non-small cell lung carcinoma,CRIZOTINIB,2,Not yet recruiting,ALK,2
non-small cell lung carcinoma,CRIZOTINIB,2,Not yet recruiting,MET,2
non-small cell lung carcinoma,CRIZOTINIB,2,Terminated,ALK,2
non-small cell lung carcinoma,CRIZOTINIB,2,Terminated,MET,2
non-small cell lung carcinoma,CRIZOTINIB,3,Recruiting,MET,2
non-small cell lung carcinoma,DACOMITINIB,1,Completed,ERBB3,2
non-small cell lung carcinoma,DACOMITINIB,1,Recruiting,EGFR,2
non-small cell lung carcinoma,DACOMITINIB,1,Recruiting,ERBB2,2
non-small cell lung carcinoma,DACOMITINIB,1,Recruiting,ERBB4,2
non-small cell lung carcinoma,CABAZITAXEL,2,Completed,TUBB8,2
non-small cell lung carcinoma,CABAZITAXEL,2,Completed,TUBB4B,2
non-small cell lung carcinoma,BINIMETINIB,1,Recruiting,MAP2K2,2
non-small cell lung carcinoma,BUPARLISIB,1,Completed,PIK3R3,2
non-small cell lung carcinoma,BMS-690514,2,Completed,EGFR,2
non-small cell lung carcinoma,BMS-690514,2,Completed,ERBB2,2
non-small cell lung carcinoma,BMS-690514,2,Completed,ERBB4,2
non-small cell lung carcinoma,BMS-690514,2,Completed,FLT1,2
non-small cell lung carcinoma,BMS-690514,2,Completed,FLT4,2
non-small cell lung carcinoma,BMS-690514,2,Completed,KDR,2
non-small cell lung carcinoma,BORTEZOMIB,1,Unknown status,PSMB5,2
non-small cell lung carcinoma,BUPARLISIB,1,Completed,PIK3CA,2
non-small cell lung carcinoma,BUPARLISIB,1,Completed,PIK3CB,2
non-small cell lung carcinoma,BUPARLISIB,1,Completed,PIK3CD,2
non-small cell lung carcinoma,BUPARLISIB,1,Completed,PIK3CG,2
non-small cell lung carcinoma,BUPARLISIB,1,Completed,PIK3R1,2
non-small cell lung carcinoma,BUPARLISIB,1,Completed,PIK3R2,2
non-small cell lung carcinoma,BUPARLISIB,1,Completed,PIK3R5,2
non-small cell lung carcinoma,CABAZITAXEL,2,Completed,TUBB4A,2
non-small cell lung carcinoma,BUPARLISIB,1,Terminated,PIK3CA,2
non-small cell lung carcinoma,BUPARLISIB,1,Terminated,PIK3CB,2
non-small cell lung carcinoma,BUPARLISIB,1,Terminated,PIK3CD,2
non-small cell lung carcinoma,BUPARLISIB,1,Terminated,PIK3CG,2
non-small cell lung carcinoma,BUPARLISIB,1,Terminated,PIK3R1,2
non-small cell lung carcinoma,BUPARLISIB,1,Terminated,PIK3R2,2
non-small cell lung carcinoma,BUPARLISIB,1,Terminated,PIK3R3,2
non-small cell lung carcinoma,BUPARLISIB,1,Terminated,PIK3R5,2
non-small cell lung carcinoma,CABAZITAXEL,2,Completed,TUBB,2
non-small cell lung carcinoma,CABAZITAXEL,2,Completed,TUBB1,2
non-small cell lung carcinoma,CABAZITAXEL,2,Completed,TUBB2A,2
non-small cell lung carcinoma,CABAZITAXEL,2,Completed,TUBB2B,2
non-small cell lung carcinoma,CABAZITAXEL,2,Completed,TUBB3,2
non-small cell lung carcinoma,GEMCITABINE,1,Terminated,POLD3,2
non-small cell lung carcinoma,ZOLEDRONIC ACID,3,Completed,FDPS,2
non-small cell lung carcinoma,GEMCITABINE,1,Terminated,POLE,2
non-small cell lung carcinoma,GEMCITABINE,1,Terminated,POLE3,2
non-small cell lung carcinoma,GEMCITABINE,4,Unknown status,RRM1,2
non-small cell lung carcinoma,GEMCITABINE,4,Unknown status,POLD1,2
non-small cell lung carcinoma,GEMCITABINE,4,Unknown status,POLA2,2
non-small cell lung carcinoma,GEMCITABINE,4,Unknown status,POLA1,2
non-small cell lung carcinoma,GEMCITABINE,3,Withdrawn,RRM1,2
non-small cell lung carcinoma,GEMCITABINE,1,Terminated,POLE2,2
non-small cell lung carcinoma,GEMCITABINE,1,Terminated,PRIM1,2
non-small cell lung carcinoma,GEMCITABINE,4,Unknown status,PRIM1,2
non-small cell lung carcinoma,GEMCITABINE,1,Terminated,PRIM2,2
non-small cell lung carcinoma,GEMCITABINE,2,Withdrawn,RRM1,2
non-small cell lung carcinoma,GEMCITABINE,2,Withdrawn,PRIM2,2
non-small cell lung carcinoma,GEMCITABINE,2,Withdrawn,PRIM1,2
non-small cell lung carcinoma,GEMCITABINE,2,Withdrawn,POLE3,2
non-small cell lung carcinoma,GEMCITABINE,2,Withdrawn,POLE2,2
non-small cell lung carcinoma,GEMCITABINE,4,Unknown status,PRIM2,2
non-small cell lung carcinoma,GEMCITABINE,4,Unknown status,POLD2,2
non-small cell lung carcinoma,GEMCITABINE,2,Withdrawn,POLD4,2
non-small cell lung carcinoma,GEMCITABINE,3,Withdrawn,POLE,2
non-small cell lung carcinoma,GEMCITABINE,3,Withdrawn,POLD3,2
non-small cell lung carcinoma,GEMCITABINE,3,Withdrawn,POLD2,2
non-small cell lung carcinoma,GEMCITABINE,3,Withdrawn,POLD1,2
non-small cell lung carcinoma,GEMCITABINE,3,Withdrawn,POLA2,2
non-small cell lung carcinoma,GEMCITABINE,3,Withdrawn,POLA1,2
non-small cell lung carcinoma,GEMCITABINE,4,Unknown status,POLE3,2
non-small cell lung carcinoma,GEMCITABINE,3,Withdrawn,POLE2,2
non-small cell lung carcinoma,GEMCITABINE,4,Unknown status,POLD3,2
non-small cell lung carcinoma,GEMCITABINE,3,Withdrawn,POLE3,2
non-small cell lung carcinoma,GEMCITABINE,3,Withdrawn,PRIM1,2
non-small cell lung carcinoma,GEMCITABINE,4,Unknown status,POLE2,2
non-small cell lung carcinoma,GEMCITABINE,4,Unknown status,POLE,2
non-small cell lung carcinoma,GEMCITABINE,4,Unknown status,POLD4,2
non-small cell lung carcinoma,GEMCITABINE,3,Withdrawn,PRIM2,2
non-small cell lung carcinoma,GEMCITABINE,2,Withdrawn,POLE,2
non-small cell lung carcinoma,GEMCITABINE,3,Withdrawn,POLD4,2
non-small cell lung carcinoma,GEMCITABINE,2,Withdrawn,POLD1,2
non-small cell lung carcinoma,GEMCITABINE,2,Withdrawn,POLD3,2
non-small cell lung carcinoma,GEMCITABINE,2,Withdrawn,POLA1,2
non-small cell lung carcinoma,GEMCITABINE,2,Withdrawn,POLA2,2
non-small cell lung carcinoma,GEMCITABINE,2,Withdrawn,POLD2,2
non-small cell lung carcinoma,GEMCITABINE,1,Terminated,RRM1,2
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",EPHB2,1
non-small cell lung carcinoma,THEOPHYLLINE,1,Unknown status,PDE4C,1
non-small cell lung carcinoma,THEOPHYLLINE,1,Unknown status,PDE4D,1
non-small cell lung carcinoma,THEOPHYLLINE,1,Withdrawn,ADORA1,1
non-small cell lung carcinoma,UCN-01,1,Completed,PRKD1,1
non-small cell lung carcinoma,THEOPHYLLINE,1,Withdrawn,ADORA2B,1
non-small cell lung carcinoma,THEOPHYLLINE,1,Withdrawn,ADORA3,1
non-small cell lung carcinoma,THEOPHYLLINE,1,Withdrawn,PDE3A,1
non-small cell lung carcinoma,THEOPHYLLINE,1,Withdrawn,PDE3B,1
non-small cell lung carcinoma,THEOPHYLLINE,1,Withdrawn,PDE4A,1
non-small cell lung carcinoma,THEOPHYLLINE,1,Withdrawn,ADORA2A,1
non-small cell lung carcinoma,THEOPHYLLINE,1,Unknown status,PDE4B,1
non-small cell lung carcinoma,THEOPHYLLINE,1,Withdrawn,PDE4C,1
non-small cell lung carcinoma,THEOPHYLLINE,1,Unknown status,PDE4A,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",EPHB3,1
non-small cell lung carcinoma,THEOPHYLLINE,1,Unknown status,PDE3B,1
non-small cell lung carcinoma,THEOPHYLLINE,1,Unknown status,PDE3A,1
non-small cell lung carcinoma,THEOPHYLLINE,1,Unknown status,ADORA3,1
non-small cell lung carcinoma,THEOPHYLLINE,1,Unknown status,ADORA2B,1
non-small cell lung carcinoma,THEOPHYLLINE,1,Unknown status,ADORA2A,1
non-small cell lung carcinoma,THEOPHYLLINE,1,Unknown status,ADORA1,1
non-small cell lung carcinoma,THALIDOMIDE,4,Recruiting,RBX1,1
non-small cell lung carcinoma,THALIDOMIDE,4,Recruiting,DDB1,1
non-small cell lung carcinoma,THEOPHYLLINE,1,Withdrawn,PDE4B,1
non-small cell lung carcinoma,TINZAPARIN SODIUM,3,Completed,SERPINC1,1
non-small cell lung carcinoma,THEOPHYLLINE,1,Withdrawn,PDE4D,1
non-small cell lung carcinoma,TIGATUZUMAB,2,Completed,TNFRSF10B,1
non-small cell lung carcinoma,TOSEDOSTAT,1,Terminated,DNPEP,1
non-small cell lung carcinoma,TOSEDOSTAT,1,Terminated,AOPEP,1
non-small cell lung carcinoma,TOSEDOSTAT,1,Terminated,ANPEP,1
non-small cell lung carcinoma,BRIGATINIB,1,Not yet recruiting,ALK,1
non-small cell lung carcinoma,TOPOTECAN,2,Completed,TOP1MT,1
non-small cell lung carcinoma,TOPOTECAN,1,Recruiting,TOP1MT,1
non-small cell lung carcinoma,TOCILIZUMAB,1,Recruiting,IL6R,1
non-small cell lung carcinoma,TIVOZANIB,1,Withdrawn,KDR,1
non-small cell lung carcinoma,TIVOZANIB,1,Withdrawn,FLT4,1
non-small cell lung carcinoma,TIVOZANIB,1,Withdrawn,FLT1,1
non-small cell lung carcinoma,TIVOZANIB,1,Completed,KDR,1
non-small cell lung carcinoma,TIVOZANIB,1,Completed,FLT4,1
non-small cell lung carcinoma,TIVOZANIB,1,Completed,FLT1,1
non-small cell lung carcinoma,TIVANTINIB,3,Completed,MET,1
non-small cell lung carcinoma,BRIGATINIB,1,Not yet recruiting,EGFR,1
non-small cell lung carcinoma,TIPIFARNIB,2,Recruiting,FNTB,1
non-small cell lung carcinoma,TIPIFARNIB,2,Recruiting,FNTA,1
non-small cell lung carcinoma,TIPIFARNIB,2,Completed,FNTB,1
non-small cell lung carcinoma,TIPIFARNIB,2,Completed,FNTA,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",EPHB1,1
non-small cell lung carcinoma,THALIDOMIDE,4,Recruiting,CRBN,1
non-small cell lung carcinoma,THALIDOMIDE,4,Recruiting,CUL4A,1
non-small cell lung carcinoma,BRIGATINIB,2,Not yet recruiting,ALK,1
non-small cell lung carcinoma,BRIGATINIB,2,"Active, not recruiting",ALK,1
non-small cell lung carcinoma,BRIGATINIB,2,"Active, not recruiting",EGFR,1
non-small cell lung carcinoma,BRIGATINIB,4,n/a,ALK,1
non-small cell lung carcinoma,BRIGATINIB,4,n/a,EGFR,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",ERBB2,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",ERBB3,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",ERBB4,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",FLT1,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",FLT4,1
non-small cell lung carcinoma,GEMCITABINE,4,Terminated,POLA1,1
non-small cell lung carcinoma,GEMCITABINE,4,Completed,RRM1,1
non-small cell lung carcinoma,LENALIDOMIDE,2,Completed,CRBN,1
non-small cell lung carcinoma,LENALIDOMIDE,2,Completed,CUL4A,1
non-small cell lung carcinoma,LENALIDOMIDE,2,Completed,DDB1,1
non-small cell lung carcinoma,SUNITINIB,2,Unknown status,RET,1
non-small cell lung carcinoma,SUNITINIB,2,Unknown status,PDGFRB,1
non-small cell lung carcinoma,SUNITINIB,2,Unknown status,PDGFRA,1
non-small cell lung carcinoma,SUNITINIB,2,Unknown status,KIT,1
non-small cell lung carcinoma,SUNITINIB,2,Unknown status,KDR,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",KDR,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",PTK6,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",RET,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",SRC,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",EPHB6,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",EPHB4,1
non-small cell lung carcinoma,BRIGATINIB,3,Not yet recruiting,EGFR,1
non-small cell lung carcinoma,TEPOTINIB,1,"Active, not recruiting",MET,1
non-small cell lung carcinoma,TOSEDOSTAT,1,Terminated,ERAP1,1
non-small cell lung carcinoma,BRIGATINIB,2,Not yet recruiting,EGFR,1
non-small cell lung carcinoma,THALIDOMIDE,2,Recruiting,RBX1,1
non-small cell lung carcinoma,THALIDOMIDE,2,Recruiting,DDB1,1
non-small cell lung carcinoma,THALIDOMIDE,2,Recruiting,CUL4A,1
non-small cell lung carcinoma,THALIDOMIDE,2,Recruiting,CRBN,1
non-small cell lung carcinoma,TEPROTUMUMAB,2,Terminated,IGF1R,1
non-small cell lung carcinoma,TEPROTUMUMAB,2,Completed,IGF1R,1
non-small cell lung carcinoma,TEPOTINIB,2,Recruiting,MET,1
non-small cell lung carcinoma,BRIGATINIB,3,"Active, not recruiting",ALK,1
non-small cell lung carcinoma,BRIGATINIB,3,Not yet recruiting,ALK,1
non-small cell lung carcinoma,TEMSIROLIMUS,1,Terminated,FKBP1A,1
non-small cell lung carcinoma,TEMSIROLIMUS,1,Completed,FKBP1A,1
non-small cell lung carcinoma,BRIGATINIB,3,"Active, not recruiting",EGFR,1
non-small cell lung carcinoma,TALAZOPARIB,1,Withdrawn,PARP2,1
non-small cell lung carcinoma,TALAZOPARIB,1,Withdrawn,PARP1,1
non-small cell lung carcinoma,SURAMIN,2,Unknown status,FGF1,1
non-small cell lung carcinoma,SURAMIN,2,Terminated,FGF1,1
non-small cell lung carcinoma,SURAMIN,2,Completed,FGF1,1
non-small cell lung carcinoma,SURAMIN,1,Completed,FGF1,1
non-small cell lung carcinoma,TOSEDOSTAT,1,Terminated,ENPEP,1
non-small cell lung carcinoma,TOSEDOSTAT,1,Terminated,ERAP2,1
non-small cell lung carcinoma,UCN-01,1,Completed,PRKCZ,1
non-small cell lung carcinoma,TREMELIMUMAB,1,Not yet recruiting,CTLA4,1
non-small cell lung carcinoma,TRETINOIN,2,Completed,RARG,1
non-small cell lung carcinoma,TRETINOIN,2,Completed,RARB,1
non-small cell lung carcinoma,TRETINOIN,2,Completed,RARA,1
non-small cell lung carcinoma,TREMELIMUMAB,3,Recruiting,CTLA4,1
non-small cell lung carcinoma,LAPATINIB,1,Completed,EGFR,1
non-small cell lung carcinoma,TREMELIMUMAB,2,Withdrawn,CTLA4,1
non-small cell lung carcinoma,TREMELIMUMAB,2,Recruiting,CTLA4,1
non-small cell lung carcinoma,TREMELIMUMAB,2,Not yet recruiting,CTLA4,1
non-small cell lung carcinoma,LAPATINIB,1,Completed,ERBB2,1
non-small cell lung carcinoma,LAPATINIB,2,Terminated,EGFR,1
non-small cell lung carcinoma,TREMELIMUMAB,1,Completed,CTLA4,1
non-small cell lung carcinoma,TRETINOIN,3,Unknown status,RARB,1
non-small cell lung carcinoma,TREMELIMUMAB,1,"Active, not recruiting",CTLA4,1
non-small cell lung carcinoma,TREBANANIB,1,Completed,ANGPT2,1
non-small cell lung carcinoma,TREBANANIB,1,Completed,ANGPT1,1
non-small cell lung carcinoma,LAPATINIB,2,Terminated,ERBB2,1
non-small cell lung carcinoma,GEMCITABINE,4,Terminated,POLD1,1
non-small cell lung carcinoma,BORTEZOMIB,1,Completed,PSMB5,1
non-small cell lung carcinoma,BORTEZOMIB,1,Terminated,PSMB5,1
non-small cell lung carcinoma,GEMCITABINE,4,Terminated,POLA2,1
non-small cell lung carcinoma,BORTEZOMIB,2,"Active, not recruiting",PSMB5,1
non-small cell lung carcinoma,BOSUTINIB,1,Recruiting,ABL1,1
non-small cell lung carcinoma,TRETINOIN,3,Unknown status,RARA,1
non-small cell lung carcinoma,TRETINOIN,3,Unknown status,RARG,1
non-small cell lung carcinoma,BOSUTINIB,1,Recruiting,LYN,1
non-small cell lung carcinoma,UCN-01,1,Completed,PRKCG,1
non-small cell lung carcinoma,UCN-01,1,Completed,PRKCQ,1
non-small cell lung carcinoma,UCN-01,1,Completed,PRKD3,1
non-small cell lung carcinoma,URELUMAB,1,Terminated,TNFRSF9,1
non-small cell lung carcinoma,VALPROIC ACID,1,Completed,ALDH5A1,1
non-small cell lung carcinoma,VALPROIC ACID,1,Unknown status,ALDH5A1,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",EGFR,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",EPHA1,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",EPHA10,1
non-small cell lung carcinoma,UCN-01,1,Completed,PRKCI,1
non-small cell lung carcinoma,UCN-01,1,Completed,PRKCH,1
non-small cell lung carcinoma,UCN-01,1,Completed,PRKCE,1
non-small cell lung carcinoma,UCN-01,1,Completed,CDK2,1
non-small cell lung carcinoma,UCN-01,1,Completed,PRKCD,1
non-small cell lung carcinoma,UCN-01,1,Completed,PRKCB,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",EPHA2,1
non-small cell lung carcinoma,UCN-01,1,Completed,PRKCA,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",EPHA3,1
non-small cell lung carcinoma,UCN-01,1,Completed,PDPK1,1
non-small cell lung carcinoma,UCN-01,1,Completed,CHEK1,1
non-small cell lung carcinoma,UCN-01,1,Completed,CDK6,1
non-small cell lung carcinoma,UCN-01,1,Completed,CDK4,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",EPHA4,1
non-small cell lung carcinoma,BOSUTINIB,1,Recruiting,HCK,1
non-small cell lung carcinoma,BOSUTINIB,1,Recruiting,SRC,1
non-small cell lung carcinoma,TOSEDOSTAT,1,Terminated,LAP3,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",EPHA7,1
non-small cell lung carcinoma,BRIGATINIB,0,Recruiting,EGFR,1
non-small cell lung carcinoma,TRAMETINIB,1,"Active, not recruiting",MAP2K2,1
non-small cell lung carcinoma,TRAMETINIB,1,"Active, not recruiting",MAP2K1,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",EPHA5,1
non-small cell lung carcinoma,TOZASERTIB,2,Terminated,AURKC,1
non-small cell lung carcinoma,SUNITINIB,2,Unknown status,FLT4,1
non-small cell lung carcinoma,TOZASERTIB,2,Terminated,AURKA,1
non-small cell lung carcinoma,TOSEDOSTAT,1,Terminated,XPNPEP3,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",EPHA6,1
non-small cell lung carcinoma,TOSEDOSTAT,1,Terminated,XPNPEP2,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",EPHA8,1
non-small cell lung carcinoma,BPI-9016,1,Unknown status,MET,1
non-small cell lung carcinoma,TOSEDOSTAT,1,Terminated,XPNPEP1,1
non-small cell lung carcinoma,TOSEDOSTAT,1,Terminated,RNPEPL1,1
non-small cell lung carcinoma,TOSEDOSTAT,1,Terminated,RNPEP,1
non-small cell lung carcinoma,TOSEDOSTAT,1,Terminated,NPEPPS,1
non-small cell lung carcinoma,TOSEDOSTAT,1,Terminated,NPEPL1,1
non-small cell lung carcinoma,TOSEDOSTAT,1,Terminated,METAP2,1
non-small cell lung carcinoma,TOSEDOSTAT,1,Terminated,METAP1D,1
non-small cell lung carcinoma,TOSEDOSTAT,1,Terminated,METAP1,1
non-small cell lung carcinoma,TOSEDOSTAT,1,Terminated,LVRN,1
non-small cell lung carcinoma,TOSEDOSTAT,1,Terminated,LNPEP,1
non-small cell lung carcinoma,BRIGATINIB,0,Recruiting,ALK,1
non-small cell lung carcinoma,BPI-9016,1,Unknown status,AXL,1
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Completed,TUBB8,1
non-small cell lung carcinoma,TRASTUZUMAB,2,Not yet recruiting,ERBB2,1
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Completed,TUBB6,1
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Completed,TUBB4B,1
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Completed,TUBB4A,1
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Completed,TUBB3,1
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Completed,TUBB2B,1
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Completed,TUBB2A,1
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Completed,TUBB1,1
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Completed,TUBB,1
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Completed,ERBB2,1
non-small cell lung carcinoma,TRASTUZUMAB,2,Terminated,ERBB2,1
non-small cell lung carcinoma,TRASTUZUMAB,2,Completed,ERBB2,1
non-small cell lung carcinoma,TRAMETINIB,1,Withdrawn,MAP2K1,1
non-small cell lung carcinoma,TRASTUZUMAB,1,Completed,ERBB2,1
non-small cell lung carcinoma,TRAMETINIB,2,Withdrawn,MAP2K2,1
non-small cell lung carcinoma,TRAMETINIB,2,Withdrawn,MAP2K1,1
non-small cell lung carcinoma,TRAMETINIB,2,Recruiting,MAP2K2,1
non-small cell lung carcinoma,TRAMETINIB,2,Recruiting,MAP2K1,1
non-small cell lung carcinoma,TRAMETINIB,2,Completed,MAP2K2,1
non-small cell lung carcinoma,TRAMETINIB,2,Completed,MAP2K1,1
non-small cell lung carcinoma,TRAMETINIB,2,"Active, not recruiting",MAP2K2,1
non-small cell lung carcinoma,TRAMETINIB,2,"Active, not recruiting",MAP2K1,1
non-small cell lung carcinoma,TRAMETINIB,1,Withdrawn,MAP2K2,1
non-small cell lung carcinoma,TOZASERTIB,2,Terminated,AURKB,1
non-small cell lung carcinoma,SUNITINIB,2,Terminated,PDGFRB,1
non-small cell lung carcinoma,SUNITINIB,2,Unknown status,FLT3,1
non-small cell lung carcinoma,RUCAPARIB,1,Recruiting,PARP1,1
non-small cell lung carcinoma,SAGOPILONE,2,Completed,TUBA4A,1
non-small cell lung carcinoma,SAGOPILONE,2,Completed,TUBA3E,1
non-small cell lung carcinoma,SAGOPILONE,2,Completed,TUBA3C,1
non-small cell lung carcinoma,SAGOPILONE,2,Completed,TUBA1C,1
non-small cell lung carcinoma,SAGOPILONE,2,Completed,TUBA1B,1
non-small cell lung carcinoma,SAGOPILONE,2,Completed,TUBA1A,1
non-small cell lung carcinoma,RUXOLITINIB,2,Terminated,JAK2,1
non-small cell lung carcinoma,RUXOLITINIB,2,Terminated,JAK1,1
non-small cell lung carcinoma,RUXOLITINIB,1,Unknown status,JAK2,1
non-small cell lung carcinoma,RUXOLITINIB,1,Unknown status,JAK1,1
non-small cell lung carcinoma,RUCAPARIB,1,Recruiting,PARP3,1
non-small cell lung carcinoma,RUCAPARIB,1,Recruiting,PARP2,1
non-small cell lung carcinoma,ROSUVASTATIN,1,Completed,HMGCR,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK15,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK9,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK8,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK7,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK6,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK5,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK4,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK3,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK20,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK2,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK19,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK18,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK17,1
non-small cell lung carcinoma,SAGOPILONE,2,Completed,TUBB,1
non-small cell lung carcinoma,SAGOPILONE,2,Completed,TUBB1,1
non-small cell lung carcinoma,SAGOPILONE,2,Completed,TUBB2A,1
non-small cell lung carcinoma,SAGOPILONE,2,Completed,TUBB2B,1
non-small cell lung carcinoma,CELECOXIB,3,Unknown status,PTGS2,1
non-small cell lung carcinoma,LONAFARNIB,3,Terminated,FNTB,1
non-small cell lung carcinoma,SELUMETINIB,1,Not yet recruiting,MAP2K2,1
non-small cell lung carcinoma,SELUMETINIB,1,Not yet recruiting,MAP2K1,1
non-small cell lung carcinoma,CERITINIB,2,Not yet recruiting,ALK,1
non-small cell lung carcinoma,LOPERAMIDE,3,Completed,OPRM1,1
non-small cell lung carcinoma,CERITINIB,4,n/a,ALK,1
non-small cell lung carcinoma,CETUXIMAB,1,Recruiting,EGFR,1
non-small cell lung carcinoma,SELINEXOR,1,Recruiting,XPO1,1
non-small cell lung carcinoma,SELICICLIB,2,Terminated,CDK9,1
non-small cell lung carcinoma,SELICICLIB,2,Terminated,CDK7,1
non-small cell lung carcinoma,SELICICLIB,2,Terminated,CDK5,1
non-small cell lung carcinoma,SELICICLIB,2,Terminated,CDK2,1
non-small cell lung carcinoma,SELICICLIB,2,Terminated,CDK1,1
non-small cell lung carcinoma,SAVOLITINIB,2,"Active, not recruiting",MET,1
non-small cell lung carcinoma,SAVOLITINIB,1,Recruiting,MET,1
non-small cell lung carcinoma,SARGRAMOSTIM,2,Completed,CSF2RA,1
non-small cell lung carcinoma,SARACATINIB,2,Completed,SRC,1
non-small cell lung carcinoma,SARACATINIB,2,Completed,ABL1,1
non-small cell lung carcinoma,SAPANISERTIB,1,Recruiting,MTOR,1
non-small cell lung carcinoma,SAGOPILONE,2,Completed,TUBB8,1
non-small cell lung carcinoma,SAGOPILONE,2,Completed,TUBB6,1
non-small cell lung carcinoma,SAGOPILONE,2,Completed,TUBB4B,1
non-small cell lung carcinoma,SAGOPILONE,2,Completed,TUBB4A,1
non-small cell lung carcinoma,SAGOPILONE,2,Completed,TUBB3,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK16,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK14,1
non-small cell lung carcinoma,SUNITINIB,2,Unknown status,FLT1,1
non-small cell lung carcinoma,RABUSERTIB,2,Completed,CHEK1,1
non-small cell lung carcinoma,RETASPIMYCIN,2,Completed,HSP90AB1,1
non-small cell lung carcinoma,RETASPIMYCIN,2,Completed,HSP90AA1,1
non-small cell lung carcinoma,RETASPIMYCIN,1,Completed,HSP90AB1,1
non-small cell lung carcinoma,RETASPIMYCIN,1,Completed,HSP90AA1,1
non-small cell lung carcinoma,RAMUCIRUMAB,4,n/a,KDR,1
non-small cell lung carcinoma,RAMUCIRUMAB,3,Completed,KDR,1
non-small cell lung carcinoma,RAMUCIRUMAB,3,"Active, not recruiting",KDR,1
non-small cell lung carcinoma,RAMUCIRUMAB,2,Withdrawn,KDR,1
non-small cell lung carcinoma,CETUXIMAB,2,Recruiting,EGFR,1
non-small cell lung carcinoma,LUCITANIB,2,Terminated,FGFR1,1
non-small cell lung carcinoma,RAMUCIRUMAB,2,"Active, not recruiting",KDR,1
non-small cell lung carcinoma,CETUXIMAB,2,Unknown status,EGFR,1
non-small cell lung carcinoma,RABUSERTIB,1,Completed,CHEK1,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK13,1
non-small cell lung carcinoma,R428,2,Recruiting,AXL,1
non-small cell lung carcinoma,R428,1,Unknown status,AXL,1
non-small cell lung carcinoma,R428,1,Recruiting,AXL,1
non-small cell lung carcinoma,CETUXIMAB,2,Withdrawn,EGFR,1
non-small cell lung carcinoma,CI-1040,2,Completed,MAP2K1,1
non-small cell lung carcinoma,PYROTINIB,1,Recruiting,ERBB2,1
non-small cell lung carcinoma,PYROTINIB,1,Recruiting,EGFR,1
non-small cell lung carcinoma,PREXASERTIB,1,Completed,CHEK2,1
non-small cell lung carcinoma,PREXASERTIB,1,Completed,CHEK1,1
non-small cell lung carcinoma,PRALATREXATE,2,Completed,DHFR,1
non-small cell lung carcinoma,PRALATREXATE,1,Withdrawn,DHFR,1
non-small cell lung carcinoma,CI-1040,2,Completed,MAP2K2,1
non-small cell lung carcinoma,RIBOCICLIB,1,Completed,CDK4,1
non-small cell lung carcinoma,RIBOCICLIB,1,Completed,CDK6,1
non-small cell lung carcinoma,RIBOCICLIB,1,Recruiting,CDK4,1
non-small cell lung carcinoma,RIBOCICLIB,1,Recruiting,CDK6,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK12,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK11B,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK10,1
non-small cell lung carcinoma,RONICICLIB,1,Withdrawn,CDK1,1
non-small cell lung carcinoma,ROMIDEPSIN,2,Completed,HDAC9,1
non-small cell lung carcinoma,ROMIDEPSIN,2,Completed,HDAC8,1
non-small cell lung carcinoma,ROMIDEPSIN,2,Completed,HDAC7,1
non-small cell lung carcinoma,ROMIDEPSIN,2,Completed,HDAC6,1
non-small cell lung carcinoma,ROMIDEPSIN,2,Completed,HDAC5,1
non-small cell lung carcinoma,ROMIDEPSIN,2,Completed,HDAC4,1
non-small cell lung carcinoma,ROMIDEPSIN,2,Completed,HDAC3,1
non-small cell lung carcinoma,ROMIDEPSIN,2,Completed,HDAC2,1
non-small cell lung carcinoma,ROMIDEPSIN,2,Completed,HDAC11,1
non-small cell lung carcinoma,ROMIDEPSIN,2,Completed,HDAC10,1
non-small cell lung carcinoma,ROMIDEPSIN,2,Completed,HDAC1,1
non-small cell lung carcinoma,ROFECOXIB,2,Completed,PTGS2,1
non-small cell lung carcinoma,ROCILETINIB,3,Terminated,EGFR,1
non-small cell lung carcinoma,ROCILETINIB,2,Withdrawn,EGFR,1
non-small cell lung carcinoma,ROCILETINIB,2,Terminated,EGFR,1
non-small cell lung carcinoma,ROCILETINIB,2,"Active, not recruiting",EGFR,1
non-small cell lung carcinoma,ROCILETINIB,1,Terminated,EGFR,1
non-small cell lung carcinoma,ROCILETINIB,1,Completed,EGFR,1
non-small cell lung carcinoma,ROCILETINIB,1,"Active, not recruiting",EGFR,1
non-small cell lung carcinoma,RIDAFOROLIMUS,2,Terminated,MTOR,1
non-small cell lung carcinoma,RIDAFOROLIMUS,1,Terminated,MTOR,1
non-small cell lung carcinoma,CELECOXIB,3,Suspended,PTGS2,1
non-small cell lung carcinoma,CELECOXIB,1,Withdrawn,PTGS2,1
non-small cell lung carcinoma,CELECOXIB,1,Completed,PTGS2,1
non-small cell lung carcinoma,GEMCITABINE,4,Completed,POLE3,1
non-small cell lung carcinoma,BUPARLISIB,2,Completed,PIK3CA,1
non-small cell lung carcinoma,BUPARLISIB,2,Completed,PIK3CB,1
non-small cell lung carcinoma,BUPARLISIB,2,Completed,PIK3CD,1
non-small cell lung carcinoma,BUPARLISIB,2,Completed,PIK3CG,1
non-small cell lung carcinoma,BUPARLISIB,2,Completed,PIK3R1,1
non-small cell lung carcinoma,BUPARLISIB,2,Completed,PIK3R2,1
non-small cell lung carcinoma,BUPARLISIB,2,Completed,PIK3R3,1
non-small cell lung carcinoma,BUPARLISIB,2,Completed,PIK3R5,1
non-small cell lung carcinoma,BUPIVACAINE,3,Recruiting,SCN4A,1
non-small cell lung carcinoma,BUPROPION,1,Withdrawn,SLC6A2,1
non-small cell lung carcinoma,BUPROPION,1,Withdrawn,SLC6A3,1
non-small cell lung carcinoma,GEMCITABINE,4,Completed,PRIM1,1
non-small cell lung carcinoma,LETROZOLE,1,Recruiting,CYP19A1,1
non-small cell lung carcinoma,LONAFARNIB,3,Terminated,FNTA,1
non-small cell lung carcinoma,LINAGLIPTIN,1,Recruiting,DPP4,1
non-small cell lung carcinoma,LINIFANIB,1,Completed,CSF1R,1
non-small cell lung carcinoma,LINIFANIB,1,Completed,FLT1,1
non-small cell lung carcinoma,SORAFENIB,2,Unknown status,RET,1
non-small cell lung carcinoma,SORAFENIB,2,Unknown status,RAF1,1
non-small cell lung carcinoma,SORAFENIB,2,Unknown status,PDGFRB,1
non-small cell lung carcinoma,SORAFENIB,2,Unknown status,KIT,1
non-small cell lung carcinoma,SORAFENIB,2,Unknown status,KDR,1
non-small cell lung carcinoma,SORAFENIB,2,Unknown status,FLT4,1
non-small cell lung carcinoma,SORAFENIB,2,Unknown status,FLT3,1
non-small cell lung carcinoma,SORAFENIB,2,Unknown status,FLT1,1
non-small cell lung carcinoma,SORAFENIB,2,Unknown status,BRAF,1
non-small cell lung carcinoma,BUPARLISIB,1,Withdrawn,PIK3R5,1
non-small cell lung carcinoma,BUPARLISIB,1,Withdrawn,PIK3R3,1
non-small cell lung carcinoma,BUPARLISIB,1,Withdrawn,PIK3R2,1
non-small cell lung carcinoma,BUPARLISIB,1,Withdrawn,PIK3R1,1
non-small cell lung carcinoma,SUNITINIB,2,Unknown status,CSF1R,1
non-small cell lung carcinoma,SUNITINIB,2,Terminated,RET,1
non-small cell lung carcinoma,L19SIP 131I,1,Terminated,FN1,1
non-small cell lung carcinoma,SUNITINIB,2,Terminated,PDGFRA,1
non-small cell lung carcinoma,SUNITINIB,2,Terminated,KIT,1
non-small cell lung carcinoma,SUNITINIB,2,Terminated,KDR,1
non-small cell lung carcinoma,SUNITINIB,2,Terminated,FLT4,1
non-small cell lung carcinoma,SUNITINIB,2,Terminated,FLT3,1
non-small cell lung carcinoma,SUNITINIB,2,Terminated,FLT1,1
non-small cell lung carcinoma,SUNITINIB,2,Terminated,CSF1R,1
non-small cell lung carcinoma,LENALIDOMIDE,2,Completed,RBX1,1
non-small cell lung carcinoma,LENVATINIB,1,Completed,FLT1,1
non-small cell lung carcinoma,LENVATINIB,1,Completed,FLT4,1
non-small cell lung carcinoma,LENVATINIB,1,Completed,KDR,1
non-small cell lung carcinoma,LENVATINIB,2,Completed,FLT1,1
non-small cell lung carcinoma,LENVATINIB,2,Completed,FLT4,1
non-small cell lung carcinoma,LENVATINIB,2,Completed,KDR,1
non-small cell lung carcinoma,LENVATINIB,2,Recruiting,FLT1,1
non-small cell lung carcinoma,LENVATINIB,2,Recruiting,FLT4,1
non-small cell lung carcinoma,LENVATINIB,2,Recruiting,KDR,1
non-small cell lung carcinoma,GEMCITABINE,4,Completed,PRIM2,1
non-small cell lung carcinoma,BUPARLISIB,1,Withdrawn,PIK3CA,1
non-small cell lung carcinoma,BUPARLISIB,1,Withdrawn,PIK3CB,1
non-small cell lung carcinoma,BUPARLISIB,1,Withdrawn,PIK3CD,1
non-small cell lung carcinoma,BUPARLISIB,1,Withdrawn,PIK3CG,1
non-small cell lung carcinoma,LINIFANIB,1,Completed,FLT3,1
non-small cell lung carcinoma,LINIFANIB,1,Completed,FLT4,1
non-small cell lung carcinoma,LINIFANIB,1,Completed,KDR,1
non-small cell lung carcinoma,CEDIRANIB,1,Terminated,KDR,1
non-small cell lung carcinoma,CEDIRANIB,1,Terminated,PDGFRA,1
non-small cell lung carcinoma,CEDIRANIB,1,Terminated,PDGFRB,1
non-small cell lung carcinoma,GEMCITABINE,4,Completed,POLD2,1
non-small cell lung carcinoma,SORAFENIB,1,"Active, not recruiting",RET,1
non-small cell lung carcinoma,SORAFENIB,1,"Active, not recruiting",RAF1,1
non-small cell lung carcinoma,SORAFENIB,1,"Active, not recruiting",PDGFRB,1
non-small cell lung carcinoma,SORAFENIB,1,"Active, not recruiting",KIT,1
non-small cell lung carcinoma,SORAFENIB,1,"Active, not recruiting",KDR,1
non-small cell lung carcinoma,SORAFENIB,1,"Active, not recruiting",FLT4,1
non-small cell lung carcinoma,SORAFENIB,1,"Active, not recruiting",FLT3,1
non-small cell lung carcinoma,SORAFENIB,1,"Active, not recruiting",FLT1,1
non-small cell lung carcinoma,SORAFENIB,1,"Active, not recruiting",BRAF,1
non-small cell lung carcinoma,SIROLIMUS,1,Withdrawn,FKBP1A,1
non-small cell lung carcinoma,GEMCITABINE,4,Completed,POLD1,1
non-small cell lung carcinoma,GEMCITABINE,4,Completed,POLA2,1
non-small cell lung carcinoma,SIMVASTATIN,2,"Active, not recruiting",HMGCR,1
non-small cell lung carcinoma,SIMVASTATIN,1,"Active, not recruiting",HMGCR,1
non-small cell lung carcinoma,SIMOTINIB,1,Unknown status,EGFR,1
non-small cell lung carcinoma,SILDENAFIL,2,Completed,PDE5A,1
non-small cell lung carcinoma,SIBROTUZUMAB,1,Terminated,FAP,1
non-small cell lung carcinoma,SELUMETINIB,3,"Active, not recruiting",MAP2K2,1
non-small cell lung carcinoma,SELUMETINIB,3,"Active, not recruiting",MAP2K1,1
non-small cell lung carcinoma,SELUMETINIB,2,Withdrawn,MAP2K2,1
non-small cell lung carcinoma,SELUMETINIB,2,Withdrawn,MAP2K1,1
non-small cell lung carcinoma,GEMCITABINE,4,Completed,POLA1,1
non-small cell lung carcinoma,CEDIRANIB,1,Terminated,KIT,1
non-small cell lung carcinoma,CEDIRANIB,1,Terminated,FLT4,1
non-small cell lung carcinoma,LINIFANIB,1,Completed,PDGFRA,1
non-small cell lung carcinoma,CEDIRANIB,1,Terminated,FLT1,1
non-small cell lung carcinoma,LINIFANIB,1,Completed,PDGFRB,1
non-small cell lung carcinoma,CABOZANTINIB,2,"Active, not recruiting",KDR,1
non-small cell lung carcinoma,CABOZANTINIB,2,"Active, not recruiting",MET,1
non-small cell lung carcinoma,CABOZANTINIB,2,Completed,KDR,1
non-small cell lung carcinoma,CABOZANTINIB,2,Completed,MET,1
non-small cell lung carcinoma,GEMCITABINE,4,Completed,POLE2,1
non-small cell lung carcinoma,GEMCITABINE,4,Completed,POLE,1
non-small cell lung carcinoma,CABOZANTINIB,2,Suspended,KDR,1
non-small cell lung carcinoma,CABOZANTINIB,2,Suspended,MET,1
non-small cell lung carcinoma,CALCITRIOL,1,Completed,VDR,1
non-small cell lung carcinoma,CALCITRIOL,1,Terminated,VDR,1
non-small cell lung carcinoma,CANAKINUMAB,1,Recruiting,IL1B,1
non-small cell lung carcinoma,CANERTINIB,1,Completed,EGFR,1
non-small cell lung carcinoma,CANERTINIB,1,Completed,ERBB2,1
non-small cell lung carcinoma,CANERTINIB,1,Completed,ERBB4,1
non-small cell lung carcinoma,CAPECITABINE,1,Not yet recruiting,TYMS,1
non-small cell lung carcinoma,CAPECITABINE,1,Terminated,TYMS,1
non-small cell lung carcinoma,GEMCITABINE,4,Completed,POLD4,1
non-small cell lung carcinoma,CAPECITABINE,3,Terminated,TYMS,1
non-small cell lung carcinoma,CAPMATINIB,0,Recruiting,MET,1
non-small cell lung carcinoma,CAPMATINIB,2,"Active, not recruiting",MET,1
non-small cell lung carcinoma,CAPMATINIB,2,Withdrawn,MET,1
non-small cell lung carcinoma,CAROTUXIMAB,1,"Active, not recruiting",ENG,1
non-small cell lung carcinoma,CAROTUXIMAB,1,Recruiting,ENG,1
non-small cell lung carcinoma,GEMCITABINE,4,Completed,POLD3,1
non-small cell lung carcinoma,VANDETANIB,1,"Active, not recruiting",TEK,1
non-small cell lung carcinoma,IXABEPILONE,2,Terminated,TUBB4A,1
non-small cell lung carcinoma,BKT140,1,Recruiting,CXCR4,1
non-small cell lung carcinoma,AMG-888,1,Completed,ERBB3,1
non-small cell lung carcinoma,ANETUMAB RAVTANSINE,1,Recruiting,MSLN,1
non-small cell lung carcinoma,ANLOTINIB,1,Recruiting,FLT4,1
non-small cell lung carcinoma,ANLOTINIB,1,Recruiting,KDR,1
non-small cell lung carcinoma,ANLOTINIB,1,Recruiting,KIT,1
non-small cell lung carcinoma,ANLOTINIB,1,Recruiting,PDGFRB,1
non-small cell lung carcinoma,IPILIMUMAB,2,"Active, not recruiting",CTLA4,1
non-small cell lung carcinoma,HYDROXYCHLOROQUINE,1,Completed,TLR7,1
non-small cell lung carcinoma,GILTERITINIB,1,Terminated,FLT3,1
non-small cell lung carcinoma,IPILIMUMAB,2,Suspended,CTLA4,1
non-small cell lung carcinoma,ANLOTINIB,2,Enrolling by invitation,FLT4,1
non-small cell lung carcinoma,ANLOTINIB,2,Enrolling by invitation,KDR,1
non-small cell lung carcinoma,ANLOTINIB,2,Enrolling by invitation,KIT,1
non-small cell lung carcinoma,ANLOTINIB,2,Enrolling by invitation,PDGFRB,1
non-small cell lung carcinoma,IPILIMUMAB,3,Not yet recruiting,CTLA4,1
non-small cell lung carcinoma,GILTERITINIB,1,Terminated,AXL,1
non-small cell lung carcinoma,IPILIMUMAB,3,Withdrawn,CTLA4,1
non-small cell lung carcinoma,ANLOTINIB,2,Unknown status,FLT4,1
non-small cell lung carcinoma,ANLOTINIB,2,Unknown status,KDR,1
non-small cell lung carcinoma,ANLOTINIB,2,Unknown status,KIT,1
non-small cell lung carcinoma,ANLOTINIB,2,Unknown status,PDGFRB,1
non-small cell lung carcinoma,ANLOTINIB,4,Recruiting,FLT4,1
non-small cell lung carcinoma,ANLOTINIB,4,Recruiting,KDR,1
non-small cell lung carcinoma,ANLOTINIB,4,Recruiting,KIT,1
non-small cell lung carcinoma,ANLOTINIB,4,Recruiting,PDGFRB,1
non-small cell lung carcinoma,IRINOTECAN,1,Unknown status,TOP1,1
non-small cell lung carcinoma,ANAMORELIN,2,Completed,GHSR,1
non-small cell lung carcinoma,ALECTINIB,4,n/a,RET,1
non-small cell lung carcinoma,APATINIB,2,Completed,KDR,1
non-small cell lung carcinoma,ALECTINIB,4,n/a,ALK,1
non-small cell lung carcinoma,AFLIBERCEPT,1,Completed,PGF,1
non-small cell lung carcinoma,AFLIBERCEPT,1,Completed,VEGFA,1
non-small cell lung carcinoma,AFLIBERCEPT,3,Completed,PGF,1
non-small cell lung carcinoma,AFLIBERCEPT,3,Completed,VEGFA,1
non-small cell lung carcinoma,AGATOLIMOD,3,Terminated,TLR9,1
non-small cell lung carcinoma,ALCLOMETASONE DIPROPIONATE,2,Completed,NR3C1,1
non-small cell lung carcinoma,ALDESLEUKIN,0,Recruiting,IL2RA,1
non-small cell lung carcinoma,ALDESLEUKIN,0,Recruiting,IL2RB,1
non-small cell lung carcinoma,ALDOXORUBICIN,2,Not yet recruiting,TOP2A,1
non-small cell lung carcinoma,IPH-2101,2,Not yet recruiting,KIR2DL1,1
non-small cell lung carcinoma,IPH-2101,2,Not yet recruiting,KIR2DL3,1
non-small cell lung carcinoma,IPH-2101,2,Recruiting,KIR2DL1,1
non-small cell lung carcinoma,IPH-2101,2,Recruiting,KIR2DL3,1
non-small cell lung carcinoma,HYDROXYCHLOROQUINE,1,Terminated,TLR9,1
non-small cell lung carcinoma,HYDROXYCHLOROQUINE,1,Terminated,TLR7,1
non-small cell lung carcinoma,ALECTINIB,2,"Active, not recruiting",ALK,1
non-small cell lung carcinoma,ALECTINIB,2,"Active, not recruiting",RET,1
non-small cell lung carcinoma,ALECTINIB,2,Not yet recruiting,ALK,1
non-small cell lung carcinoma,ALECTINIB,2,Not yet recruiting,RET,1
non-small cell lung carcinoma,IPILIMUMAB,1,Not yet recruiting,CTLA4,1
non-small cell lung carcinoma,HYDROXYCHLOROQUINE,1,Completed,TLR9,1
non-small cell lung carcinoma,ALECTINIB,3,Completed,ALK,1
non-small cell lung carcinoma,ALECTINIB,3,Completed,RET,1
non-small cell lung carcinoma,ALECTINIB,3,Not yet recruiting,ALK,1
non-small cell lung carcinoma,ALECTINIB,3,Not yet recruiting,RET,1
non-small cell lung carcinoma,APATINIB,2,"Active, not recruiting",KDR,1
non-small cell lung carcinoma,IRINOTECAN,2,Terminated,TOP1,1
non-small cell lung carcinoma,VEMURAFENIB,2,Recruiting,BRAF,1
non-small cell lung carcinoma,ASPIRIN,3,Withdrawn,PTGS2,1
non-small cell lung carcinoma,IRX-4204,1,Recruiting,RXRG,1
non-small cell lung carcinoma,ATEZOLIZUMAB,1,Completed,CD274,1
non-small cell lung carcinoma,VINFLUNINE,2,Completed,TUBB8,1
non-small cell lung carcinoma,VINFLUNINE,2,Completed,TUBB6,1
non-small cell lung carcinoma,VINFLUNINE,2,Completed,TUBB4B,1
non-small cell lung carcinoma,VINFLUNINE,2,Completed,TUBB4A,1
non-small cell lung carcinoma,VINFLUNINE,2,Completed,TUBB3,1
non-small cell lung carcinoma,VINFLUNINE,2,Completed,TUBB2B,1
non-small cell lung carcinoma,VINFLUNINE,2,Completed,TUBB2A,1
non-small cell lung carcinoma,VINFLUNINE,2,Completed,TUBB1,1
non-small cell lung carcinoma,VINFLUNINE,2,Completed,TUBB,1
non-small cell lung carcinoma,VINFLUNINE,2,Completed,TUBA4A,1
non-small cell lung carcinoma,VINFLUNINE,2,Completed,TUBA3E,1
non-small cell lung carcinoma,VINFLUNINE,2,Completed,TUBA3C,1
non-small cell lung carcinoma,VINFLUNINE,2,Completed,TUBA1C,1
non-small cell lung carcinoma,VINFLUNINE,2,Completed,TUBA1B,1
non-small cell lung carcinoma,VINFLUNINE,2,Completed,TUBA1A,1
non-small cell lung carcinoma,VINBLASTINE,3,Not yet recruiting,TUBB8,1
non-small cell lung carcinoma,VINBLASTINE,3,Not yet recruiting,TUBB6,1
non-small cell lung carcinoma,VINBLASTINE,3,Not yet recruiting,TUBB4B,1
non-small cell lung carcinoma,VINBLASTINE,3,Not yet recruiting,TUBB4A,1
non-small cell lung carcinoma,VINBLASTINE,3,Not yet recruiting,TUBB3,1
non-small cell lung carcinoma,VINBLASTINE,3,Not yet recruiting,TUBB2B,1
non-small cell lung carcinoma,VINBLASTINE,3,Not yet recruiting,TUBB2A,1
non-small cell lung carcinoma,VINBLASTINE,3,Not yet recruiting,TUBB1,1
non-small cell lung carcinoma,ATEZOLIZUMAB,0,Completed,CD274,1
non-small cell lung carcinoma,ASPIRIN,3,Withdrawn,PTGS1,1
non-small cell lung carcinoma,APATINIB,4,Not yet recruiting,KDR,1
non-small cell lung carcinoma,ASPIRIN,2,Unknown status,PTGS2,1
non-small cell lung carcinoma,APREPITANT,2,Recruiting,TACR1,1
non-small cell lung carcinoma,APREPITANT,3,Unknown status,TACR1,1
non-small cell lung carcinoma,APRICOXIB,1,Completed,PTGS2,1
non-small cell lung carcinoma,ARMODAFINIL,1,Withdrawn,SLC6A3,1
non-small cell lung carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB8,1
non-small cell lung carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB6,1
non-small cell lung carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB4B,1
non-small cell lung carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB4A,1
non-small cell lung carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB3,1
non-small cell lung carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB2B,1
non-small cell lung carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB2A,1
non-small cell lung carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB1,1
non-small cell lung carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB,1
non-small cell lung carcinoma,VINORELBINE,1,Terminated,TUBB8,1
non-small cell lung carcinoma,VINORELBINE,1,Terminated,TUBB6,1
non-small cell lung carcinoma,VINORELBINE,1,Terminated,TUBB4B,1
non-small cell lung carcinoma,VINORELBINE,1,Terminated,TUBB4A,1
non-small cell lung carcinoma,VINORELBINE,1,Terminated,TUBB3,1
non-small cell lung carcinoma,VINORELBINE,1,Terminated,TUBB2B,1
non-small cell lung carcinoma,VINORELBINE,1,Terminated,TUBB2A,1
non-small cell lung carcinoma,VINORELBINE,1,Terminated,TUBB1,1
non-small cell lung carcinoma,VINORELBINE,1,Terminated,TUBB,1
non-small cell lung carcinoma,IRX-4204,1,Recruiting,RXRA,1
non-small cell lung carcinoma,IRX-4204,1,Recruiting,RXRB,1
non-small cell lung carcinoma,ASPIRIN,2,Unknown status,PTGS1,1
non-small cell lung carcinoma,AFATINIB,4,n/a,ERBB4,1
non-small cell lung carcinoma,AFATINIB,4,n/a,ERBB2,1
non-small cell lung carcinoma,AFATINIB,4,n/a,EGFR,1
non-small cell lung carcinoma,XL-281,1,Completed,RAF1,1
non-small cell lung carcinoma,X-396,3,"Active, not recruiting",ALK,1
non-small cell lung carcinoma,X-396,2,Recruiting,ALK,1
non-small cell lung carcinoma,X-396,2,Not yet recruiting,ALK,1
non-small cell lung carcinoma,X-396,1,Recruiting,ALK,1
non-small cell lung carcinoma,VOXTALISIB,1,Completed,PIK3R5,1
non-small cell lung carcinoma,VOXTALISIB,1,Completed,PIK3R3,1
non-small cell lung carcinoma,VOXTALISIB,1,Completed,PIK3R2,1
non-small cell lung carcinoma,VOXTALISIB,1,Completed,PIK3R1,1
non-small cell lung carcinoma,VOXTALISIB,1,Completed,PIK3CG,1
non-small cell lung carcinoma,VOXTALISIB,1,Completed,PIK3CD,1
non-small cell lung carcinoma,VOXTALISIB,1,Completed,PIK3CB,1
non-small cell lung carcinoma,VOXTALISIB,1,Completed,PIK3CA,1
non-small cell lung carcinoma,VOXTALISIB,1,Completed,MTOR,1
non-small cell lung carcinoma,VOSAROXIN,2,Completed,TOP2B,1
non-small cell lung carcinoma,VOSAROXIN,2,Completed,TOP2A,1
non-small cell lung carcinoma,VORINOSTAT,2,Terminated,HDAC6,1
non-small cell lung carcinoma,VORINOSTAT,2,Terminated,HDAC3,1
non-small cell lung carcinoma,VORINOSTAT,2,Terminated,HDAC2,1
non-small cell lung carcinoma,VORINOSTAT,2,Terminated,HDAC1,1
non-small cell lung carcinoma,ABEMACICLIB,1,Recruiting,CDK4,1
non-small cell lung carcinoma,ABEMACICLIB,1,Recruiting,CDK6,1
non-small cell lung carcinoma,HYDROXYCHLOROQUINE,2,Completed,TLR9,1
non-small cell lung carcinoma,IBRUTINIB,2,Withdrawn,BTK,1
non-small cell lung carcinoma,ABEMACICLIB,3,"Active, not recruiting",CDK4,1
non-small cell lung carcinoma,ABEMACICLIB,3,"Active, not recruiting",CDK6,1
non-small cell lung carcinoma,XL-281,1,Completed,BRAF,1
non-small cell lung carcinoma,XL-999,1,Terminated,FGFR1,1
non-small cell lung carcinoma,AFATINIB,4,Terminated,ERBB4,1
non-small cell lung carcinoma,XL-999,1,Terminated,FGFR2,1
non-small cell lung carcinoma,ZOLEDRONIC ACID,2,Recruiting,FDPS,1
non-small cell lung carcinoma,ZOLEDRONIC ACID,2,Completed,FDPS,1
non-small cell lung carcinoma,ZIBOTENTAN,2,Completed,EDNRA,1
non-small cell lung carcinoma,ZALUTUMUMAB,2,Withdrawn,EGFR,1
non-small cell lung carcinoma,ZALUTUMUMAB,2,Terminated,EGFR,1
non-small cell lung carcinoma,XL-999,2,Terminated,PDGFRB,1
non-small cell lung carcinoma,XL-999,2,Terminated,PDGFRA,1
non-small cell lung carcinoma,XL-999,2,Terminated,KIT,1
non-small cell lung carcinoma,XL-999,2,Terminated,KDR,1
non-small cell lung carcinoma,XL-999,2,Terminated,FLT4,1
non-small cell lung carcinoma,XL-999,2,Terminated,FLT3,1
non-small cell lung carcinoma,XL-999,2,Terminated,FLT1,1
non-small cell lung carcinoma,XL-999,2,Terminated,FGFR4,1
non-small cell lung carcinoma,XL-999,2,Terminated,FGFR3,1
non-small cell lung carcinoma,XL-999,2,Terminated,FGFR2,1
non-small cell lung carcinoma,XL-999,2,Terminated,FGFR1,1
non-small cell lung carcinoma,XL-999,1,Terminated,PDGFRB,1
non-small cell lung carcinoma,XL-999,1,Terminated,PDGFRA,1
non-small cell lung carcinoma,XL-999,1,Terminated,KIT,1
non-small cell lung carcinoma,XL-999,1,Terminated,KDR,1
non-small cell lung carcinoma,XL-999,1,Terminated,FLT4,1
non-small cell lung carcinoma,XL-999,1,Terminated,FLT3,1
non-small cell lung carcinoma,XL-999,1,Terminated,FLT1,1
non-small cell lung carcinoma,XL-999,1,Terminated,FGFR4,1
non-small cell lung carcinoma,XL-999,1,Terminated,FGFR3,1
non-small cell lung carcinoma,ACALABRUTINIB,2,Unknown status,BTK,1
non-small cell lung carcinoma,HYDROXYCHLOROQUINE,2,"Active, not recruiting",TLR7,1
non-small cell lung carcinoma,VORINOSTAT,1,Recruiting,HDAC6,1
non-small cell lung carcinoma,VORINOSTAT,1,Recruiting,HDAC3,1
non-small cell lung carcinoma,VINORELBINE,3,Withdrawn,TUBB2B,1
non-small cell lung carcinoma,VINORELBINE,3,Withdrawn,TUBB2A,1
non-small cell lung carcinoma,VINORELBINE,3,Withdrawn,TUBB1,1
non-small cell lung carcinoma,VINORELBINE,3,Withdrawn,TUBB,1
non-small cell lung carcinoma,AFATINIB,2,Recruiting,ERBB4,1
non-small cell lung carcinoma,AFATINIB,2,Suspended,EGFR,1
non-small cell lung carcinoma,AFATINIB,2,Suspended,ERBB2,1
non-small cell lung carcinoma,AFATINIB,2,Suspended,ERBB4,1
non-small cell lung carcinoma,AFATINIB,2,Terminated,EGFR,1
non-small cell lung carcinoma,AFATINIB,2,Terminated,ERBB2,1
non-small cell lung carcinoma,AFATINIB,2,Terminated,ERBB4,1
non-small cell lung carcinoma,IMGATUZUMAB,2,Completed,EGFR,1
non-small cell lung carcinoma,IMGATUZUMAB,2,Completed,FCGR3A,1
non-small cell lung carcinoma,IMIQUIMOD,2,Completed,TLR7,1
non-small cell lung carcinoma,AFATINIB,3,"Active, not recruiting",EGFR,1
non-small cell lung carcinoma,AFATINIB,3,"Active, not recruiting",ERBB2,1
non-small cell lung carcinoma,AFATINIB,3,"Active, not recruiting",ERBB4,1
non-small cell lung carcinoma,AFATINIB,4,"Active, not recruiting",EGFR,1
non-small cell lung carcinoma,AFATINIB,4,"Active, not recruiting",ERBB2,1
non-small cell lung carcinoma,AFATINIB,4,"Active, not recruiting",ERBB4,1
non-small cell lung carcinoma,AFATINIB,4,Completed,EGFR,1
non-small cell lung carcinoma,AFATINIB,4,Completed,ERBB2,1
non-small cell lung carcinoma,AFATINIB,4,Completed,ERBB4,1
non-small cell lung carcinoma,AFATINIB,4,Terminated,EGFR,1
non-small cell lung carcinoma,AFATINIB,4,Terminated,ERBB2,1
non-small cell lung carcinoma,VINORELBINE,3,Withdrawn,TUBB3,1
non-small cell lung carcinoma,VINORELBINE,3,Withdrawn,TUBB4A,1
non-small cell lung carcinoma,VINORELBINE,3,Withdrawn,TUBB4B,1
non-small cell lung carcinoma,IMGATUZUMAB,1,Withdrawn,EGFR,1
non-small cell lung carcinoma,VORINOSTAT,1,Recruiting,HDAC2,1
non-small cell lung carcinoma,VORINOSTAT,1,Recruiting,HDAC1,1
non-small cell lung carcinoma,HYDROXYCHLOROQUINE,1,Unknown status,TLR9,1
non-small cell lung carcinoma,HYDROXYCHLOROQUINE,1,Unknown status,TLR7,1
non-small cell lung carcinoma,AFATINIB,1,Not yet recruiting,EGFR,1
non-small cell lung carcinoma,AFATINIB,1,Not yet recruiting,ERBB2,1
non-small cell lung carcinoma,AFATINIB,1,Not yet recruiting,ERBB4,1
non-small cell lung carcinoma,AFATINIB,1,Recruiting,EGFR,1
non-small cell lung carcinoma,AFATINIB,1,Recruiting,ERBB2,1
non-small cell lung carcinoma,AFATINIB,1,Recruiting,ERBB4,1
non-small cell lung carcinoma,IMETELSTAT,2,Completed,TERT,1
non-small cell lung carcinoma,VOLASERTIB,2,Completed,PLK1,1
non-small cell lung carcinoma,VINORELBINE,3,Withdrawn,TUBB6,1
non-small cell lung carcinoma,VINTAFOLIDE,2,Completed,FOLR1,1
non-small cell lung carcinoma,IMGATUZUMAB,1,Withdrawn,FCGR3A,1
non-small cell lung carcinoma,AFATINIB,1,Withdrawn,EGFR,1
non-small cell lung carcinoma,AFATINIB,1,Withdrawn,ERBB2,1
non-small cell lung carcinoma,AFATINIB,1,Withdrawn,ERBB4,1
non-small cell lung carcinoma,AFATINIB,2,Not yet recruiting,EGFR,1
non-small cell lung carcinoma,AFATINIB,2,Not yet recruiting,ERBB2,1
non-small cell lung carcinoma,AFATINIB,2,Not yet recruiting,ERBB4,1
non-small cell lung carcinoma,AFATINIB,2,Recruiting,EGFR,1
non-small cell lung carcinoma,AFATINIB,2,Recruiting,ERBB2,1
non-small cell lung carcinoma,VINORELBINE,3,Withdrawn,TUBB8,1
non-small cell lung carcinoma,VINBLASTINE,3,Not yet recruiting,TUBB,1
non-small cell lung carcinoma,ATEZOLIZUMAB,1,Not yet recruiting,CD274,1
non-small cell lung carcinoma,BINIMETINIB,1,Withdrawn,MAP2K2,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",EPHB3,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",EPHB1,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",EPHA8,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",EPHA7,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",EPHA6,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",EPHA5,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",EPHA4,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",EPHA3,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",EPHA2,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",EPHA10,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",EPHA1,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",EGFR,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,TEK,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,SRC,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,RET,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,PTK6,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,KDR,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,FLT4,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,FLT1,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,ERBB4,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,ERBB3,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,ERBB2,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,EPHB6,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,EPHB4,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,EPHB3,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,EPHB2,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",EPHB2,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",EPHB4,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,EPHA8,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",EPHB6,1
non-small cell lung carcinoma,AZD-4547,1,Completed,FGFR3,1
non-small cell lung carcinoma,AZD-4547,1,Completed,FGFR4,1
non-small cell lung carcinoma,AZD-4547,2,"Active, not recruiting",FGFR1,1
non-small cell lung carcinoma,AZD-4547,2,"Active, not recruiting",FGFR2,1
non-small cell lung carcinoma,AZD-4547,2,"Active, not recruiting",FGFR3,1
non-small cell lung carcinoma,AZD-4547,2,"Active, not recruiting",FGFR4,1
non-small cell lung carcinoma,AZD-4547,2,Recruiting,FGFR1,1
non-small cell lung carcinoma,AZD-4547,2,Recruiting,FGFR2,1
non-small cell lung carcinoma,AZD-4547,2,Recruiting,FGFR3,1
non-small cell lung carcinoma,AZD-4547,2,Recruiting,FGFR4,1
non-small cell lung carcinoma,AZD-5363,2,"Active, not recruiting",AKT1,1
non-small cell lung carcinoma,AZD-5363,2,"Active, not recruiting",AKT2,1
non-small cell lung carcinoma,AZD-5363,2,"Active, not recruiting",AKT3,1
non-small cell lung carcinoma,AZD-5363,2,Recruiting,AKT1,1
non-small cell lung carcinoma,AZD-5363,2,Recruiting,AKT2,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",TEK,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",SRC,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",RET,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",PTK6,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",KDR,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",FLT4,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",FLT1,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",ERBB4,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",ERBB3,1
non-small cell lung carcinoma,VANDETANIB,2,"Active, not recruiting",ERBB2,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,EPHB1,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,EPHA7,1
non-small cell lung carcinoma,ATEZOLIZUMAB,1,Terminated,CD274,1
non-small cell lung carcinoma,GEMCITABINE,4,Terminated,POLD4,1
non-small cell lung carcinoma,GEMCITABINE,4,Terminated,POLD2,1
non-small cell lung carcinoma,IXABEPILONE,2,Terminated,TUBB,1
non-small cell lung carcinoma,IXABEPILONE,2,Terminated,TUBB1,1
non-small cell lung carcinoma,BERZOSERTIB,1,Recruiting,ATR,1
non-small cell lung carcinoma,BEVACIZUMAB,1,Not yet recruiting,VEGFA,1
non-small cell lung carcinoma,BEVACIZUMAB,2,"Active, not recruiting",VEGFA,1
non-small cell lung carcinoma,BEVACIZUMAB,2,Withdrawn,VEGFA,1
non-small cell lung carcinoma,IXABEPILONE,2,Terminated,TUBB2A,1
non-small cell lung carcinoma,BEVACIZUMAB,3,Unknown status,VEGFA,1
non-small cell lung carcinoma,IXABEPILONE,2,Terminated,TUBB2B,1
non-small cell lung carcinoma,BEVACIZUMAB,4,n/a,VEGFA,1
non-small cell lung carcinoma,BEXAROTENE,1,Terminated,RXRA,1
non-small cell lung carcinoma,BEXAROTENE,1,Terminated,RXRB,1
non-small cell lung carcinoma,BEXAROTENE,1,Terminated,RXRG,1
non-small cell lung carcinoma,BEXAROTENE,2,Completed,RXRA,1
non-small cell lung carcinoma,BEXAROTENE,2,Completed,RXRB,1
non-small cell lung carcinoma,BEXAROTENE,2,Completed,RXRG,1
non-small cell lung carcinoma,IXABEPILONE,2,Terminated,TUBB3,1
non-small cell lung carcinoma,CILENGITIDE,1,Completed,ITGB3,1
non-small cell lung carcinoma,IXABEPILONE,2,Terminated,TUBB4B,1
non-small cell lung carcinoma,BI-2536,1,Completed,PLK1,1
non-small cell lung carcinoma,BI-2536,2,Completed,PLK1,1
non-small cell lung carcinoma,IXABEPILONE,2,Terminated,TUBB6,1
non-small cell lung carcinoma,IXABEPILONE,2,Terminated,TUBB8,1
non-small cell lung carcinoma,BINIMETINIB,1,Withdrawn,MAP2K1,1
non-small cell lung carcinoma,GEMCITABINE,4,Terminated,POLD3,1
non-small cell lung carcinoma,GEMCITABINE,4,Terminated,POLE,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,EPHA6,1
non-small cell lung carcinoma,GEMCITABINE,4,Terminated,POLE2,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,EPHA5,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,EPHA4,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,EPHA3,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,EPHA2,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,EPHA10,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,EPHA1,1
non-small cell lung carcinoma,VANDETANIB,1,Withdrawn,EGFR,1
non-small cell lung carcinoma,AZD-5363,2,Recruiting,AKT3,1
non-small cell lung carcinoma,AZD-6738,2,Not yet recruiting,ATR,1
non-small cell lung carcinoma,AZD-6738,2,Recruiting,ATR,1
non-small cell lung carcinoma,BELINOSTAT,1,Completed,HDAC1,1
non-small cell lung carcinoma,BELINOSTAT,1,Completed,HDAC10,1
non-small cell lung carcinoma,BELINOSTAT,1,Completed,HDAC11,1
non-small cell lung carcinoma,BELINOSTAT,1,Completed,HDAC2,1
non-small cell lung carcinoma,BELINOSTAT,1,Completed,HDAC3,1
non-small cell lung carcinoma,BELINOSTAT,1,Completed,HDAC4,1
non-small cell lung carcinoma,BELINOSTAT,1,Completed,HDAC5,1
non-small cell lung carcinoma,BELINOSTAT,1,Completed,HDAC6,1
non-small cell lung carcinoma,BELINOSTAT,1,Completed,HDAC7,1
non-small cell lung carcinoma,BELINOSTAT,1,Completed,HDAC8,1
non-small cell lung carcinoma,BELINOSTAT,1,Completed,HDAC9,1
non-small cell lung carcinoma,GEMCITABINE,4,Terminated,RRM1,1
non-small cell lung carcinoma,GEMCITABINE,4,Terminated,PRIM2,1
non-small cell lung carcinoma,GEMCITABINE,4,Terminated,PRIM1,1
non-small cell lung carcinoma,GEMCITABINE,4,Terminated,POLE3,1
non-small cell lung carcinoma,AZD-4547,1,Completed,FGFR2,1
non-small cell lung carcinoma,AZD-4547,1,Completed,FGFR1,1
non-small cell lung carcinoma,AZD-2014,2,Terminated,MTOR,1
non-small cell lung carcinoma,AZACITIDINE,1,Terminated,DNMT1,1
non-small cell lung carcinoma,AZACITIDINE,1,Unknown status,DNMT1,1
non-small cell lung carcinoma,AZACITIDINE,1,Unknown status,DNMT3A,1
non-small cell lung carcinoma,AZACITIDINE,2,"Active, not recruiting",DNMT1,1
non-small cell lung carcinoma,AZACITIDINE,2,"Active, not recruiting",DNMT3A,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",TEK,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",SRC,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",RET,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",PTK6,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",KDR,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",FLT4,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",FLT1,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",ERBB4,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",ERBB3,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",ERBB2,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",EPHB6,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",EPHB4,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",EPHB3,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",EPHB2,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",EPHB1,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",EPHA8,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",EPHA7,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",EPHA6,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",EPHA5,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",EPHA4,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",EPHA3,1
non-small cell lung carcinoma,AZACITIDINE,1,Terminated,DNMT3A,1
non-small cell lung carcinoma,AXL-1717,2,Completed,IGF1R,1
non-small cell lung carcinoma,AZD-2014,2,"Active, not recruiting",MTOR,1
non-small cell lung carcinoma,AXL-1717,1,Completed,IGF1R,1
non-small cell lung carcinoma,ITACITINIB,2,Recruiting,JAK1,1
non-small cell lung carcinoma,ATEZOLIZUMAB,2,Withdrawn,CD274,1
non-small cell lung carcinoma,ATEZOLIZUMAB,3,Completed,CD274,1
non-small cell lung carcinoma,ITACITINIB,2,Terminated,JAK1,1
non-small cell lung carcinoma,ATEZOLIZUMAB,3,Terminated,CD274,1
non-small cell lung carcinoma,ATEZOLIZUMAB,4,"Active, not recruiting",CD274,1
non-small cell lung carcinoma,AVELUMAB,0,Recruiting,CD274,1
non-small cell lung carcinoma,VATALANIB,2,Completed,PDGFRB,1
non-small cell lung carcinoma,VATALANIB,2,Completed,PDGFRA,1
non-small cell lung carcinoma,VATALANIB,2,Completed,KIT,1
non-small cell lung carcinoma,VATALANIB,2,Completed,KDR,1
non-small cell lung carcinoma,VATALANIB,2,Completed,FLT4,1
non-small cell lung carcinoma,VATALANIB,2,Completed,FLT1,1
non-small cell lung carcinoma,VATALANIB,2,Completed,CSF1R,1
non-small cell lung carcinoma,AVELUMAB,1,"Active, not recruiting",CD274,1
non-small cell lung carcinoma,AVELUMAB,1,Not yet recruiting,CD274,1
non-small cell lung carcinoma,ITACITINIB,2,Withdrawn,JAK1,1
non-small cell lung carcinoma,AVELUMAB,2,Not yet recruiting,CD274,1
non-small cell lung carcinoma,AVELUMAB,2,Recruiting,CD274,1
non-small cell lung carcinoma,AXITINIB,1,Completed,FLT1,1
non-small cell lung carcinoma,AXITINIB,1,Completed,FLT4,1
non-small cell lung carcinoma,AXITINIB,1,Completed,KDR,1
non-small cell lung carcinoma,AXITINIB,1,Recruiting,FLT1,1
non-small cell lung carcinoma,AXITINIB,1,Recruiting,FLT4,1
non-small cell lung carcinoma,AXITINIB,1,Recruiting,KDR,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",EPHA2,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",EPHA10,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",EPHA1,1
non-small cell lung carcinoma,VANDETANIB,3,"Active, not recruiting",EGFR,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,PTK6,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,KDR,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,FLT4,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,FLT1,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,ERBB4,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,ERBB3,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,ERBB2,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,EPHB6,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,EPHB4,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,EPHB3,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,EPHB2,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,EPHB1,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,EPHA8,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,EPHA7,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,EPHA6,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,EPHA5,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,EPHA4,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,EPHA3,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,EPHA2,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,EPHA10,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,EPHA1,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,EGFR,1
non-small cell lung carcinoma,AZACITIDINE,2,Recruiting,DNMT1,1
non-small cell lung carcinoma,AZACITIDINE,2,Recruiting,DNMT3A,1
non-small cell lung carcinoma,AZD-1480,1,Terminated,JAK2,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,RET,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,SRC,1
non-small cell lung carcinoma,VANDETANIB,2,Unknown status,TEK,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,EPHB4,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,TEK,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,SRC,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,RET,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,PTK6,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,KDR,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,FLT4,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,FLT1,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,ERBB4,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,ERBB3,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,ERBB2,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,EPHB6,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,EPHB3,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,EGFR,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,EPHB2,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,EPHB1,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,EPHA8,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,EPHA7,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,EPHA6,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,EPHA5,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,EPHA4,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,EPHA3,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,EPHA2,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,EPHA10,1
non-small cell lung carcinoma,VANDETANIB,2,Withdrawn,EPHA1,1
non-small cell lung carcinoma,LUCITANIB,2,Terminated,FGFR2,1
non-small cell lung carcinoma,PLINABULIN,3,Recruiting,TUBB4A,1
non-small cell lung carcinoma,CILENGITIDE,1,Completed,ITGB5,1
non-small cell lung carcinoma,ENTINOSTAT,2,Recruiting,HDAC4,1
non-small cell lung carcinoma,OSIMERTINIB,1,Completed,ERBB3,1
non-small cell lung carcinoma,OSIMERTINIB,1,Completed,ERBB2,1
non-small cell lung carcinoma,ENTINOSTAT,2,Recruiting,HDAC5,1
non-small cell lung carcinoma,ENTINOSTAT,2,Recruiting,HDAC6,1
non-small cell lung carcinoma,ENTINOSTAT,2,Recruiting,HDAC7,1
non-small cell lung carcinoma,ENTINOSTAT,2,Recruiting,HDAC8,1
non-small cell lung carcinoma,ENTINOSTAT,2,Recruiting,HDAC9,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFA12,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFA13,1
non-small cell lung carcinoma,OLMUTINIB,2,Completed,EGFR,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFA2,1
non-small cell lung carcinoma,OLMUTINIB,1,Completed,EGFR,1
non-small cell lung carcinoma,OLARATUMAB,2,Completed,PDGFRA,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFA3,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFA4,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFA4L2,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFA5,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFA6,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFA7,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFA8,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFA9,1
non-small cell lung carcinoma,ENZASTAURIN,1,Completed,PRKCB,1
non-small cell lung carcinoma,OLAPARIB,1,Completed,PARP3,1
non-small cell lung carcinoma,OLAPARIB,1,Completed,PARP2,1
non-small cell lung carcinoma,OLAPARIB,1,Completed,PARP1,1
non-small cell lung carcinoma,OSIMERTINIB,1,Completed,ERBB4,1
non-small cell lung carcinoma,OSIMERTINIB,1,Not yet recruiting,ERBB2,1
non-small cell lung carcinoma,LUCITANIB,2,Terminated,FLT1,1
non-small cell lung carcinoma,OSIMERTINIB,1,Not yet recruiting,ERBB3,1
non-small cell lung carcinoma,ENTINOSTAT,1,Terminated,HDAC5,1
non-small cell lung carcinoma,ENTINOSTAT,1,Terminated,HDAC6,1
non-small cell lung carcinoma,ENTINOSTAT,1,Terminated,HDAC7,1
non-small cell lung carcinoma,ENTINOSTAT,1,Terminated,HDAC8,1
non-small cell lung carcinoma,ENTINOSTAT,1,Terminated,HDAC9,1
non-small cell lung carcinoma,ENTINOSTAT,2,Completed,HDAC1,1
non-small cell lung carcinoma,ENTINOSTAT,2,Completed,HDAC10,1
non-small cell lung carcinoma,ENTINOSTAT,2,Completed,HDAC11,1
non-small cell lung carcinoma,ENTINOSTAT,2,Completed,HDAC2,1
non-small cell lung carcinoma,ENTINOSTAT,2,Completed,HDAC3,1
non-small cell lung carcinoma,ENTINOSTAT,2,Completed,HDAC4,1
non-small cell lung carcinoma,ENTINOSTAT,2,Completed,HDAC5,1
non-small cell lung carcinoma,OSIMERTINIB,2,Completed,ERBB4,1
non-small cell lung carcinoma,OSIMERTINIB,2,Completed,ERBB3,1
non-small cell lung carcinoma,OSIMERTINIB,2,Completed,ERBB2,1
non-small cell lung carcinoma,ENTINOSTAT,2,Completed,HDAC6,1
non-small cell lung carcinoma,ENTINOSTAT,2,Completed,HDAC7,1
non-small cell lung carcinoma,ENTINOSTAT,2,Completed,HDAC8,1
non-small cell lung carcinoma,ENTINOSTAT,2,Completed,HDAC9,1
non-small cell lung carcinoma,ENTINOSTAT,2,Recruiting,HDAC1,1
non-small cell lung carcinoma,ENTINOSTAT,2,Recruiting,HDAC10,1
non-small cell lung carcinoma,ENTINOSTAT,2,Recruiting,HDAC11,1
non-small cell lung carcinoma,ENTINOSTAT,2,Recruiting,HDAC2,1
non-small cell lung carcinoma,ENTINOSTAT,2,Recruiting,HDAC3,1
non-small cell lung carcinoma,OSIMERTINIB,1,Not yet recruiting,ERBB4,1
non-small cell lung carcinoma,NIVOLUMAB,4,n/a,PDCD1,1
non-small cell lung carcinoma,EPACADOSTAT,1,"Active, not recruiting",IDO1,1
non-small cell lung carcinoma,NIVOLUMAB,3,Terminated,PDCD1,1
non-small cell lung carcinoma,EPACADOSTAT,1,Recruiting,IDO1,1
non-small cell lung carcinoma,NINTEDANIB,3,Terminated,FGFR4,1
non-small cell lung carcinoma,NINTEDANIB,3,Terminated,FGFR3,1
non-small cell lung carcinoma,NINTEDANIB,3,Terminated,FGFR2,1
non-small cell lung carcinoma,NINTEDANIB,3,Terminated,FGFR1,1
non-small cell lung carcinoma,NINTEDANIB,3,Completed,PDGFRB,1
non-small cell lung carcinoma,NINTEDANIB,3,Completed,PDGFRA,1
non-small cell lung carcinoma,NINTEDANIB,3,Completed,KDR,1
non-small cell lung carcinoma,NINTEDANIB,3,Completed,FLT4,1
non-small cell lung carcinoma,NINTEDANIB,3,Completed,FLT1,1
non-small cell lung carcinoma,NINTEDANIB,3,Completed,FGFR4,1
non-small cell lung carcinoma,NINTEDANIB,3,Completed,FGFR3,1
non-small cell lung carcinoma,NINTEDANIB,3,Completed,FGFR2,1
non-small cell lung carcinoma,NINTEDANIB,3,Completed,FGFR1,1
non-small cell lung carcinoma,ERIBULIN,1,Unknown status,TUBB2B,1
non-small cell lung carcinoma,ERIBULIN,1,Unknown status,TUBB3,1
non-small cell lung carcinoma,ERIBULIN,1,Unknown status,TUBB4A,1
non-small cell lung carcinoma,ERIBULIN,1,Unknown status,TUBB4B,1
non-small cell lung carcinoma,ERIBULIN,1,Unknown status,TUBB6,1
non-small cell lung carcinoma,ERIBULIN,1,Unknown status,TUBB8,1
non-small cell lung carcinoma,ERIBULIN,3,Completed,TUBB,1
non-small cell lung carcinoma,ERIBULIN,3,Completed,TUBB1,1
non-small cell lung carcinoma,ERIBULIN,3,Completed,TUBB2A,1
non-small cell lung carcinoma,NINTEDANIB,1,Terminated,PDGFRB,1
non-small cell lung carcinoma,NINTEDANIB,1,Terminated,PDGFRA,1
non-small cell lung carcinoma,NINTEDANIB,1,Terminated,KDR,1
non-small cell lung carcinoma,NINTEDANIB,3,Terminated,FLT1,1
non-small cell lung carcinoma,NINTEDANIB,3,Terminated,FLT4,1
non-small cell lung carcinoma,NINTEDANIB,3,Terminated,KDR,1
non-small cell lung carcinoma,EPINEPHRINE,3,Recruiting,ADRB1,1
non-small cell lung carcinoma,NIVOLUMAB,3,Not yet recruiting,PDCD1,1
non-small cell lung carcinoma,EPINEPHRINE,3,Recruiting,ADRA1A,1
non-small cell lung carcinoma,EPINEPHRINE,3,Recruiting,ADRA1B,1
non-small cell lung carcinoma,NIVOLUMAB,2,Terminated,PDCD1,1
non-small cell lung carcinoma,NIVOLUMAB,2,Suspended,PDCD1,1
non-small cell lung carcinoma,EPINEPHRINE,3,Recruiting,ADRA1D,1
non-small cell lung carcinoma,EPINEPHRINE,3,Recruiting,ADRA2A,1
non-small cell lung carcinoma,EPINEPHRINE,3,Recruiting,ADRA2B,1
non-small cell lung carcinoma,NIVOLUMAB,1,Withdrawn,PDCD1,1
non-small cell lung carcinoma,NIVOLUMAB,1,Terminated,PDCD1,1
non-small cell lung carcinoma,EPINEPHRINE,3,Recruiting,ADRA2C,1
non-small cell lung carcinoma,NIVOLUMAB,1,Completed,PDCD1,1
non-small cell lung carcinoma,NINTEDANIB,3,Terminated,PDGFRA,1
non-small cell lung carcinoma,EPINEPHRINE,3,Recruiting,ADRB2,1
non-small cell lung carcinoma,NIVOLUMAB,0,Recruiting,PDCD1,1
non-small cell lung carcinoma,NIVOLUMAB,0,Enrolling by invitation,PDCD1,1
non-small cell lung carcinoma,EPINEPHRINE,3,Recruiting,ADRB3,1
non-small cell lung carcinoma,ERIBULIN,1,Unknown status,TUBB,1
non-small cell lung carcinoma,NITROGLYCERIN,2,Terminated,GUCY1B2,1
non-small cell lung carcinoma,NITROGLYCERIN,2,Terminated,GUCY1B1,1
non-small cell lung carcinoma,NIRAPARIB,1,Recruiting,PARP3,1
non-small cell lung carcinoma,ERIBULIN,1,Unknown status,TUBB1,1
non-small cell lung carcinoma,ERIBULIN,1,Unknown status,TUBB2A,1
non-small cell lung carcinoma,NINTEDANIB,3,Terminated,PDGFRB,1
non-small cell lung carcinoma,ENTINOSTAT,1,Terminated,HDAC4,1
non-small cell lung carcinoma,OSIMERTINIB,3,Recruiting,ERBB2,1
non-small cell lung carcinoma,OSIMERTINIB,3,Recruiting,ERBB3,1
non-small cell lung carcinoma,ENMD-981693,1,Completed,PDGFRA,1
non-small cell lung carcinoma,DULANERMIN,2,Completed,TNFRSF10A,1
non-small cell lung carcinoma,DULANERMIN,2,Completed,TNFRSF10B,1
non-small cell lung carcinoma,DURVALUMAB,0,Not yet recruiting,CD274,1
non-small cell lung carcinoma,DURVALUMAB,1,Completed,CD274,1
non-small cell lung carcinoma,DURVALUMAB,1,Suspended,CD274,1
non-small cell lung carcinoma,DURVALUMAB,3,Not yet recruiting,CD274,1
non-small cell lung carcinoma,DURVALUMAB,4,n/a,CD274,1
non-small cell lung carcinoma,EGF816,1,"Active, not recruiting",EGFR,1
non-small cell lung carcinoma,EGF816,2,Recruiting,EGFR,1
non-small cell lung carcinoma,EMIBETUZUMAB,2,"Active, not recruiting",MET,1
non-small cell lung carcinoma,EMIBETUZUMAB,2,Completed,MET,1
non-small cell lung carcinoma,ENCORAFENIB,2,Withdrawn,BRAF,1
non-small cell lung carcinoma,ENMD-981693,1,Completed,AURKA,1
non-small cell lung carcinoma,ENMD-981693,1,Completed,BLK,1
non-small cell lung carcinoma,ENMD-981693,1,Completed,FGFR1,1
non-small cell lung carcinoma,ENMD-981693,1,Completed,FGFR2,1
non-small cell lung carcinoma,ENMD-981693,1,Completed,FGFR3,1
non-small cell lung carcinoma,ENMD-981693,1,Completed,FGFR4,1
non-small cell lung carcinoma,ENMD-981693,1,Completed,FGR,1
non-small cell lung carcinoma,ENMD-981693,1,Completed,FLT3,1
non-small cell lung carcinoma,ENMD-981693,1,Completed,FRK,1
non-small cell lung carcinoma,ENMD-981693,1,Completed,FYN,1
non-small cell lung carcinoma,ENMD-981693,1,Completed,HCK,1
non-small cell lung carcinoma,ENMD-981693,1,Completed,KDR,1
non-small cell lung carcinoma,ENMD-981693,1,Completed,LCK,1
non-small cell lung carcinoma,DROZITUMAB,2,Completed,TNFRSF10B,1
non-small cell lung carcinoma,DOXYCYCLINE,2,Completed,MMP8,1
non-small cell lung carcinoma,DOXYCYCLINE,2,Completed,MMP7,1
non-small cell lung carcinoma,DOVITINIB,1,Terminated,PDGFRA,1
non-small cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLD3,1
non-small cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLD2,1
non-small cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLD1,1
non-small cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLA2,1
non-small cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLA1,1
non-small cell lung carcinoma,DOVITINIB,1,Terminated,FGFR3,1
non-small cell lung carcinoma,DOVITINIB,1,Terminated,FLT1,1
non-small cell lung carcinoma,DOVITINIB,1,Terminated,FLT3,1
non-small cell lung carcinoma,DOVITINIB,1,Terminated,FLT4,1
non-small cell lung carcinoma,DOVITINIB,1,Terminated,KDR,1
non-small cell lung carcinoma,DOVITINIB,1,Terminated,KIT,1
non-small cell lung carcinoma,DOVITINIB,1,Terminated,PDGFRB,1
non-small cell lung carcinoma,DOXYCYCLINE,2,Completed,MMP13,1
non-small cell lung carcinoma,DOVITINIB,2,Unknown status,FGFR3,1
non-small cell lung carcinoma,DOVITINIB,2,Unknown status,FLT1,1
non-small cell lung carcinoma,DOVITINIB,2,Unknown status,FLT3,1
non-small cell lung carcinoma,DOVITINIB,2,Unknown status,FLT4,1
non-small cell lung carcinoma,DOVITINIB,2,Unknown status,KDR,1
non-small cell lung carcinoma,DOVITINIB,2,Unknown status,KIT,1
non-small cell lung carcinoma,DOVITINIB,2,Unknown status,PDGFRA,1
non-small cell lung carcinoma,DOVITINIB,2,Unknown status,PDGFRB,1
non-small cell lung carcinoma,DOXORUBICIN,1,Unknown status,TOP2A,1
non-small cell lung carcinoma,DOXORUBICIN,2,Not yet recruiting,TOP2A,1
non-small cell lung carcinoma,DOXYCYCLINE,2,Completed,MMP1,1
non-small cell lung carcinoma,ENMD-981693,1,Completed,LYN,1
non-small cell lung carcinoma,ENMD-981693,1,Completed,PDGFRB,1
non-small cell lung carcinoma,OSIMERTINIB,3,Recruiting,ERBB4,1
non-small cell lung carcinoma,ENMD-981693,1,Completed,SRC,1
non-small cell lung carcinoma,PACLITAXEL,0,Terminated,TUBB6,1
non-small cell lung carcinoma,PACLITAXEL,0,Terminated,TUBB4B,1
non-small cell lung carcinoma,PACLITAXEL,0,Terminated,TUBB4A,1
non-small cell lung carcinoma,PACLITAXEL,0,Terminated,TUBB3,1
non-small cell lung carcinoma,PACLITAXEL,0,Terminated,TUBB2B,1
non-small cell lung carcinoma,PACLITAXEL,0,Terminated,TUBB2A,1
non-small cell lung carcinoma,PACLITAXEL,0,Terminated,TUBB1,1
non-small cell lung carcinoma,PACLITAXEL,0,Terminated,TUBB,1
non-small cell lung carcinoma,PACLITAXEL,0,Recruiting,TUBB8,1
non-small cell lung carcinoma,PACLITAXEL,0,Recruiting,TUBB6,1
non-small cell lung carcinoma,PACLITAXEL,0,Recruiting,TUBB4B,1
non-small cell lung carcinoma,PACLITAXEL,0,Recruiting,TUBB4A,1
non-small cell lung carcinoma,PACLITAXEL,0,Recruiting,TUBB3,1
non-small cell lung carcinoma,PACLITAXEL,0,Recruiting,TUBB2B,1
non-small cell lung carcinoma,PACLITAXEL,0,Recruiting,TUBB2A,1
non-small cell lung carcinoma,PACLITAXEL,0,Recruiting,TUBB1,1
non-small cell lung carcinoma,PACLITAXEL,0,Recruiting,TUBB,1
non-small cell lung carcinoma,OSIMERTINIB,4,n/a,ERBB4,1
non-small cell lung carcinoma,OSIMERTINIB,4,n/a,ERBB3,1
non-small cell lung carcinoma,OSIMERTINIB,4,n/a,ERBB2,1
non-small cell lung carcinoma,ENTINOSTAT,1,Terminated,HDAC2,1
non-small cell lung carcinoma,OSIMERTINIB,4,Not yet recruiting,ERBB4,1
non-small cell lung carcinoma,OSIMERTINIB,4,Not yet recruiting,ERBB3,1
non-small cell lung carcinoma,OSIMERTINIB,4,Not yet recruiting,ERBB2,1
non-small cell lung carcinoma,ENTINOSTAT,1,Terminated,HDAC3,1
non-small cell lung carcinoma,PACLITAXEL,0,Terminated,TUBB8,1
non-small cell lung carcinoma,PACLITAXEL,0,Unknown status,TUBB,1
non-small cell lung carcinoma,PACLITAXEL,0,Unknown status,TUBB1,1
non-small cell lung carcinoma,METFORMIN,2,Completed,MT-ND6,1
non-small cell lung carcinoma,ENMD-981693,1,Completed,SRMS,1
non-small cell lung carcinoma,ENMD-981693,1,Completed,YES1,1
non-small cell lung carcinoma,ENOXAPARIN SODIUM,3,Completed,SERPINC1,1
non-small cell lung carcinoma,ENOXAPARIN SODIUM,3,Terminated,SERPINC1,1
non-small cell lung carcinoma,METFORMIN,2,Completed,GPD2,1
non-small cell lung carcinoma,METFORMIN,2,Completed,MT-ND1,1
non-small cell lung carcinoma,METFORMIN,2,Completed,MT-ND2,1
non-small cell lung carcinoma,METFORMIN,2,Completed,MT-ND3,1
non-small cell lung carcinoma,METFORMIN,2,Completed,MT-ND4,1
non-small cell lung carcinoma,METFORMIN,2,Completed,MT-ND4L,1
non-small cell lung carcinoma,METFORMIN,2,Completed,MT-ND5,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFA1,1
non-small cell lung carcinoma,PACLITAXEL,0,Unknown status,TUBB2A,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFA10,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFA11,1
non-small cell lung carcinoma,ENTINOSTAT,1,Terminated,HDAC1,1
non-small cell lung carcinoma,ENTINOSTAT,1,Terminated,HDAC10,1
non-small cell lung carcinoma,ENTINOSTAT,1,Terminated,HDAC11,1
non-small cell lung carcinoma,PACLITAXEL,0,Unknown status,TUBB8,1
non-small cell lung carcinoma,PACLITAXEL,0,Unknown status,TUBB6,1
non-small cell lung carcinoma,PACLITAXEL,0,Unknown status,TUBB4B,1
non-small cell lung carcinoma,PACLITAXEL,0,Unknown status,TUBB4A,1
non-small cell lung carcinoma,PACLITAXEL,0,Unknown status,TUBB3,1
non-small cell lung carcinoma,PACLITAXEL,0,Unknown status,TUBB2B,1
non-small cell lung carcinoma,NINTEDANIB,1,Terminated,FLT4,1
non-small cell lung carcinoma,NINTEDANIB,1,Terminated,FLT1,1
non-small cell lung carcinoma,NINTEDANIB,1,Terminated,FGFR4,1
non-small cell lung carcinoma,FULVESTRANT,1,Not yet recruiting,ESR1,1
non-small cell lung carcinoma,FAMITINIB,2,"Active, not recruiting",PDGFRB,1
non-small cell lung carcinoma,FAMOTIDINE,1,Completed,HRH2,1
non-small cell lung carcinoma,FEXOFENADINE,1,"Active, not recruiting",HRH1,1
non-small cell lung carcinoma,FICLATUZUMAB,2,Terminated,HGF,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFB9,1
non-small cell lung carcinoma,FIGITUMUMAB,3,Withdrawn,IGF1R,1
non-small cell lung carcinoma,FILGRASTIM,1,Withdrawn,CSF3R,1
non-small cell lung carcinoma,FILGRASTIM,2,Completed,CSF3R,1
non-small cell lung carcinoma,FILGRASTIM,3,"Active, not recruiting",CSF3R,1
non-small cell lung carcinoma,FINASTERIDE,2,Terminated,SRD5A2,1
non-small cell lung carcinoma,FLUOROURACIL,1,Not yet recruiting,TYMS,1
non-small cell lung carcinoma,FLUOROURACIL,2,Not yet recruiting,TYMS,1
non-small cell lung carcinoma,FLURBIPROFEN,4,Terminated,PTGS1,1
non-small cell lung carcinoma,FLURBIPROFEN,4,Terminated,PTGS2,1
non-small cell lung carcinoma,FRESOLIMUMAB,1,Recruiting,TGFB1,1
non-small cell lung carcinoma,FRESOLIMUMAB,1,Recruiting,TGFB2,1
non-small cell lung carcinoma,FRESOLIMUMAB,1,Recruiting,TGFB3,1
non-small cell lung carcinoma,FRUQUINTINIB,2,"Active, not recruiting",FLT1,1
non-small cell lung carcinoma,FRUQUINTINIB,2,"Active, not recruiting",FLT4,1
non-small cell lung carcinoma,FRUQUINTINIB,2,"Active, not recruiting",KDR,1
non-small cell lung carcinoma,FRUQUINTINIB,2,Completed,FLT1,1
non-small cell lung carcinoma,FRUQUINTINIB,2,Completed,FLT4,1
non-small cell lung carcinoma,FRUQUINTINIB,2,Completed,KDR,1
non-small cell lung carcinoma,FRUQUINTINIB,3,Completed,FLT1,1
non-small cell lung carcinoma,FRUQUINTINIB,3,Completed,FLT4,1
non-small cell lung carcinoma,FAMITINIB,2,"Active, not recruiting",PDGFRA,1
non-small cell lung carcinoma,FAMITINIB,2,"Active, not recruiting",KIT,1
non-small cell lung carcinoma,FAMITINIB,2,"Active, not recruiting",KDR,1
non-small cell lung carcinoma,METHYLPREDNISOLONE,2,Recruiting,NR3C1,1
non-small cell lung carcinoma,MGCD-265,2,Completed,MST1R,1
non-small cell lung carcinoma,MGCD-265,2,Completed,MET,1
non-small cell lung carcinoma,MGCD-265,2,Completed,KDR,1
non-small cell lung carcinoma,MGCD-265,2,Completed,FLT4,1
non-small cell lung carcinoma,MGCD-265,2,Completed,FLT1,1
non-small cell lung carcinoma,MGCD-265,1,Terminated,TEK,1
non-small cell lung carcinoma,MGCD-265,1,Terminated,MST1R,1
non-small cell lung carcinoma,MGCD-265,1,Terminated,MET,1
non-small cell lung carcinoma,MGCD-265,1,Terminated,KDR,1
non-small cell lung carcinoma,MGCD-265,1,Terminated,FLT4,1
non-small cell lung carcinoma,MGCD-265,1,Terminated,FLT1,1
non-small cell lung carcinoma,EXEMESTANE,1,"Active, not recruiting",CYP19A1,1
non-small cell lung carcinoma,FAMITINIB,2,"Active, not recruiting",FLT4,1
non-small cell lung carcinoma,EXEMESTANE,2,Recruiting,CYP19A1,1
non-small cell lung carcinoma,EZATIOSTAT,2,Terminated,GSTP1,1
non-small cell lung carcinoma,FAMITINIB,1,Completed,FLT1,1
non-small cell lung carcinoma,FAMITINIB,1,Completed,FLT3,1
non-small cell lung carcinoma,FAMITINIB,1,Completed,FLT4,1
non-small cell lung carcinoma,FAMITINIB,1,Completed,KDR,1
non-small cell lung carcinoma,FAMITINIB,1,Completed,KIT,1
non-small cell lung carcinoma,FAMITINIB,1,Completed,PDGFRA,1
non-small cell lung carcinoma,FAMITINIB,1,Completed,PDGFRB,1
non-small cell lung carcinoma,FAMITINIB,2,"Active, not recruiting",FLT1,1
non-small cell lung carcinoma,FAMITINIB,2,"Active, not recruiting",FLT3,1
non-small cell lung carcinoma,FRUQUINTINIB,3,Completed,KDR,1
non-small cell lung carcinoma,FULVESTRANT,1,Not yet recruiting,ESR2,1
non-small cell lung carcinoma,MIDAZOLAM,1,Not yet recruiting,GABRA1,1
non-small cell lung carcinoma,FULVESTRANT,1,Recruiting,ESR1,1
non-small cell lung carcinoma,GEFITINIB,2,Withdrawn,EGFR,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFS3,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFS4,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFS5,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFS6,1
non-small cell lung carcinoma,GEFITINIB,4,Not yet recruiting,EGFR,1
non-small cell lung carcinoma,GEFITINIB,4,Recruiting,EGFR,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFS7,1
non-small cell lung carcinoma,GEFITINIB,4,Unknown status,EGFR,1
non-small cell lung carcinoma,GEFITINIB,4,n/a,EGFR,1
non-small cell lung carcinoma,GEMCITABINE,1,Not yet recruiting,POLA1,1
non-small cell lung carcinoma,GEMCITABINE,1,Not yet recruiting,POLA2,1
non-small cell lung carcinoma,GEMCITABINE,1,Not yet recruiting,POLD1,1
non-small cell lung carcinoma,GEMCITABINE,1,Not yet recruiting,POLD2,1
non-small cell lung carcinoma,GEMCITABINE,1,Not yet recruiting,POLD3,1
non-small cell lung carcinoma,GEMCITABINE,1,Not yet recruiting,POLD4,1
non-small cell lung carcinoma,GEMCITABINE,1,Not yet recruiting,POLE,1
non-small cell lung carcinoma,GEMCITABINE,1,Not yet recruiting,POLE2,1
non-small cell lung carcinoma,GEMCITABINE,1,Not yet recruiting,POLE3,1
non-small cell lung carcinoma,GEMCITABINE,1,Not yet recruiting,PRIM1,1
non-small cell lung carcinoma,GEMCITABINE,1,Not yet recruiting,PRIM2,1
non-small cell lung carcinoma,GEMCITABINE,1,Not yet recruiting,RRM1,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFS8,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFV1,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFV2,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFS2,1
non-small cell lung carcinoma,GEFITINIB,2,Suspended,EGFR,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFS1,1
non-small cell lung carcinoma,GANETESPIB,3,Terminated,HSP90AB1,1
non-small cell lung carcinoma,FULVESTRANT,1,Recruiting,ESR2,1
non-small cell lung carcinoma,FULVESTRANT,1,Withdrawn,ESR1,1
non-small cell lung carcinoma,FULVESTRANT,1,Withdrawn,ESR2,1
non-small cell lung carcinoma,FULVESTRANT,2,Terminated,ESR1,1
non-small cell lung carcinoma,FULVESTRANT,2,Terminated,ESR2,1
non-small cell lung carcinoma,FUTUXIMAB,1,Withdrawn,EGFR,1
non-small cell lung carcinoma,GANETESPIB,2,Completed,HSP90AA1,1
non-small cell lung carcinoma,GANETESPIB,2,Completed,HSP90AB1,1
non-small cell lung carcinoma,GANETESPIB,2,Terminated,HSP90AA1,1
non-small cell lung carcinoma,GANETESPIB,2,Terminated,HSP90AB1,1
non-small cell lung carcinoma,GANETESPIB,3,Terminated,HSP90AA1,1
non-small cell lung carcinoma,GANITUMAB,1,Terminated,IGF1R,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFC2,1
non-small cell lung carcinoma,GEDATOLISIB,1,"Active, not recruiting",MTOR,1
non-small cell lung carcinoma,GEDATOLISIB,1,"Active, not recruiting",PIK3CA,1
non-small cell lung carcinoma,GEDATOLISIB,1,"Active, not recruiting",PIK3CB,1
non-small cell lung carcinoma,GEDATOLISIB,1,"Active, not recruiting",PIK3CD,1
non-small cell lung carcinoma,GEDATOLISIB,1,"Active, not recruiting",PIK3CG,1
non-small cell lung carcinoma,GEDATOLISIB,1,"Active, not recruiting",PIK3R1,1
non-small cell lung carcinoma,GEDATOLISIB,1,"Active, not recruiting",PIK3R2,1
non-small cell lung carcinoma,GEDATOLISIB,1,"Active, not recruiting",PIK3R3,1
non-small cell lung carcinoma,GEDATOLISIB,1,"Active, not recruiting",PIK3R5,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFC1,1
non-small cell lung carcinoma,GEFITINIB,1,Withdrawn,EGFR,1
non-small cell lung carcinoma,MGCD-265,2,Completed,TEK,1
non-small cell lung carcinoma,MIDAZOLAM,1,Not yet recruiting,GABRA2,1
non-small cell lung carcinoma,NINTEDANIB,1,Terminated,FGFR3,1
non-small cell lung carcinoma,MUPARFOSTAT,2,Completed,VEGFA,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFB10,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFB11,1
non-small cell lung carcinoma,NIMOTUZUMAB,2,Recruiting,EGFR,1
non-small cell lung carcinoma,NIMOTUZUMAB,2,Completed,EGFR,1
non-small cell lung carcinoma,NIMOTUZUMAB,1,Withdrawn,EGFR,1
non-small cell lung carcinoma,NIMOTUZUMAB,1,Unknown status,EGFR,1
non-small cell lung carcinoma,NIMOTUZUMAB,1,Terminated,EGFR,1
non-small cell lung carcinoma,NIMOTUZUMAB,1,Recruiting,EGFR,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFB2,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFB3,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFB4,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFB5,1
non-small cell lung carcinoma,NECITUMUMAB,4,n/a,EGFR,1
non-small cell lung carcinoma,NECITUMUMAB,3,Suspended,EGFR,1
non-small cell lung carcinoma,NECITUMUMAB,3,"Active, not recruiting",EGFR,1
non-small cell lung carcinoma,NECITUMUMAB,2,Withdrawn,EGFR,1
non-small cell lung carcinoma,NECITUMUMAB,2,Terminated,EGFR,1
non-small cell lung carcinoma,ETOPOSIDE,2,Unknown status,TOP2A,1
non-small cell lung carcinoma,NECITUMUMAB,2,"Active, not recruiting",EGFR,1
non-small cell lung carcinoma,ETOPOSIDE,2,Unknown status,TOP2B,1
non-small cell lung carcinoma,ETOPOSIDE,2,Withdrawn,TOP2A,1
non-small cell lung carcinoma,NAVITOCLAX,1,Recruiting,BCL2L2-PABPN1,1
non-small cell lung carcinoma,NAVITOCLAX,1,Recruiting,BCL2L1,1
non-small cell lung carcinoma,NAVITOCLAX,1,Recruiting,BCL2,1
non-small cell lung carcinoma,NAPTUMOMAB ESTAFENATOX,1,Completed,TPBG,1
non-small cell lung carcinoma,ETOPOSIDE,1,Unknown status,TOP2B,1
non-small cell lung carcinoma,ETOPOSIDE,1,Unknown status,TOP2A,1
non-small cell lung carcinoma,ETOPOSIDE,1,Recruiting,TOP2B,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFAF1,1
non-small cell lung carcinoma,NINTEDANIB,1,Terminated,FGFR2,1
non-small cell lung carcinoma,NINTEDANIB,1,Terminated,FGFR1,1
non-small cell lung carcinoma,ERIBULIN,3,Completed,TUBB2B,1
non-small cell lung carcinoma,ERIBULIN,3,Completed,TUBB3,1
non-small cell lung carcinoma,ERIBULIN,3,Completed,TUBB4A,1
non-small cell lung carcinoma,ERIBULIN,3,Completed,TUBB4B,1
non-small cell lung carcinoma,ERIBULIN,3,Completed,TUBB6,1
non-small cell lung carcinoma,ERIBULIN,3,Completed,TUBB8,1
non-small cell lung carcinoma,ERLOTINIB,0,Recruiting,EGFR,1
non-small cell lung carcinoma,ERLOTINIB,0,Withdrawn,EGFR,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFAB1,1
non-small cell lung carcinoma,ERLOTINIB,2,Enrolling by invitation,EGFR,1
non-small cell lung carcinoma,ETOPOSIDE,1,Recruiting,TOP2A,1
non-small cell lung carcinoma,ERLOTINIB,2,Not yet recruiting,EGFR,1
non-small cell lung carcinoma,ERLOTINIB,2,Suspended,EGFR,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFAF2,1
non-small cell lung carcinoma,ERLOTINIB,3,Suspended,EGFR,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFAF3,1
non-small cell lung carcinoma,ERLOTINIB,4,Recruiting,EGFR,1
non-small cell lung carcinoma,ERLOTINIB,4,Suspended,EGFR,1
non-small cell lung carcinoma,ERLOTINIB,4,Unknown status,EGFR,1
non-small cell lung carcinoma,ETIRINOTECAN PEGOL,2,Completed,TOP1,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFAF4,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFB1,1
non-small cell lung carcinoma,NALOXEGOL,2,Recruiting,OPRM1,1
non-small cell lung carcinoma,MUPARFOSTAT,2,Completed,HPSE,1
non-small cell lung carcinoma,MIDAZOLAM,1,Not yet recruiting,GABRA3,1
non-small cell lung carcinoma,MUPARFOSTAT,2,Completed,FGF2,1
non-small cell lung carcinoma,MOGAMULIZUMAB,1,Completed,CCR4,1
non-small cell lung carcinoma,MODAFINIL,4,Completed,SLC6A3,1
non-small cell lung carcinoma,MODAFINIL,2,Withdrawn,SLC6A3,1
non-small cell lung carcinoma,MOCETINOSTAT,2,Recruiting,HDAC8,1
non-small cell lung carcinoma,MOCETINOSTAT,2,Recruiting,HDAC3,1
non-small cell lung carcinoma,MOCETINOSTAT,2,Recruiting,HDAC2,1
non-small cell lung carcinoma,MOCETINOSTAT,2,Recruiting,HDAC11,1
non-small cell lung carcinoma,MOCETINOSTAT,2,Recruiting,HDAC1,1
non-small cell lung carcinoma,MM-121,1,Completed,ERBB3,1
non-small cell lung carcinoma,MK-2206,2,Completed,AKT3,1
non-small cell lung carcinoma,MK-2206,2,Completed,AKT2,1
non-small cell lung carcinoma,MK-2206,2,Completed,AKT1,1
non-small cell lung carcinoma,MIFEPRISTONE,2,Recruiting,PGR,1
non-small cell lung carcinoma,MIFEPRISTONE,2,Recruiting,NR3C1,1
non-small cell lung carcinoma,MIDAZOLAM,1,Recruiting,GABRG3,1
non-small cell lung carcinoma,MIDAZOLAM,1,Recruiting,GABRG2,1
non-small cell lung carcinoma,MIDAZOLAM,1,Recruiting,GABRG1,1
non-small cell lung carcinoma,MIDAZOLAM,1,Recruiting,GABRA5,1
non-small cell lung carcinoma,MIDAZOLAM,1,Recruiting,GABRA3,1
non-small cell lung carcinoma,MIDAZOLAM,1,Recruiting,GABRA2,1
non-small cell lung carcinoma,MIDAZOLAM,1,Recruiting,GABRA1,1
non-small cell lung carcinoma,MIDAZOLAM,1,Not yet recruiting,GABRG3,1
non-small cell lung carcinoma,MIDAZOLAM,1,Not yet recruiting,GABRG2,1
non-small cell lung carcinoma,MIDAZOLAM,1,Not yet recruiting,GABRG1,1
non-small cell lung carcinoma,MIDAZOLAM,1,Not yet recruiting,GABRA5,1
non-small cell lung carcinoma,EVEROLIMUS,2,Completed,FKBP1A,1
non-small cell lung carcinoma,EVEROLIMUS,1,Unknown status,FKBP1A,1
non-small cell lung carcinoma,MOTESANIB,1,Completed,FLT1,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFB8,1
non-small cell lung carcinoma,MUPARFOSTAT,2,Completed,FGF1,1
non-small cell lung carcinoma,MOTEXAFIN GADOLINIUM,1,Completed,TXNRD1,1
non-small cell lung carcinoma,MOTEXAFIN GADOLINIUM,1,Completed,RRM2B,1
non-small cell lung carcinoma,MOTEXAFIN GADOLINIUM,1,Completed,RRM2,1
non-small cell lung carcinoma,MOTEXAFIN GADOLINIUM,1,Completed,RRM1,1
non-small cell lung carcinoma,ETOPOSIDE,2,Withdrawn,TOP2B,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFB6,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFB7,1
non-small cell lung carcinoma,ETOPOSIDE,3,Terminated,TOP2A,1
non-small cell lung carcinoma,ETOPOSIDE,3,Terminated,TOP2B,1
non-small cell lung carcinoma,EVEROLIMUS,1,"Active, not recruiting",FKBP1A,1
non-small cell lung carcinoma,MOTESANIB,2,Terminated,RET,1
non-small cell lung carcinoma,MOTESANIB,1,Completed,FLT4,1
non-small cell lung carcinoma,MOTESANIB,2,Terminated,PDGFRB,1
non-small cell lung carcinoma,MOTESANIB,2,Terminated,PDGFRA,1
non-small cell lung carcinoma,MOTESANIB,2,Terminated,KIT,1
non-small cell lung carcinoma,MOTESANIB,2,Terminated,KDR,1
non-small cell lung carcinoma,MOTESANIB,2,Terminated,FLT4,1
non-small cell lung carcinoma,MOTESANIB,2,Terminated,FLT1,1
non-small cell lung carcinoma,MOTESANIB,1,Completed,RET,1
non-small cell lung carcinoma,MOTESANIB,1,Completed,PDGFRB,1
non-small cell lung carcinoma,MOTESANIB,1,Completed,PDGFRA,1
non-small cell lung carcinoma,MOTESANIB,1,Completed,KIT,1
non-small cell lung carcinoma,MOTESANIB,1,Completed,KDR,1
non-small cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLD4,1
non-small cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLE,1
non-small cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLE2,1
non-small cell lung carcinoma,LY-3023414,1,"Active, not recruiting",PIK3R1,1
non-small cell lung carcinoma,CRIZOTINIB,4,Recruiting,MET,1
non-small cell lung carcinoma,CRIZOTINIB,4,n/a,ALK,1
non-small cell lung carcinoma,CRIZOTINIB,4,n/a,MET,1
non-small cell lung carcinoma,CUDC-101,1,Completed,EGFR,1
non-small cell lung carcinoma,CUDC-101,1,Completed,ERBB2,1
non-small cell lung carcinoma,CUDC-101,1,Completed,HDAC1,1
non-small cell lung carcinoma,CUDC-101,1,Completed,HDAC10,1
non-small cell lung carcinoma,CUDC-101,1,Completed,HDAC11,1
non-small cell lung carcinoma,CUDC-101,1,Completed,HDAC2,1
non-small cell lung carcinoma,CUDC-101,1,Completed,HDAC3,1
non-small cell lung carcinoma,CUDC-101,1,Completed,HDAC4,1
non-small cell lung carcinoma,CUDC-101,1,Completed,HDAC5,1
non-small cell lung carcinoma,CUDC-101,1,Completed,HDAC6,1
non-small cell lung carcinoma,CUDC-101,1,Completed,HDAC7,1
non-small cell lung carcinoma,CUDC-101,1,Completed,HDAC8,1
non-small cell lung carcinoma,CUDC-101,1,Completed,HDAC9,1
non-small cell lung carcinoma,DABRAFENIB,2,Withdrawn,BRAF,1
non-small cell lung carcinoma,PEMETREXED,2,Suspended,TYMS,1
non-small cell lung carcinoma,PEMETREXED,2,Suspended,GART,1
non-small cell lung carcinoma,PEMETREXED,2,Suspended,DHFR,1
non-small cell lung carcinoma,LY-3023414,1,"Active, not recruiting",MTOR,1
non-small cell lung carcinoma,LY-3023414,1,"Active, not recruiting",PIK3CA,1
non-small cell lung carcinoma,LY-3023414,1,"Active, not recruiting",PIK3CB,1
non-small cell lung carcinoma,DACOMITINIB,1,Recruiting,ERBB3,1
non-small cell lung carcinoma,LY-3023414,1,"Active, not recruiting",PIK3CD,1
non-small cell lung carcinoma,CRIZOTINIB,4,Recruiting,ALK,1
non-small cell lung carcinoma,LY-3009120,1,Terminated,RAF1,1
non-small cell lung carcinoma,HYDROXYCHLOROQUINE,2,Completed,TLR7,1
non-small cell lung carcinoma,CRIZOTINIB,1,Terminated,MET,1
non-small cell lung carcinoma,PEMETREXED,4,Unknown status,TYMS,1
non-small cell lung carcinoma,PEMETREXED,4,Unknown status,GART,1
non-small cell lung carcinoma,PEMETREXED,4,Unknown status,DHFR,1
non-small cell lung carcinoma,CRIZOTINIB,0,Withdrawn,ALK,1
non-small cell lung carcinoma,CRIZOTINIB,0,Withdrawn,MET,1
non-small cell lung carcinoma,CRIZOTINIB,1,"Active, not recruiting",ALK,1
non-small cell lung carcinoma,PEMETREXED,4,Not yet recruiting,TYMS,1
non-small cell lung carcinoma,PEMETREXED,4,Not yet recruiting,GART,1
non-small cell lung carcinoma,PEMETREXED,4,Not yet recruiting,DHFR,1
non-small cell lung carcinoma,CRIZOTINIB,1,"Active, not recruiting",MET,1
non-small cell lung carcinoma,CRIZOTINIB,1,Terminated,ALK,1
non-small cell lung carcinoma,CRIZOTINIB,2,Completed,ALK,1
non-small cell lung carcinoma,CRIZOTINIB,3,Completed,MET,1
non-small cell lung carcinoma,CRIZOTINIB,2,Completed,MET,1
non-small cell lung carcinoma,LUMRETUZUMAB,1,Terminated,ERBB3,1
non-small cell lung carcinoma,LY-2584702,1,Terminated,RPS6KB1,1
non-small cell lung carcinoma,LY-3009120,1,Terminated,ARAF,1
non-small cell lung carcinoma,LY-3009120,1,Terminated,BRAF,1
non-small cell lung carcinoma,CRIZOTINIB,2,Withdrawn,ALK,1
non-small cell lung carcinoma,CRIZOTINIB,2,Withdrawn,MET,1
non-small cell lung carcinoma,CRIZOTINIB,3,Completed,ALK,1
non-small cell lung carcinoma,PEMETREXED,3,Suspended,TYMS,1
non-small cell lung carcinoma,PEMETREXED,3,Suspended,GART,1
non-small cell lung carcinoma,PEMETREXED,3,Suspended,DHFR,1
non-small cell lung carcinoma,LY-3023414,1,"Active, not recruiting",PIK3CG,1
non-small cell lung carcinoma,DACOMITINIB,1,Suspended,ERBB3,1
non-small cell lung carcinoma,PEMETREXED,4,n/a,GART,1
non-small cell lung carcinoma,LY-3023414,1,"Active, not recruiting",PIK3R2,1
non-small cell lung carcinoma,PEMETREXED,0,Unknown status,GART,1
non-small cell lung carcinoma,PEMETREXED,0,Unknown status,DHFR,1
non-small cell lung carcinoma,PEMETREXED,0,Recruiting,TYMS,1
non-small cell lung carcinoma,PEMETREXED,0,Recruiting,GART,1
non-small cell lung carcinoma,PEMETREXED,0,Recruiting,DHFR,1
non-small cell lung carcinoma,PEMBROLIZUMAB,4,Not yet recruiting,PDCD1,1
non-small cell lung carcinoma,LY-3023414,2,Terminated,PIK3CD,1
non-small cell lung carcinoma,LY-3023414,2,Terminated,PIK3CG,1
non-small cell lung carcinoma,LY-3023414,2,Terminated,PIK3R1,1
non-small cell lung carcinoma,PEMBROLIZUMAB,2,Unknown status,PDCD1,1
non-small cell lung carcinoma,LY-3023414,2,Terminated,PIK3R2,1
non-small cell lung carcinoma,LY-3023414,2,Terminated,PIK3R3,1
non-small cell lung carcinoma,LY-3023414,2,Terminated,PIK3R5,1
non-small cell lung carcinoma,PEMBROLIZUMAB,1,Withdrawn,PDCD1,1
non-small cell lung carcinoma,MATUZUMAB,2,Completed,EGFR,1
non-small cell lung carcinoma,MERESTINIB,2,Recruiting,MET,1
non-small cell lung carcinoma,PEMBROLIZUMAB,1,Completed,PDCD1,1
non-small cell lung carcinoma,PELITINIB,2,Completed,EGFR,1
non-small cell lung carcinoma,PEGFILGRASTIM,4,Completed,CSF3R,1
non-small cell lung carcinoma,PD-0325901,2,Terminated,MAP2K2,1
non-small cell lung carcinoma,PD-0325901,2,Terminated,MAP2K1,1
non-small cell lung carcinoma,PD-0325901,1,"Active, not recruiting",MAP2K2,1
non-small cell lung carcinoma,PD-0325901,1,"Active, not recruiting",MAP2K1,1
non-small cell lung carcinoma,PBF-509,1,Recruiting,ADORA2A,1
non-small cell lung carcinoma,PAZOPANIB,2,Withdrawn,PDGFRB,1
non-small cell lung carcinoma,PEMETREXED,0,Unknown status,TYMS,1
non-small cell lung carcinoma,LY-3023414,2,Terminated,PIK3CB,1
non-small cell lung carcinoma,LY-3023414,2,Terminated,PIK3CA,1
non-small cell lung carcinoma,LY-3023414,1,Recruiting,PIK3CG,1
non-small cell lung carcinoma,LY-3023414,1,"Active, not recruiting",PIK3R3,1
non-small cell lung carcinoma,LY-3023414,1,"Active, not recruiting",PIK3R5,1
non-small cell lung carcinoma,DACOMITINIB,1,Terminated,ERBB3,1
non-small cell lung carcinoma,PEMETREXED,1,Withdrawn,TYMS,1
non-small cell lung carcinoma,PEMETREXED,1,Withdrawn,GART,1
non-small cell lung carcinoma,PEMETREXED,1,Withdrawn,DHFR,1
non-small cell lung carcinoma,LY-3023414,1,Recruiting,MTOR,1
non-small cell lung carcinoma,LY-3023414,1,Recruiting,PIK3CA,1
non-small cell lung carcinoma,LY-3023414,1,Recruiting,PIK3CB,1
non-small cell lung carcinoma,DACOMITINIB,2,"Active, not recruiting",ERBB3,1
non-small cell lung carcinoma,LY-3023414,1,Recruiting,PIK3CD,1
non-small cell lung carcinoma,PEMETREXED,1,Suspended,TYMS,1
non-small cell lung carcinoma,DARATUMUMAB,1,"Active, not recruiting",CD38,1
non-small cell lung carcinoma,PEMETREXED,1,Suspended,GART,1
non-small cell lung carcinoma,PEMETREXED,1,Suspended,DHFR,1
non-small cell lung carcinoma,LY-3023414,1,Recruiting,PIK3R1,1
non-small cell lung carcinoma,DACOMITINIB,3,"Active, not recruiting",ERBB3,1
non-small cell lung carcinoma,LY-3023414,1,Recruiting,PIK3R2,1
non-small cell lung carcinoma,LY-3023414,1,Recruiting,PIK3R3,1
non-small cell lung carcinoma,LY-3023414,1,Recruiting,PIK3R5,1
non-small cell lung carcinoma,DACOMITINIB,3,Completed,ERBB3,1
non-small cell lung carcinoma,LY-3023414,2,Terminated,MTOR,1
non-small cell lung carcinoma,DALOTUZUMAB,1,Completed,IGF1R,1
non-small cell lung carcinoma,DALOTUZUMAB,2,Completed,IGF1R,1
non-small cell lung carcinoma,PEMETREXED,4,n/a,DHFR,1
non-small cell lung carcinoma,PEMETREXED,4,n/a,TYMS,1
non-small cell lung carcinoma,PAZOPANIB,2,Withdrawn,LCK,1
non-small cell lung carcinoma,PIOGLITAZONE,2,Recruiting,PPARG,1
non-small cell lung carcinoma,PLINABULIN,1,Terminated,TUBB2B,1
non-small cell lung carcinoma,PLINABULIN,1,Terminated,TUBB2A,1
non-small cell lung carcinoma,PLINABULIN,1,Terminated,TUBB1,1
non-small cell lung carcinoma,PLINABULIN,1,Terminated,TUBB,1
non-small cell lung carcinoma,PLINABULIN,1,Terminated,TUBA4A,1
non-small cell lung carcinoma,PLINABULIN,1,Terminated,TUBA3E,1
non-small cell lung carcinoma,PLINABULIN,1,Terminated,TUBA3C,1
non-small cell lung carcinoma,PLINABULIN,1,Terminated,TUBA1C,1
non-small cell lung carcinoma,PLINABULIN,1,Terminated,TUBA1B,1
non-small cell lung carcinoma,PLINABULIN,1,Terminated,TUBA1A,1
non-small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBB8,1
non-small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBB6,1
non-small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBB4B,1
non-small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBB4A,1
non-small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBB3,1
non-small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBB2B,1
non-small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBB2A,1
non-small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBB1,1
non-small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBB,1
non-small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBA4A,1
non-small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBA3E,1
non-small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBA3C,1
non-small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBA1C,1
non-small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBA1B,1
non-small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBA1A,1
non-small cell lung carcinoma,PLINABULIN,1,Terminated,TUBB3,1
non-small cell lung carcinoma,PLINABULIN,1,Terminated,TUBB4A,1
non-small cell lung carcinoma,PLINABULIN,1,Terminated,TUBB4B,1
non-small cell lung carcinoma,METFORMIN,2,Completed,NDUFV3,1
non-small cell lung carcinoma,CILENGITIDE,2,Completed,ITGB3,1
non-small cell lung carcinoma,CILENGITIDE,2,Completed,ITGB5,1
non-small cell lung carcinoma,CIXUTUMUMAB,1,Completed,IGF1R,1
non-small cell lung carcinoma,CIXUTUMUMAB,2,Terminated,IGF1R,1
non-small cell lung carcinoma,CM-082,2,Not yet recruiting,FLT3,1
non-small cell lung carcinoma,CM-082,2,Not yet recruiting,KDR,1
non-small cell lung carcinoma,CM-082,2,Not yet recruiting,KIT,1
non-small cell lung carcinoma,PLX-8394,1,Terminated,BRAF,1
non-small cell lung carcinoma,PLINABULIN,3,Recruiting,TUBB8,1
non-small cell lung carcinoma,PLINABULIN,3,Recruiting,TUBB6,1
non-small cell lung carcinoma,PLINABULIN,3,Recruiting,TUBB4B,1
non-small cell lung carcinoma,PLINABULIN,3,Recruiting,TUBB3,1
non-small cell lung carcinoma,PLINABULIN,1,Terminated,TUBB6,1
non-small cell lung carcinoma,PLINABULIN,3,Recruiting,TUBB2B,1
non-small cell lung carcinoma,PLINABULIN,3,Recruiting,TUBB2A,1
non-small cell lung carcinoma,PLINABULIN,3,Recruiting,TUBB1,1
non-small cell lung carcinoma,PLINABULIN,3,Recruiting,TUBB,1
non-small cell lung carcinoma,PLINABULIN,3,Recruiting,TUBA4A,1
non-small cell lung carcinoma,PLINABULIN,3,Recruiting,TUBA3E,1
non-small cell lung carcinoma,PLINABULIN,3,Recruiting,TUBA3C,1
non-small cell lung carcinoma,PLINABULIN,3,Recruiting,TUBA1C,1
non-small cell lung carcinoma,PLINABULIN,3,Recruiting,TUBA1B,1
non-small cell lung carcinoma,PLINABULIN,3,Recruiting,TUBA1A,1
non-small cell lung carcinoma,PLINABULIN,1,Terminated,TUBB8,1
non-small cell lung carcinoma,CM-082,2,Not yet recruiting,PDGFRB,1
non-small cell lung carcinoma,PIMASERTIB,1,Completed,MAP2K2,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,ADORA2A,1
non-small cell lung carcinoma,PIMASERTIB,1,Completed,MAP2K1,1
non-small cell lung carcinoma,PERTUZUMAB,1,Completed,ERBB2,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE9A,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE8B,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE8A,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE7B,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE7A,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE6H,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE6G,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE6D,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE6C,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE6B,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE6A,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE5A,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE4D,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE4C,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE4B,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE4A,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE3B,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE3A,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE2A,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE1C,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE1B,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE1A,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,PDE10A,1
non-small cell lung carcinoma,PENTOXIFYLLINE,2,Recruiting,ADORA2B,1
non-small cell lung carcinoma,CONATUMUMAB,1,Completed,TNFRSF10B,1
non-small cell lung carcinoma,PERTUZUMAB,2,Not yet recruiting,ERBB2,1
non-small cell lung carcinoma,PEVONEDISTAT,2,Recruiting,NAE1,1
non-small cell lung carcinoma,PICTILISIB,2,Completed,PIK3R1,1
non-small cell lung carcinoma,PILARALISIB,1,Completed,PIK3R5,1
non-small cell lung carcinoma,PILARALISIB,1,Completed,PIK3R3,1
non-small cell lung carcinoma,PILARALISIB,1,Completed,PIK3R2,1
non-small cell lung carcinoma,PILARALISIB,1,Completed,PIK3R1,1
non-small cell lung carcinoma,PILARALISIB,1,Completed,PIK3CG,1
non-small cell lung carcinoma,PILARALISIB,1,Completed,PIK3CD,1
non-small cell lung carcinoma,PILARALISIB,1,Completed,PIK3CB,1
non-small cell lung carcinoma,PILARALISIB,1,Completed,PIK3CA,1
non-small cell lung carcinoma,PICTILISIB,2,Completed,PIK3R5,1
non-small cell lung carcinoma,PICTILISIB,2,Completed,PIK3R3,1
non-small cell lung carcinoma,PICTILISIB,2,Completed,PIK3R2,1
non-small cell lung carcinoma,PICTILISIB,2,Completed,PIK3CG,1
non-small cell lung carcinoma,PEVONEDISTAT,2,Recruiting,UBA3,1
non-small cell lung carcinoma,PICTILISIB,2,Completed,PIK3CD,1
non-small cell lung carcinoma,PICTILISIB,2,Completed,PIK3CB,1
non-small cell lung carcinoma,PICTILISIB,2,Completed,PIK3CA,1
non-small cell lung carcinoma,COBICISTAT,0,Not yet recruiting,CYP3A4,1
non-small cell lung carcinoma,COBICISTAT,0,Not yet recruiting,CYP3A43,1
non-small cell lung carcinoma,COBICISTAT,0,Not yet recruiting,CYP3A5,1
non-small cell lung carcinoma,COBICISTAT,0,Not yet recruiting,CYP3A7,1
non-small cell lung carcinoma,LUCITANIB,2,Terminated,FLT4,1
non-small cell lung carcinoma,LUCITANIB,2,Terminated,KDR,1
non-small cell lung carcinoma,COBIMETINIB,2,Recruiting,MAP2K1,1
non-small cell lung carcinoma,COBIMETINIB,2,Recruiting,MAP2K2,1
non-small cell lung carcinoma,PAZOPANIB,2,Withdrawn,PDGFRA,1
non-small cell lung carcinoma,PAZOPANIB,2,Withdrawn,KIT,1
non-small cell lung carcinoma,DOCETAXEL,4,Terminated,TUBB8,1
non-small cell lung carcinoma,DOCETAXEL,0,Unknown status,TUBB2B,1
non-small cell lung carcinoma,PACLITAXEL,4,Completed,TUBB4B,1
non-small cell lung carcinoma,PACLITAXEL,4,Completed,TUBB4A,1
non-small cell lung carcinoma,PACLITAXEL,4,Completed,TUBB3,1
non-small cell lung carcinoma,PACLITAXEL,4,Completed,TUBB2B,1
non-small cell lung carcinoma,PACLITAXEL,4,Completed,TUBB2A,1
non-small cell lung carcinoma,PACLITAXEL,4,Completed,TUBB1,1
non-small cell lung carcinoma,PACLITAXEL,4,Completed,TUBB,1
non-small cell lung carcinoma,DECITABINE,2,"Active, not recruiting",DNMT3A,1
non-small cell lung carcinoma,DEFACTINIB,2,Completed,PTK2,1
non-small cell lung carcinoma,DEFACTINIB,2,Completed,PTK2B,1
non-small cell lung carcinoma,DEMCIZUMAB,1,Completed,DLL4,1
non-small cell lung carcinoma,DEMCIZUMAB,2,Completed,DLL4,1
non-small cell lung carcinoma,DENOSUMAB,2,Completed,TNFSF11,1
non-small cell lung carcinoma,DESLORATADINE,2,Recruiting,HRH1,1
non-small cell lung carcinoma,DEXAMETHASONE,1,Completed,NR3C1,1
non-small cell lung carcinoma,DEXAMETHASONE,3,"Active, not recruiting",NR3C1,1
non-small cell lung carcinoma,GEMCITABINE,3,Not yet recruiting,POLD1,1
non-small cell lung carcinoma,DEXAMETHASONE,4,Terminated,NR3C1,1
non-small cell lung carcinoma,DIGOXIN,2,Terminated,ATP1A1,1
non-small cell lung carcinoma,DIGOXIN,2,Terminated,ATP1A2,1
non-small cell lung carcinoma,DIGOXIN,2,Terminated,ATP1A3,1
non-small cell lung carcinoma,DIGOXIN,2,Terminated,ATP1A4,1
non-small cell lung carcinoma,DISULFIRAM,2,Completed,ALDH2,1
non-small cell lung carcinoma,DOCETAXEL,0,Unknown status,TUBB,1
non-small cell lung carcinoma,DOCETAXEL,0,Unknown status,TUBB1,1
non-small cell lung carcinoma,PACLITAXEL,4,Completed,TUBB6,1
non-small cell lung carcinoma,PACLITAXEL,4,Completed,TUBB8,1
non-small cell lung carcinoma,PACLITAXEL,4,Unknown status,TUBB,1
non-small cell lung carcinoma,DASATINIB,2,Completed,YES1,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBB1,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBB,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBA4A,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBA3E,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBA3C,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBA1C,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBA1B,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBA1A,1
non-small cell lung carcinoma,DASATINIB,2,Completed,PDGFRB,1
non-small cell lung carcinoma,DASATINIB,2,Completed,SRC,1
non-small cell lung carcinoma,DASATINIB,2,Completed,SRMS,1
non-small cell lung carcinoma,GEMCITABINE,3,Not yet recruiting,POLD3,1
non-small cell lung carcinoma,PACLITAXEL,4,Unknown status,TUBB1,1
non-small cell lung carcinoma,GEMCITABINE,3,Not yet recruiting,POLD2,1
non-small cell lung carcinoma,DECITABINE,1,Recruiting,DNMT1,1
non-small cell lung carcinoma,DECITABINE,1,Recruiting,DNMT3A,1
non-small cell lung carcinoma,DECITABINE,2,"Active, not recruiting",DNMT1,1
non-small cell lung carcinoma,PACLITAXEL,4,Unknown status,TUBB8,1
non-small cell lung carcinoma,PACLITAXEL,4,Unknown status,TUBB6,1
non-small cell lung carcinoma,PACLITAXEL,4,Unknown status,TUBB4B,1
non-small cell lung carcinoma,PACLITAXEL,4,Unknown status,TUBB4A,1
non-small cell lung carcinoma,PACLITAXEL,4,Unknown status,TUBB3,1
non-small cell lung carcinoma,PACLITAXEL,4,Unknown status,TUBB2B,1
non-small cell lung carcinoma,PACLITAXEL,4,Unknown status,TUBB2A,1
non-small cell lung carcinoma,DOCETAXEL,0,Unknown status,TUBB2A,1
non-small cell lung carcinoma,DOCETAXEL,0,Unknown status,TUBB3,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBB2B,1
non-small cell lung carcinoma,DOCETAXEL,0,Unknown status,TUBB4A,1
non-small cell lung carcinoma,DOCETAXEL,3,Suspended,TUBB4A,1
non-small cell lung carcinoma,DOCETAXEL,3,Suspended,TUBB4B,1
non-small cell lung carcinoma,DOCETAXEL,3,Suspended,TUBB6,1
non-small cell lung carcinoma,DOCETAXEL,3,Suspended,TUBB8,1
non-small cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",RRM1,1
non-small cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",PRIM2,1
non-small cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",PRIM1,1
non-small cell lung carcinoma,GEMCITABINE,2,"Active, not recruiting",POLE3,1
non-small cell lung carcinoma,DOCETAXEL,4,Not yet recruiting,TUBB,1
non-small cell lung carcinoma,DOCETAXEL,4,Not yet recruiting,TUBB1,1
non-small cell lung carcinoma,DOCETAXEL,4,Not yet recruiting,TUBB2A,1
non-small cell lung carcinoma,DOCETAXEL,4,Not yet recruiting,TUBB2B,1
non-small cell lung carcinoma,DOCETAXEL,4,Not yet recruiting,TUBB3,1
non-small cell lung carcinoma,DOCETAXEL,4,Not yet recruiting,TUBB4A,1
non-small cell lung carcinoma,DOCETAXEL,4,Not yet recruiting,TUBB4B,1
non-small cell lung carcinoma,DOCETAXEL,4,Not yet recruiting,TUBB6,1
non-small cell lung carcinoma,DOCETAXEL,4,Not yet recruiting,TUBB8,1
non-small cell lung carcinoma,DOCETAXEL,4,Terminated,TUBB,1
non-small cell lung carcinoma,DOCETAXEL,4,Terminated,TUBB1,1
non-small cell lung carcinoma,DOCETAXEL,4,Terminated,TUBB2A,1
non-small cell lung carcinoma,DOCETAXEL,4,Terminated,TUBB2B,1
non-small cell lung carcinoma,DOCETAXEL,4,Terminated,TUBB3,1
non-small cell lung carcinoma,DOCETAXEL,4,Terminated,TUBB4A,1
non-small cell lung carcinoma,DOCETAXEL,4,Terminated,TUBB4B,1
non-small cell lung carcinoma,DOCETAXEL,4,Terminated,TUBB6,1
non-small cell lung carcinoma,DOCETAXEL,3,Suspended,TUBB3,1
non-small cell lung carcinoma,DOCETAXEL,3,Suspended,TUBB2B,1
non-small cell lung carcinoma,DOCETAXEL,3,Suspended,TUBB2A,1
non-small cell lung carcinoma,DOCETAXEL,2,Enrolling by invitation,TUBB4B,1
non-small cell lung carcinoma,DOCETAXEL,0,Unknown status,TUBB4B,1
non-small cell lung carcinoma,DOCETAXEL,0,Unknown status,TUBB6,1
non-small cell lung carcinoma,DOCETAXEL,0,Unknown status,TUBB8,1
non-small cell lung carcinoma,GEMCITABINE,3,Not yet recruiting,POLA2,1
non-small cell lung carcinoma,GEMCITABINE,3,Not yet recruiting,POLA1,1
non-small cell lung carcinoma,DOCETAXEL,2,Enrolling by invitation,TUBB,1
non-small cell lung carcinoma,DOCETAXEL,2,Enrolling by invitation,TUBB1,1
non-small cell lung carcinoma,DOCETAXEL,2,Enrolling by invitation,TUBB2A,1
non-small cell lung carcinoma,DOCETAXEL,2,Enrolling by invitation,TUBB2B,1
non-small cell lung carcinoma,DOCETAXEL,2,Enrolling by invitation,TUBB3,1
non-small cell lung carcinoma,DOCETAXEL,2,Enrolling by invitation,TUBB4A,1
non-small cell lung carcinoma,DOCETAXEL,2,Enrolling by invitation,TUBB6,1
non-small cell lung carcinoma,DOCETAXEL,3,Suspended,TUBB1,1
non-small cell lung carcinoma,DOCETAXEL,2,Enrolling by invitation,TUBB8,1
non-small cell lung carcinoma,DOCETAXEL,2,Suspended,TUBB,1
non-small cell lung carcinoma,DOCETAXEL,2,Suspended,TUBB1,1
non-small cell lung carcinoma,DOCETAXEL,2,Suspended,TUBB2A,1
non-small cell lung carcinoma,DOCETAXEL,2,Suspended,TUBB2B,1
non-small cell lung carcinoma,DOCETAXEL,2,Suspended,TUBB3,1
non-small cell lung carcinoma,DOCETAXEL,2,Suspended,TUBB4A,1
non-small cell lung carcinoma,DOCETAXEL,2,Suspended,TUBB4B,1
non-small cell lung carcinoma,DOCETAXEL,2,Suspended,TUBB6,1
non-small cell lung carcinoma,DOCETAXEL,2,Suspended,TUBB8,1
non-small cell lung carcinoma,DOCETAXEL,3,Suspended,TUBB,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBB2A,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBB3,1
non-small cell lung carcinoma,PAZOPANIB,2,Withdrawn,KDR,1
non-small cell lung carcinoma,PANOBINOSTAT,1,Completed,HDAC11,1
non-small cell lung carcinoma,DASATINIB,2,Completed,BLK,1
non-small cell lung carcinoma,DASATINIB,2,Completed,EPHA2,1
non-small cell lung carcinoma,DASATINIB,2,Completed,FGR,1
non-small cell lung carcinoma,DASATINIB,2,Completed,FRK,1
non-small cell lung carcinoma,DASATINIB,2,Completed,FYN,1
non-small cell lung carcinoma,PAZOPANIB,1,"Active, not recruiting",PDGFRB,1
non-small cell lung carcinoma,PAZOPANIB,1,"Active, not recruiting",PDGFRA,1
non-small cell lung carcinoma,PAZOPANIB,1,"Active, not recruiting",LCK,1
non-small cell lung carcinoma,PAZOPANIB,1,"Active, not recruiting",KIT,1
non-small cell lung carcinoma,PAZOPANIB,1,"Active, not recruiting",KDR,1
non-small cell lung carcinoma,PAZOPANIB,1,"Active, not recruiting",ITK,1
non-small cell lung carcinoma,PAZOPANIB,1,"Active, not recruiting",FLT4,1
non-small cell lung carcinoma,PAZOPANIB,1,"Active, not recruiting",FLT1,1
non-small cell lung carcinoma,PAZOPANIB,1,"Active, not recruiting",FGFR3,1
non-small cell lung carcinoma,PAZOPANIB,1,"Active, not recruiting",FGFR1,1
non-small cell lung carcinoma,PAZOPANIB,1,"Active, not recruiting",CSF1R,1
non-small cell lung carcinoma,PATRITUMAB,3,Terminated,ERBB3,1
non-small cell lung carcinoma,PARSATUZUMAB,2,Completed,EGFL7,1
non-small cell lung carcinoma,PANOBINOSTAT,1,Completed,HDAC9,1
non-small cell lung carcinoma,PANOBINOSTAT,1,Completed,HDAC8,1
non-small cell lung carcinoma,PANOBINOSTAT,1,Completed,HDAC7,1
non-small cell lung carcinoma,PANOBINOSTAT,1,Completed,HDAC6,1
non-small cell lung carcinoma,PANOBINOSTAT,1,Completed,HDAC5,1
non-small cell lung carcinoma,PANOBINOSTAT,1,Completed,HDAC4,1
non-small cell lung carcinoma,PANOBINOSTAT,1,Completed,HDAC3,1
non-small cell lung carcinoma,DASATINIB,2,Completed,ABL1,1
non-small cell lung carcinoma,DASATINIB,1,Terminated,YES1,1
non-small cell lung carcinoma,DASATINIB,1,Terminated,SRMS,1
non-small cell lung carcinoma,GEMCITABINE,3,Not yet recruiting,POLE,1
non-small cell lung carcinoma,PAZOPANIB,2,Withdrawn,ITK,1
non-small cell lung carcinoma,PAZOPANIB,2,Withdrawn,FLT4,1
non-small cell lung carcinoma,PAZOPANIB,2,Withdrawn,FLT1,1
non-small cell lung carcinoma,PAZOPANIB,2,Withdrawn,FGFR3,1
non-small cell lung carcinoma,PAZOPANIB,2,Withdrawn,FGFR1,1
non-small cell lung carcinoma,PAZOPANIB,2,Withdrawn,CSF1R,1
non-small cell lung carcinoma,GEMCITABINE,3,Not yet recruiting,RRM1,1
non-small cell lung carcinoma,GEMCITABINE,3,Not yet recruiting,PRIM2,1
non-small cell lung carcinoma,GEMCITABINE,3,Not yet recruiting,PRIM1,1
non-small cell lung carcinoma,GEMCITABINE,3,Not yet recruiting,POLE3,1
non-small cell lung carcinoma,GEMCITABINE,3,Not yet recruiting,POLE2,1
non-small cell lung carcinoma,GEMCITABINE,3,Not yet recruiting,POLD4,1
non-small cell lung carcinoma,DASATINIB,1,Terminated,SRC,1
non-small cell lung carcinoma,DASATINIB,1,Terminated,ABL1,1
non-small cell lung carcinoma,DASATINIB,1,Terminated,BLK,1
non-small cell lung carcinoma,DASATINIB,1,Terminated,EPHA2,1
non-small cell lung carcinoma,DASATINIB,1,Terminated,FGR,1
non-small cell lung carcinoma,DASATINIB,1,Terminated,FRK,1
non-small cell lung carcinoma,DASATINIB,1,Terminated,FYN,1
non-small cell lung carcinoma,DASATINIB,1,Terminated,HCK,1
non-small cell lung carcinoma,DASATINIB,1,Terminated,KIT,1
non-small cell lung carcinoma,DASATINIB,1,Terminated,LCK,1
non-small cell lung carcinoma,DASATINIB,1,Terminated,LYN,1
non-small cell lung carcinoma,DASATINIB,1,Terminated,PDGFRB,1
non-small cell lung carcinoma,PANOBINOSTAT,1,Completed,HDAC2,1
non-small cell lung carcinoma,PANOBINOSTAT,1,Completed,HDAC10,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBB4A,1
non-small cell lung carcinoma,PANOBINOSTAT,1,Completed,HDAC1,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,3,Terminated,TUBB,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,3,Terminated,TUBA4A,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,3,Terminated,TUBA3E,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,3,Terminated,TUBA3C,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,3,Terminated,TUBA1C,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,3,Terminated,TUBA1B,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,3,Terminated,TUBA1A,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Terminated,TUBB8,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Terminated,TUBB6,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Terminated,TUBB4B,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Terminated,TUBB4A,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Terminated,TUBB3,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Terminated,TUBB2B,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Terminated,TUBB2A,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Terminated,TUBB1,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Terminated,TUBB,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Terminated,TUBA4A,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Terminated,TUBA3E,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Terminated,TUBA3C,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Terminated,TUBA1C,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Terminated,TUBA1B,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Terminated,TUBA1A,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBB8,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBB6,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBB4B,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,3,Terminated,TUBB1,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,3,Terminated,TUBB2A,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,3,Terminated,TUBB2B,1
non-small cell lung carcinoma,DASATINIB,2,Completed,KIT,1
non-small cell lung carcinoma,PANITUMUMAB,2,Terminated,EGFR,1
non-small cell lung carcinoma,PANITUMUMAB,2,Suspended,EGFR,1
non-small cell lung carcinoma,PANITUMUMAB,2,Completed,EGFR,1
non-small cell lung carcinoma,PANITUMUMAB,1,Withdrawn,EGFR,1
non-small cell lung carcinoma,PANITUMUMAB,1,Completed,EGFR,1
non-small cell lung carcinoma,PANITUMUMAB,1,"Active, not recruiting",EGFR,1
non-small cell lung carcinoma,PALBOCICLIB,2,Recruiting,CDK6,1
non-small cell lung carcinoma,PALBOCICLIB,2,Recruiting,CDK4,1
non-small cell lung carcinoma,DASATINIB,2,Completed,HCK,1
non-small cell lung carcinoma,PALBOCICLIB,2,"Active, not recruiting",CDK6,1
non-small cell lung carcinoma,PALBOCICLIB,2,"Active, not recruiting",CDK4,1
non-small cell lung carcinoma,PALBOCICLIB,1,Recruiting,CDK6,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,3,Terminated,TUBB3,1
non-small cell lung carcinoma,PALBOCICLIB,1,Recruiting,CDK4,1
non-small cell lung carcinoma,DASATINIB,2,Completed,LCK,1
non-small cell lung carcinoma,PALBOCICLIB,1,"Active, not recruiting",CDK6,1
non-small cell lung carcinoma,PALBOCICLIB,1,"Active, not recruiting",CDK4,1
non-small cell lung carcinoma,DASATINIB,2,Completed,LYN,1
non-small cell lung carcinoma,PACRITINIB,1,Terminated,JAK2,1
non-small cell lung carcinoma,PACRITINIB,1,Terminated,FLT3,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,3,Terminated,TUBB8,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,3,Terminated,TUBB6,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,3,Terminated,TUBB4B,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,3,Terminated,TUBB4A,1
non-small cell lung carcinoma,HYDROXYCHLOROQUINE,2,"Active, not recruiting",TLR9,1
